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The number of clinical procedures performed in the USA using bone graft substitutes 
was estimated at 1.1 million in 2010 and is projected to reach 1.3 million in 2015. 
This increasing demand for bone graft substitutes is a result of an ever-ageing 
population coupled with recent reports in the clinical literature of concerns regarding 
the safety of allograft and recombinant bone morphogenetic proteins such as rh-
BMP-2 and the supply of autograft, which has led to an increased clinical interest in 
synthetic alternatives to allograft; autograft; and recombinant growth factors.  
 
One such synthetic material is silicate-substituted hydroxyapatite (SiCaP). 
Mechanical testing revealed SiCaP to have similar mechanical behaviour to 
morcellised cancellous bone. In computated spinal and hip models the simulated 
stresses in SiCaP were determined to be low when in situ, indicating a stress-
shielding effect from the implanted metalwork and surrounding bone. We also found 
an inverse relationship between porosity and Young’s Modulus. Our results 
indicated that the strut-porosity of a material substrate should be increased to 
maximise the potential for formation of a precursor to bone-like apatite after 
implantation in osseous defects and further confirmed previous reports that beta-
tricalcium phosphate is less bioactive than hydroxyapatite. We demonstrated a direct 
link between the amount of strut-porosity and the osteoinductivity of SiCaP. We 
learned that adding a resorbable carrier phase did not impair the osteoinductive 
potential of SiCaP, suggesting that osteoinductivity is not necessarily determined in 
the first 24-48 hours post implantation. Most notably from our studies we determined 
that the osteoinductivity of SiCaP correlated with its performance in orthotopic 
defects. 
 
Our research confirmed our hypothesis that modifying the micron-scale physical 
structure of a hierarchical porous SiCaP based biomaterial influences its functional 
performance in vitro and such modifications can be applied to improve its 
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VIII Glossary 
 
 Biomaterial: Any non-drug material that can be used to treat, enhance, or 
replace any tissue, organ, or function in an organism. Also refers to 
biologically derived material that is used for its structural rather than its 
biological properties, for example, using collagen, the protein found in bone 
and connective tissues, as a cosmetic ingredient. Carbohydrates modified 
with biotechnological processes have been used as lubricants for biomedical 
applications or as bulking agents in food manufacture (Dark 1997). 
 Bone Morphogenetic Protein (BMP): The osteogenetic chemical 
components of the matrix of bone, dentin, and other hard tissues that are 
deinsulated by demineralization and associated intimately with collagen 
fibrils, are termed the bone morphogenetic proteins (Urist 1965). 
 Bone Morphogenetic Substratum: The structure of the demineralized 
matrix is a substratum for differentiation of mesenchymal cells, not only into 
bone as a tissue, but also bone as an organ consisting of a shell of lamellar 
bone with a marrow cavity filled with hematopoietic bone marrow (Urist 
1965). 
 Callus: Mass of new bony trabeculae and cartilaginous tissue formed by 
osteoblasts early in the healing of a bone fracture (Dark 1997). 
 Cell Contact: The contact between inducing and responding cells is 
mediated by intercellular substances and is dynamic rather than static in 
nature (Urist 1965). 
 Demineralised Bone Matrix: Bone divested of inorganic salts, with minimal 
leaching or denaturation of the organic components of the matrix is 
demineralized bone matrix. Demineralization is carried out in the cold at 2 
degrees Celsius, avoiding protein-polysaccharide extractants such as 
Ethylenediaminetetraacetic acid (EDTA). Acids such as hydrochloric acid, 
phosphoric acid, or citric acid, over a period of not more than three to five 
days, at concentrations of not more than 0.6 N, are preferable. Higher 
temperatures, higher concentration, and most organic acids extract variable 
quantities of the organic components of bone matrix and destroy bone 
morphogenetic proteins. The highly cross-linked matrix of dentin, although 
highly permeable, protects the BMP against the deleterious actions of organic 
acids, high temperatures, and long periods of exposure (Urist 1965). 
 Filopodial Extensions of the Cell: Tubular extensions of the plasma 
membranes of mesenchymal cells, containing micro filaments, free of other 
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cell organelles, averaging about 1 µm in length and 0.3 µm in diameter, are 
termed filopodial extensions. Comparable to filopods of migratory ameboid 
cells, filopods of mesenchymal cells are contractile organs that probe the 
microcanalicular system, vascular channels, and other interstices of an 
implant of bone matrix (Urist 1965). 
 Hydroxyapatite: A calcium phosphate ceramic with a calcium to 
phosphorous ratio of 1.67 and nominal composition (Ca10(PO4)6(OH)2). HA 
is similar to the mineral constituent of bone (Park and Bronzino 2003).  
 Induction: The process of tissue differentiation initiated by close contact and 
mutual interaction of cell populations of diverse origins is called induction 
(Urist 1965). 
 Inductive Matrix: The organic framework produced by demineralization of 
bones, teeth, and other calcified tissues serves as an inductive matrix for 
differentiation of mesenchymal cell populations with determination or 
competence to develop into cartilage, bone, and bone marrow (Urist 1965). 
 Lacunae: any small cavity, such as those containing bone or cartilage cells 
(Thain and Hickman 1994). 
 Lacunocanalicular porosity: complex structure of pores and cannels 
(Burger and Klein-Nulend 1999a). 
 Mechanotransduction: is the process in which mechanical energy in 
converted into electrical and or biochemical signals (Burger and Klein-
Nulend 1999a). 
 Osteoconductive: Osteoconduction is a phenomenon in which there is an 
ingrowth of sprouting capillaries, perivascular mesenchymal tissues, and 
osteoprogenitor cells from the recipient host bed into the three-dimensional 
structure of an implant or graft (Einhorn 2003). 
 Osteoinductive: Osteoinduction is a phenomenon in which there is a 
mitogenesis of undifferentiated perivascular mesenchymal cells leading to the 
formation of osteoprogenitor cells with the capacity to form new bone 
(Einhorn 2003). 
 Osteointegration: procedure by which mature bone is deposited directly 
onto implant materials without intervening soft and/or fibrous tissue (Ahmad, 
McCarthy et al. 1999). 
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1. Chapter One: Introduction 
1.1 Background 
The number of clinical procedures performed in the USA in which bone graft was 
implanted was estimated at 1,109,000 in 2010 and is projected to reach 1,295,260 in 
2015 (BioMedGPS 2012). This increasing demand for bone graft substitutes as a 
result of an ever-ageing population coupled with recent reports in the clinical 
literature of concerns regarding the safety of recombinant bone morphogenetic 
proteins such as rh-BMP-2 (Carragee, Ghanayem et al. 2011, Carragee, Hurwitz et 
al. 2011a, Carragee, Hurwitz et al. 2011b, Carragee, Mitsunaga et al. 2011) has led 
to an increased clinical interest in synthetic alternatives (such as porous calcium 
phosphate ceramics) to allograft; autograft; and recombinant growth factors.  
 
Whilst the preclinical and clinical efficacy of calcium phosphates is relatively well 
described in the scientific and clinical literature there is still a need to better 
understand the mechanisms behind their therapeutic action so that the next 
generation of synthetic bone graft substitutes can be developed with improved safety 
and efficacy.  The impact of characteristics such as phase purity, metal oxide 
composition, surface area, total porosity, pore size, and pore interconnectivity on the 
occurrence and extent of bone growth in bony (orthotopic) and non-bony (ectopic) 
sites treated with calcium phosphate based biomaterials has been reported in the 
literature across a number of preclinical studies (Hing, Best et al. 1998b, Hing, 
Gibson et al. 1998, Hing, Merry et al. 1999, Hing, Gibson et al. 2001, Hing 2004b, 
Hing 2004a, Hing, Saeed et al. 2004, Hing, Best et al. 2004, Hing 2005, Hing, Annaz 
et al. 2005, Hing, Revell et al. 2006, Hing, Wilson et al. 2007, Campion, Chander et 
al. 2011). However, a gap in understanding currently exists between knowing how to 
manipulate the properties of such devices to elicit the desired biological response in 
situ and knowing by which mechanisms this manipulation takes effect.  
 
This author wishes to fill that gap in scientific knowledge by elucidating the 
mechanisms behind calcium phosphate biomaterial-derived osteoinductivity and its 
impact on performance in clinically relevant treatment sites. This will be achieved by 
evaluating test articles of well-defined physiochemical properties using a 
combination of in vitro characterisation, in vivo ectopic performance testing, and in 
vivo orthotopic performance studies. This knowledge could be used to commercialise 
a calcium phosphate based biomaterial with improved bone healing properties, 
ultimately leading to improved patient outcomes. 
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1.2 Hypothesis 
Modifying the micron-scale physical structure of a hierarchical porous calcium 
phosphate based biomaterial influences its functional performance in vitro, which 
can be applied to improve its performance outcomes in ectopic and orthotopic 
treatment sites in vivo. 
 
1.3 Objectives 
In order to test this hypothesis this research is intended to: 
 
 characterise a calcium phosphate biomaterial of varying microporosity using 
all chemical and physical analytical techniques described for osteoinductive 
calcium phosphates in the scientific literature;  
 
 determine the effect of microporosity on the mechanical properties of 
calcium phosphate biomaterials using a combination of physical testing and a 
computational model; 
 
 determine the effect of structure and chemistry on propensity of a calcium 
phosphate to form an apatite-like layer once submerged in simulated body 
fluid 
 
 determine the effect of calcium and phosphorus dissolution on the 
osteoinductivity of calcium phosphate biomaterials; 
 
 determine the effect of microporosity on performance of  calcium phosphate 
biomaterials in an orthotopic bone defect study 
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2. Chapter Two: Literature Review 
2.1 Introduction 
In addition to its role in mineral homeostasis, bone performs a mechanical function 
by bearing loads during anatomical movement and by providing support to soft 
tissues all over the human body. It is the combination of the porous, brittle bone 
apatite mineral with a biological matrix of collagen, proteins, cells and 
polysaccharides to form a strong, non-brittle composite material that allows bone to 
fulfil this function. Attempts to develop synthetic hydroxyapatite bone substitute 
materials have centred on providing a porous mineral scaffold through which the 
surrounding bone can vascularise, then infiltrate and, therefore, regain the 
mechanical integrity of the lost bone (Ripamonti 1996, Gauthier, Bouler et al. 1998, 
Yuan, Yang et al. 2001, Hing 2005). It is also not only intended that the bone matrix 
infiltrates the porous structure of a bone substitute but also that new mineral bone 
itself forms within the implant and ultimately replaces the substitute material with 
new bone by the process of chemical resorption or more favourably cellular 
remodelling. Bone undergoes continuous remodelling in response to mechanical 
loading according to Wolff’s law. However, the underlying mechanism by which 
bone cells respond to their changing environment, that is strain in the load-bearing 
matrix or fluid flow through the porous canicular network, has not been fully 
resolved or understood. 
 
Novel synthetic calcium phosphate bone graft substitute materials with improved 
biological performance mediated through chemical and structural enhancements are 
being developed in relatively large numbers (Hing 2005). However, whilst a 
significant amount of work has been undertaken to investigate the relationship 
between substrate chemistry and bioactivity (Hing, Merry et al. 1999, Hing, Gibson 
et al. 2001, Balas, Perez-Pariente et al. 2003, Hing 2004a) and between pore 
structure, material permeability and bioactivity (Annaz 2003, Bignon, Chouteau et 
al. 2003, Annaz, Hing et al. 2004a, Annaz, Hing et al. 2004b, Hing 2004b, Hing, 
Best et al. 2004, Hing, Annaz et al. 2005) in hydroxyapatite materials, there have 
been no significant advances in characterising the role of substrate structure in 
determining the mechanical environment and the subsequent effects of the 
mechanical environment on the biological responses to synthetic bone graft 
substitutes and in particular synthetic hydroxyapatite bone graft substitutes. 
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The trade-off for ceramic bone graft materials by incorporating a large volume 
fraction of porosity to aid bone in-growth is that they lack structural integrity until a 
sufficient volume of new bone has filled the pores. Any steps taken to up-regulate 
the rate of bone growth within the substitute through the characterisation and 
optimisation of its mechanical properties could reduce the period of time for which 
the defect experiences mechanical instability and, therefore, increase the likelihood 
of successful graft incorporation.  
 
In the following sections this author examines through literature review the structure 
and chemistry of physiological bone. As the subject of this thesis is to understand 
how both structure and chemistry affect bone repair at the cellular and macroscopic 
level, further attention is paid to in vitro studies of mechanobiology, specifically how 
substrate structure and physical properties relate to bone cell response. Next we will 
examine the various types of bone graft currently used in the clinical field of bone 
repair to understand the need for research in this area of biomaterials. Last of all, in 
order to consider the possible mechanisms for osteogenic potential in biomaterials 
and to inform the design of our own preclinical models we will research through the 
literature in vitro and in vivo studies of osteoinductivity. 
 
2.2 Bone Physiology 
Bone is a fine example of a natural material which humans can only dream of having 
invented. It has evolved to cope with the extremes of the mechanical environment 
forced upon it from early development right through to the end of its exceptionally 
dynamic life. Day to day it actively adapts its composition, structure and its 
interactions with its surroundings to cope with the chemical and physical demands 
placed upon it. It is bone’s multiphase composition that allows it to behave as one of 
the most multifunctional organs of the human body. The composite structure of bone 
can be divided into the organic (collagen fibres, lipids, peptides, proteins, 
glycoproteins, polysaccharides and citrates) and the inorganic (calcium-phosphates, 
carbonates, sodium, magnesium and fluoride salts) (Hing 2004c). The make-up of 
bone depends on its location, age, and role in the body. Therefore, its composition 
varies considerably across the skeletal system and, in addition, between individuals 
depending on their diet, age and health (Boyne 1970, Heiple, Goldberg et al. 1987, 
Buckwalter, Einhorn et al. 1996, Betz 2003). The roles of bone can be categorized as 
support, storage of minerals and lipids, blood cell production, protection and 
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promote the formation of hydroxyapatite in vitro (Cowles, DeRome et al. 1998, 
Knabe, Berger et al. 2004).  
 
Bone sialoprotein: this non-collagenous protein is proposed to act as a crystal 
nucleator (Roach 1994). BSP, as it is often referred to, has other proposed 
mechanisms of action; specifically that it mediates osteoblastic cell adhesion and 
stimulates the differentiation of osteoblasts. BSP has been suggested to be critical in 
de novo bone formation, whereas it is less important in bone growth (Cowles, 
DeRome et al. 1998, Knabe, Berger et al. 2004).  
 
Osteopontin: sialoproteins are those that are conjugated with sialic acid. Osteopontin 
is one such sialic protein and is implicated in cell attachment within bone matrix. 
According to Roach et al., the role of osteopontin is less certain than for bone 
sialoprotein, but might be related to ensuring that only the right type of crystal is 
formed (Roach 1994). It was also proposed by Uemura et al., that osteopontin may 
be involved in signalling between osteoblasts and osteoclasts, via autocrine and 
paracrine interactions (Cowles, DeRome et al. 1998, Puleo and Nanci 1999, Uemura, 
Nemoto et al. 2001). 
 
Alkaline phosphatase: ALP is a non-collagenous protein that is secreted from 
osteoblasts and is commonly used by researchers as a means to test for osteoblastic 
differentiation in vitro and in vivo. It is thought to promote crystal formation in 
matrix vesicles by removing nucleation inhibitors (Cowles, DeRome et al. 1998).  
 
Fibronectin: this protein is expressed during intramembranous bone formation. 
Fibronectin has the ability to stimulate osteoblast progenitor proliferation, which 
makes this protein critical in early bone formation (Cowles, Brailey et al. 2000). As 
FN has also been shown to readily be adsorbed onto hydroxyapatite and cause the 
proliferation of osteoblasts, this protein is interesting to the researchers with an 
interest in osteoblast upregulation on biomaterials (Veiga, Elias et al. 1997, Garcia, 
Ducheyne et al. 1998, Degasne, Basle et al. 1999).  
 
Vitronectin: this non-collagenous protein is necessary for cell attachment (Kim, 
Arakawa et al. 2003) and for cell migration (McKeown-Longo and Panetti 1996). 
Fibronectin and vitronectin are incorporated into extracellular matrices, including 
soft tissue organs, as well as being abundant in the human serum (Kilpadi, Sawyer et 
al. 2004) at a concentration varying between 200 and 400µg/ml (McKeown-Longo 
and Panetti 1996). 
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2.2.4.A.d Soluble Factors 
Prostaglandins: these fatty acids promote the proliferation and differentiation of 
osteoclasts over extended periods. In contrast, they play an inhibitory role early on in 
the process of remodeling (Buckwalter, Glimcher et al. 1996b, Buckwalter, 
Glimcher et al. 1996a). 
 
Fibroblast growth factors (FGF): this family of growth factors stimulate the 
proliferation of mesenchymal stem cells, pre-osteoblasts, osteoblasts and 
chondrocytes.  
 
Insulin-like growth factors (IGF): this family of growth factors stimulate the 
proliferation of osteoblasts and chondrocytes and upregulates extracellular matrix 
secretion from both cell phenotypes (Buckwalter, Glimcher et al. 1996b, Buckwalter, 
Glimcher et al. 1996a). 
 
Platelet-derived growth factor (PDGF): this growth factor upregulates the 
proliferation of chondrocytes and osteoblasts. At certain concentrations it has been 
found to have a down-regulating effect and has been linked to resorption 
(Buckwalter, Glimcher et al. 1996b, Buckwalter, Glimcher et al. 1996a). 
 
Transforming growth factor (TGF): this growth factor upregulates differentiation of 
mesenchymal stem cells into chondrocytes, and may also induce osteoblast 
proliferation. Similarly to PDGF, TGF has been shown to increase bone resorption 
so it is thought to be responsible for coupling bone formation and resorption 
mechanisms (Buckwalter, Glimcher et al. 1996b, Buckwalter, Glimcher et al. 
1996a). 
 
Bone morphogenic proteins (BMP): this cellular messaging molecule is a cytokine 
and member of the TGF family of factors that stimulates proliferation and 
differentiation of both chondrocytes and osteoblasts (Buckwalter, Glimcher et al. 
1996b, Buckwalter, Glimcher et al. 1996a).  
 
Parathyroid hormone (PTH): this polypeptide causes the release of calcium from 
bone as well as upregulating osteoclast differentiation from osteoprecursor cells. It is 
thought to inhibit osteoblast function (Buckwalter, Glimcher et al. 1996b, 
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differentiated from pre-osteoblasts known as osteoprogenitor cells that originate 
from pluripotent mesenchymal stems cells of the bone marrow. When active, 
osteoblasts adopt a cuboidal morphology and are found on the surface of new bone, 
where there is active bone formation. The principal function of osteoblasts is to lay 
down new bone through the process of lamellar bone formation. They achieve this 
by secreting extracellular matrix that is subsequently mineralised to form woven 
bone. Type I collagen is produced in vast amounts by osteoblasts during the process 
of bone formation. Osteoblasts also release extracellular organelles, known as matrix 
vesicles which contain alkaline phosphatase amongst other regulating molecules 
(Mohamed 2008). 
 
2.2.4.B.b Osteocytes and bone lining cells 
Osteocytes are cells that have become trapped in mineralising matrix as the process 
of lamellar bone proceeds. They are effectively osteoblasts that have been 
submerged within the mineralised extracellular matrix that they themselves have 
produced. Osteocytes are post-proliferative and constitute the final cell phenotype in 
the osteoblastic lineage. The osteocytes reside in lacunae, which are the regularly 
distributed pores and channels of approximately 25 microns in size that are found in 
the microstructure of mature physiological bone. The morphology of osteocytes 
becomes gradually more and more dendritic and they become less populated by 
organelles as they age. The dendritic extensions of osteocytes allow them to 
communicate between each other and osteoblasts in the mineralising front 
(Mohamed 2008). 
2.2.4.B.c Osteoclasts 
Osteoclasts are multinucleated phagocytic cells derived from the macrophage 
monocyte lineage. These cells migrate from bone marrow and can fuse together to 
from de novo multinucleated cells. Osteoclasts are involved in bone remodelling 
through resorption of mineralised bone matrix. During resorption osteoclasts exhibit 
characteristic ruffled borders, a sealing zone, the basal membrane, and a functional 
membrane zone. Within the ruffled zone, organic acids and proteolytic enzymes, 
such as collagenase, are secreted onto the surface of bone. The sealing zone localises 
these organic acids and proteinases on the surface of the substrate. The dissolved 
inorganic components and digested organic molecules are enveloped by the 
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a dominant negative form of the small GTPase Rho, or by microinjection into the 
cells of a proteolytic fragment of α-actinin that inhibits α-actinin-mediated anchoring 
of actin filaments to integrins at the plasma membrane each blocked fluid-shear-
induced gene expression in osteoblasts. Rho-mediated stress fibre formation and the 
α-actinin-dependent anchorage of stress fibres to integrins in focal adhesions may 
promote fluid-shear-induced metabolic changes in osteoblasts. 
 
Osteoblastic bone cells respond to flow in a dose-dependent manner (Bakker, 
Soejima et al. 2001). Increasing viscosity also increases responses. Increasing the 
viscosity will simultaneously heighten the mean shear stress and the amplitude of the 
pulsatile shear stress, but the exact mode of Upregulation has not determined. In a 
second study of the effects of viscosity dextran was added to the media to increase 
the viscosity which increased mineralised matrix deposition (Sikavitsas, Bancroft et 
al. 2003). Alkaline phosphatise (AP) was significantly higher for fluid sheared cells. 
Upregulation from a change in fluid shear stress modulated by viscosity and not flow 
rate indicates that the rate of chemotransport is not a factor in the upregulation of 
osteoblastic cells in response to increased fluid shear. 
 
Bone cell response to fluid shear stress is rate-dependent (Bacabac, Smit et al. 2004). 
Increasing amplitude or frequency without changing average stress enhances NO 
production. NO production is linearly dependent on the rate of fluid shear stress. 
Later it was shown that although osteoblastic cell response to fluid stress is rate 
dependent, an initial stress kick is required for the cells to respond (Bacabac, Smit et 
al. 2005).  Cytoskeletal arrangement during a pre-treatment phase may explain the 
lack of response without a stress kick. Cellular sensitivity to stress occurs in under 1 
min. However, cells were not affected by a short stress kick (10s; 0.7Pa) so the effect 
of stress on NO production occurs between 10s - 1min. In addition, treatment with 
parathyroid hormone (PTH) without shear stress stimulated PGE2 production but not 
NO production (Bakker, Joldersma et al. 2003). When PTH was added <1min before 
shear stress treatment it blocked NO production. It is suggested, therefore, that PTH 
inhibits NOS (ecNOS) in bone cell production of NO. 
 
PGE2 and PGI2 have been upregulated in mature human osteoblasts following PFF 
treatment, whereas PGF2 was upregulated for 1 hour only (Joldersma, Burger et al. 
2000). Treatment with PFF increased COX-2 but not COX-1 expression. The levels 
of prostaglandin production varied significantly between cell-donors and were 
related to the variation in residual osteocyte population numbers. Interestingly, a 
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exception of a sterilizing, preserving, or storage agent).  Consequently, DBM 
products that are combined with carriers (e.g. calcium phosphate, glycerol, sodium 
hyaluronate) are classified as a medical device and are regulated under the Centre for 
Devices and Radiological Health (CDRH).   
 
Since this ruling, most DBM products combined with carriers received FDA 
approval via the 510k regulatory process as bone void fillers with specific 
indications.  Many of these products claim to be osteoinductive, but test each batch 
for this attribute in order to be deemed suitable for clinical use.  These 
osteoinductive batch validation tests either consist of in-vivo athymic rodent models 
or in-vitro tests that have been validated to correlate with athymic rodent models.  
Approximately half of the in vivo validation assays specify athymic mice, while the 
other half specifies athymic rats.  It can thus be concluded that the FDA accepts both 
athymic mice and rat models to verify osteoinductivity.  
 
While the specific in-vivo osteoinductivity test protocols are not provided in the 
510k summaries, some details have been published in peer-reviewed articles, white 
papers, or product brochures (Bacterin , Etex , Synthes , Zhang, Powers et al. 1997b, 
Zhang, Powers et al. 1997a, Edwards, Diegmann et al. 1998, Coulson and Lalor 
2000, Takikawa, Bauer et al. 2003, Kay 2004, Honsawek, Powers et al. 2005, Boyan, 
Ranly et al. 2006a).  Eight of these studies utilised athymic mice while three utilised 
athymic rats.  Within the athymic mouse studies; two studies performed 
subcutaneous implantation (Etex , Zhang, Powers et al. 1997b) while the remaining 
performed muscle implantation in the longissimus dorsi (Zhang, Powers et al. 1997a, 
Zhang, Powers et al. 1997b, Honsawek, Powers et al. 2005), hamstrings (Synthes), 
quadriceps (Kay 2004), gastrocnemius (Boyan, Ranly et al. 2006a), and biceps 
femoris (Bacterin). Within the athymic rat studies; two performed subcutaneous 
implantation (Edwards, Diegmann et al. 1998, Coulson and Lalor 2000) while the 
rest conducted muscle implantation in the pectoralis muscle (Takikawa, Bauer et al. 
2003) and in the upper hind limb (at the interface of semimembranous and adductor 
brevis muscles) (Edwards, Diegmann et al. 1998, Takikawa, Bauer et al. 2003).  
 
On average, ~20 mg (ranging from 11-40 mg) of DBM was placed in the 
implantation site.  Eight of the studies had a time point of 28 days, one study had a 
time point of 21 days (Coulson and Lalor 2000), and another study had a time point 
of 56 days (Boyan, Ranly et al. 2006a).  Most of the studies performed decalcified 
paraffin-embedded histology to assess ectopic bone formation.  Three studies 
performed non-decalcified resin-embedded histology (Edwards, Diegmann et al. 
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1998, Coulson and Lalor 2000, Takikawa, Bauer et al. 2003), two studies performed 
non-decalcified resin-embedded histomorphometry (Edwards, Diegmann et al. 1998, 
Coulson and Lalor 2000), two studies performed decalcified paraffin-embedded 
histomorphometry (Honsawek, Powers et al. 2005, Boyan, Ranly et al. 2006a), two 
studies evaluated explant calcium content (Zhang, Powers et al. 1997b, Zhang, 
Powers et al. 1997a), and two studies assessed explant alkaline phosphatase content 
(Coulson and Lalor 2000, Kay 2004).  
 
Bone morphogenetic proteins (BMP) comprise two commercially available products 
as INFUSE® (BMP-2: Medtronic) and OP-1™ (BMP-7: Olympus Biotech 
Corporation).  INFUSE® and OP-1™ do not have to perform batch to batch 
osteoinductivity validation testing.  However, Barr et al. published an in-vivo mouse 
thigh muscle pouch study comparing the osteoinductivity of the two products (Barr, 
McNamara et al. 2010).  After 28 days of implantation, ectopic bone formation was 
assessed with micro CT measurement of bone volume and decalcified paraffin 
embedded histology with haematoxylin and eosin staining.  The in-vivo mouse 
muscle pouch study showed that OP-1™ induced greater bone volume than 
INFUSE®.  Barr et al. also assessed INFUSE® and OP-1™ in an in-vitro C2C12 
cell assay in the same publication and found that INFUSE® stimulated greater 
alkaline phosphatase activity compared to OP-1™ (Barr, McNamara et al. 2010). 
 
A literature search of more recently published articles also confirmed that the 
athymic mouse model has been used to assess biologic devices consisting of carriers 
combined with live cells, carriers combined with growth factors (including bone 
morphogenetic proteins but not specifically INFUSE® or OP-1™), as well as 
carriers combined with live cells and growth factors (Ranly, McMillan et al. 2005, 
Boyan, Ranly et al. 2006b, Lin, Wang et al. 2007, Liu, Zhao et al. 2007, Na, Kim et 
al. 2007, Ranly, Lohmann et al. 2007, Han, Sun et al. 2008, Tampieri, Sandri et al. 
2008, Oliveira, Mijares et al. 2009, Schaeren, Jaquiery et al. 2010, Wang, Ma et al. 
2011, Wang, Huang et al. 2011, Zhang, Mao et al. 2011).  
 
Boyan et al. conducted gastrocnemius muscle implantation with 10 mg of material 
per implantation site (Ranly, McMillan et al. 2005, Boyan, Ranly et al. 2006b, 
Ranly, Lohmann et al. 2007).  The remaining studies used dorsal subcutaneous 
implantation and indicated the material quantities volumetrically (250 μl)(Na, Kim et 
al. 2007), or as blocks (5 mm x 5 mm x 1.5 mm (Lin, Wang et al. 2007), 3 mm x 3 
mm x 3 mm (Lin, Wang et al. 2007), 4 mm x 4 mm x 1 mm (Oliveira, Mijares et al. 
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Since Urist’s 1965 study, osteoinductivity has been investigated in many different 
species of animal, including but not limited to: mice (Yuan, van Blitterswijk et al. 
2006b), Fischer rats (Okumura, Ohgushi et al. 1991), Sprague-Dawley rats (Urist 
and Strates 1971), hamsters (Heughebaert, LeGeros et al. 1988), cats (Daculsi 2004), 
beagle dogs (Piecuch 1982), milk goats (Barrere, van der Valk et al. 2003), Saanen 
goats (Bodde, Cammaert et al. 2007), Dutch goats (Li, Habibovic et al. 2007), sheep 
(Gosain, Song et al. 2002), pigs (Urist 1965), baboons (Ripamonti 1991). A more 
complete list of the species studied can be found in Appendix II of this thesis. The 
outcomes of these studies were variable, however confounding factors such as the 
test material; implantation site, length of implantation, and histological method may 
contribute significantly towards this variation. Despite this, a common theme was 
apparent: osteoinductivity of biomaterials was more frequently observed in larger 
animals, such as rabbits; dogs; and goats, than in smaller animals, such as rodents.  
 
In 1996 Ripamonti investigated osteoinduction in porous hydroxyapatite following 
implantation in heterotopic sites of different animal models (Ripamonti 1996). This 
was the first study of its kind, since Urists 1965 work, in which most research 
parameters were kept constant whilst investigating the effect of genetic deposition to 
biomaterial-derived osteoinductivity. Study materials comprised replicas of porous 
hydroxyapatite that had been obtained after hydrothermal conversion of the calcium 
carbonate exoskeleton of coral (genus Goniopora). A total of 40 hydroxyapatite rods 
were implanted bilaterally in intramuscular pouches created by sharp and blunt 
dissection in the rectus abdominis of four clinically healthy outbred Chacma baboons 
(Papio ursinus) with normal haematological and biochemical profiles; two adult 
inbred beagles; and four adult rabbits which were of the New Zealand white strain. 
Ripamonti found that implants harvested from rabbits and dogs were less 
vascularised than those from Baboons at the macroscopic level. Bone area in Rabbits 
was 0.5±0.3%; in Dogs was 0.79±0.49%; and in Baboons was 11.3±3.02%. The 
amount of bone did vary considerably between specimens. Ripamonti speculated that 
osteoinductivity is not inherent but that bone morphogenetic proteins (BMP’s) bind 
preferentially to the surface of the materials tested in the study. Bone differentiation 
occurred after sixty days post-implantation. However, no bone formation occurred 
after thirty days implantation so Ripamonti postulated that this indicates that a 
critical level of endogenous BMP is required to be adsorbed to the surface to start the 
bone formation cascade.  
 
In 2006 Yuan and van Blitterswijk embarked on a cross-species comparison of 
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al. 2003, Barradas, Yuan et al. 2011). This group suggested that osteoinduction by 
porous Ca-P ceramics can be attributed to either (1) the incorporation and 
concentration of bone morphogenetic proteins (BMPs) by Ca-P crystals; (2) a low 
oxygen tension in the central region of the implant that triggered the pericytes of 
microvessels to differentiate into osteoblasts; (3) a rough surface produced by the 3D 
microstructure, which caused the asymmetrical division of mesenchymal cells that 
produce osteoblasts; (4) the surface charge of the substrate, which triggered cell 
differentiation; (5) the bone-like apatite layer formed in vivo that recognized 
mesenchymal cells; and/or (6) the local high level of free Ca2+ provided by the Ca-P 
material, which triggered cell differentiation and bone formation (Figure 2-1). 
 
Figure 2-1: Important physiochemical and structural properties of Osteoinductive biomaterials 
 
Modified from Barradas, Yuan et al. (2011). This mechanism for calcium phosphate derived 
osteoinductivity, proposed by Barradas et al., includes both physical and chemical cues for bone 
formation in non-bony sites. The authors propose that physico-chemical and/or structural 
properties of osteoinductive biomaterials may trigger the process of heterotopic bone formation 
directly or indirectly. Micro and nano structural properties can favour the interaction with 
BMPs and other essential endogenous proteins that in turn trigger stem cell differentiation into 
osteoblasts and hence bone formation. But surface topography and inorganic ion release (in the 
case of calcium phosphate based ceramics), may also be a direct trigger of the process of 
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cartilage formation in chicks and later demonstrated that chicks fed a silicon 
supplemented diet had enhanced bone growth, increased amounts of cartilage, 
increased bone water content and biochemical changes in the mineral, hexosamine 
and collagen content of bone (Carlisle 1970, Carlisle 1972, Carlisle 1974, Carlisle 
1975, Carlisle 1976, Carlisle 1980a, Carlisle 1980b, Carlisle 1981, Carlisle 1982, 
Carlisle 1986, Carlisle 1988). Schwarz also corroborated the importance of dietary 
silicon intake on normal bone physiology (Schwarz 1973).  
 
Preclinical studies demonstrate that the speed, extent and quality of de novo bone 
formation is dependent upon the amount of silicon substituted into hydroxyapatite 
biomaterials when tested in orthotopic defect sites in vivo (Hing 2004a, Hing, Saeed 
et al. 2004, Hing, Revell et al. 2006, Hing, Wilson et al. 2007).  A more recent study 
demonstrated that the amount of silicon substituted into hydroxyapatite can also 
affect the amount of bone formation observed in ectopic defect sites in vivo 
(Coathup, Samizadeh et al. 2011). In Coathup’s study implants with a macroporosity 
of 80% and a strut porosity of 30% were inserted into sites located in the left and 
right paraspinal muscles of six female sheep. After twelve weeks in vivo, a 
longitudinal thin section was prepared through the centre of each implant. Bone 
formation within the implant, bone formation in contact with the implant surface, 
and implant resorption were quantified from histology with use of a line intersection 
method. The specimens were also analysed with the use of backscattered scanning 
electron microscopy and energy-dispersive x-ray analysis. Silicate substitution had a 
significant effect on the formation of bone both within the hydroxyapatite implants 
and on the implant surface during the twelve-week period. Bone area within the 
implant was greater in the silicate-substituted hydroxyapatite group (mean, 7.65% 
+/- 3.2%) than in the stoichiometric hydroxyapatite group (0.99% +/- 0.9%, p = 
0.01). The amount of bone formed at the surface of the implant was also significantly 
greater in the silicate-substituted hydroxyapatite group (mean, 26.00% +/- 7.8%) 
than in the stoichiometric hydroxyapatite group (2.2% +/- 2.0%, p = 0.01). Scanning 
electron microscopy demonstrated bone formation within pores that were <5 mum in 
size, and energy-dispersive x-ray analysis confirmed the presence of silicon within 
the new bone in the silicate-substituted hydroxyapatite group. New bone formation 
occurred through an intramembranous process within the implant structure. The 
precise mechanism for these observations of a silicon-dependent upregulation of 
bone formation in orthotopic and ectopic preclinical studies has so far not been 
elucidated. It is unknown whether the silicon is imparting a direct influence on cell 
metabolism and on protein synthesis or an in-direct effect on cell recruitment, 
attachment, differentiation and proliferation. However, several studies have 
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investigated the effects of silicon on bone healing, some of which are discussed in 
the following text. 
 
Silicon-containing calcium phosphates such as silicon-substituted hydroxyapatite 
have been shown to dissolve in vivo, eliciting free silicon in the form of orthosilicic 
acid into the surrounding tissues. Studies by Porter et al., examining the in vivo 
dissolution processes in phase-pure hydroxyapatite and silicon-substituted 
hydroxyapatite found that an increased number of triple junctions in silicon-
substituted hydroxyapatite compared to hydroxyapatite may have a significant role in 
increasing the solubility of the material and the subsequent rate at which bone 
apposes these ceramics (Porter, Patel et al. 2003, Porter, Best et al. 2004, Porter, 
Botelho et al. 2004, Porter, Patel et al. 2004). In one of these studies, high-resolution 
transmission electron microscopy was used to observe dissolution from 
hydroxyapatite (HA), 0.8 wt% silicon-substituted hydroxyapatite (0.8wt% Si-HA) 
and 1.5 wt% silicon-substituted hydroxyapatite (1.5wt% Si-HA) implants after 6 and 
12 weeks in vivo (Porter, Patel et al. 2003). Observations confirmed that defects, in 
particular those involving grain boundaries, were the starting point of dissolution in 
vivo. Dissolution was observed to follow the order 1.5 wt% Si-HA>0.8 wt% Si-
HA>pure HA and it was found to be particularly prevalent at grain boundaries and 
triple-junctions. These observations may help to explain the mechanism by which 
silicate ions increase the in vivo bioactivity of hydroxyapatite. 
 
Much of the earlier work investigating the role of free silicon on bone formation 
focused on its role in collagen synthesis. Schwarz demonstrated that silicon is 
essential to the normal development of the glycosaminoglycan network in the 
extracellular matrix, helping to stabilise complex polysaccharide structures and 
forming crosslinks via silanolate (R–O–Si–O–R and R–O–Si–O–Si–O–R) bonds that 
regulate the structure and function of these molecules (Schwarz 1973). Carlisle’s 
analysis of chick bone development revealed that silicon was concentrated in the 
growth areas of bone. In the developing chicks, silicon supplementation led to a 
100% increase in bone collagen content over silicon-deficient bones after twelve 
days in culture (Carlisle 1974). Later studies demonstrated that in vitro, collagen 
type I expression is upregulated in human osteoblasts which were supplemented with 
orthosilicic acid (Reffitt, Ogston et al. 2003). Silicon, in the form of orthosilicic acid, 
has also been implicated in the binding of aluminium to form aluminosilicates which 
prevent aluminium competing from metal ion binding sites (Birchall 1993). For 
example, complexes of silicon and aluminium prevent aluminium ions competing 
with iron for binding sites in molecules involved in collagen synthesis, such as prolyl 
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hydroxlase.  
 
More recent research has focused on the role of free silicon on the upregulation of 
osteoblast cells in vitro. Gao et al. studied the impact of varying silicon content of 
two bioglass compositions in 2001 (Gao, Aro et al. 2001). Saos-2 osteoblastic cells 
with proven osteogenic phenotype were cultured for 4, 7 and 14 days on two 
bioactive glasses with different silicon contents. Gao et al., observed a significant 
increase in Col-I, ALP and BMP-2 mRNA levels in cells grown on the two bioactive 
glasses when compared with those grown on controls containing no silicon at 4 and 7 
days. The BMP-2 mRNA level was greatest for the test material containing the 
largest amount of silicon at 4, 7 and 14 days, although this did not reach statistical 
significance. The effect of the ionic products of Bioglass 45S5 dissolution on the 
gene-expression profile of human osteoblasts was investigated with cDNA 
microarray analysis by Xynos et al. (Xynos, Edgar et al. 2001). The increase in 
silicon concentration in the supernatant was substantially higher than the other ionic 
products (Ca, P, Na). Xynos et al., observed the induction of genes with known roles 
in processes relevant to osteoblast metabolism and bone homeostasis. These included 
genes that encode products that can induce osteoblast proliferation (e.g. RCL), 
participate in the dynamic processes of extracellular matrix remodelling (e.g. 
metalloproteinases), perform differentiated functions (e.g. CD44), and promote cell-
cell and cell matrix attachment (e.g., integrin β1). Studies of other silicon-containing 
biomaterials, such as silicate-substituted hydroxyapatite, have also demonstrated that 
osteoblast cells are upregulated by silicon. Osteoblasts cultured on silicate-
substituted hydroxyapatite were upregulated compared to stoichiometric 
hydroxyapatite (Gibson, Huang et al. 1999, Cameron, Travers et al. 2013, Cameron, 
Travers et al. In Press) and bioglass (De Godoy, Hutchens et al. 2015). 
 
The role of silicon in bone development in biomaterials may be indirect instead of or 
as well as the direct mechanisms described above. Upregulated bone development 
can be explained in part by other in vitro studies in which substitution of silicate into 
hydroxyapatite has been demonstrated to influence the surface charge, 
hydrophilicity, protein adsorption, and cell attachment of silicate-substituted 
hydroxyapatite biomaterials in vitro (Rashid 2008, Guth, Campion et al. 2010a, 
Guth, Campion et al. 2010b).  In this instance the role of silicon is to modify the 
inherent properties of the material surface (such as surface charge and surface free 
energy) such that an optimal layer of protein is adsorbed to the biomaterial surface 
after implantation. This layer of protein, comprising predominantly fibronectin and 
vitronectin, two proteins with a well-established role in bone cell attachment, leads 
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to the preferential attachment and subsequent differentiation of preosteoblasts. Other 
researchers have discovered alternative mechanisms for the indirect role of silicon in 
bone formation. Li and Chang found that silicon ions upregulated endothelial growth 
factor (VEGF) expression in fibroblasts and endothelial cells, and since VEGF 
upregulates bone morphogenetic protein expression, silicon might play an indirect 
role in bone formation via this molecular pathway (Li and Chang 2013). The effect 
of bioglass ionic dissolution products on the metabolism of osteoclasts was studied 
by Mladenovic et al., (Mladenovic, Johansson et al. 2014). Mladenovic et al., 
concluded that silicon causes significant inhibition of osteoclast phenotypic gene 




Bone is an incredibly complex and dynamic organ of the human body and as such 
there exists disparity in the efficacy of current treatments to augment or replace bone 
in the clinical setting. In vitro experiments have come a long way to understand the 
mechanobiology of material substrates and their impact on bone cell upregulation 
either in response to fluid shear or direct substrate strain. However, a lot is still 
unknown with respect to the precise mechanisms for biomaterial-derived osteogenic 
potential of synthetic bone grafts. Studies for osteoinductivity have highlighted the 
importance of bone graft stability, propensity for apatite-like layer formation, 
osteogenic factor upregulation, bone cell attachment, bone cell differentiation, and 
bone cell proliferation but the precise relationship between these factors is not clear. 
The many intrinsic properties (e.g. pore size, pore connectivity, pore volume etc.) 
and associated functional characteristics (e.g. permeability & dissolution) of a 
biomaterial can affect multiple components of the bone formation process (e.g. cell 
attachment, differentiation, proliferation etc.), meaning that in reality the mechanism 
for biomaterial-derived osteoinductivity is far more complex (Figure 2-6) than that 
proposed by Barradas et al. (Barradas, Yuan et al. 2011). Silicon has been 
demonstrated to have a significant impact on bone formation both in orthotopic and 
also in ectopic defects in vivo, but despite much research in this area, whether this 
occurs via direct or indirect bone cell upregulation is not understood. In all 
likelihood it is a combination of some or all of these mechanisms. Additional 
research is required to uncover the role of physiochemical parameters in the 
osteogenic potential of  phosphate biomaterials. 
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Figure 2-6: Role of Physiochemical 
Parameters in the osteoinductivity 
of calcium phosphate biomaterials 
- as proposed by this author.  
 
The many intrinsic properties (e.g. 
pore size, pore connectivity, pore 
volume etc.) and associated 
functional characteristics (e.g. 
permeability & dissolution) of a 
biomaterial can affect multiple 
components of the bone formation 
process (e.g. cell attachment, 
differentiation, proliferation etc.), 
meaning that in reality the 
mechanism for biomaterial-
derived osteoinductivity is far 
more complex than that proposed 
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Table 3-1 Test material summary 
Test 
Group 










SiCaP material (Actifuse® Microgranules, 
ApaTech, Herts, UK) consisted of porous 
(80-82.5% total porosity), irregularly 
shaped microgranules (1–2 mm) of phase 
pure SiCaP (0.8 wt% Si) with a strut 




SiCaP-23G granules in an aqueous carrier 




SiCaP material (ApaTech, Herts, UK) 
consisted of porous (80-82.5% total 
porosity), irregularly shaped microgranules 
(1–2 mm) of phase pure SiCaP (0.8 wt% Si) 




SiCaP-32G granules in an aqueous carrier 




SiCaP material (ApaTech, Herts, UK) 
consisted of porous (80-82.5% total 
porosity), irregularly shaped microgranules 
(1–2 mm) of phase pure SiCaP (0.8 wt% Si) 




SiCaP-46G granules in an aqueous carrier 
containing 33% by weight Poloxamer 407 
80 46 
β-TCP Vitoss® Scaffold Morsels, (Orthovita, 
USA) consisting of porous (90 % total 
porosity) irregularly shaped granules (1–4 
mm) of beta-tricalcium phosphate (β-TCP, 
Ca3(PO4)2) with a strut-porosity of 48% 
90 48 
 
3.3 Methods of Characterisation 
The materials were first characterised for phase purity, ionic composition, and 
crystallinity in order to confirm the claims of the manufacturers from whom the 
commercially available products were supplied (Table 3-1). The same characteristics 
were also used to assess the impact of suspending the SiCaP granules in an aqueous 
based carrier. To determine the effects of structure on the osteogenic potential and 
mechanical properties of calcium phosphates in later chapters, the silicate-substituted 
calcium phosphate materials were fully characterised in this chapter for strut-
porosity; device density; total porosity; and surface area. The elements of 
microstructure and chemistry of the silicate-substituted calcium phosphate and 
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Figure 3-5 Typical MIP Intrusion Curve 
Sample shown is SiCaP-32G. This intrusion curve demonstrates a step change in 
intrusion at approximately 1 ml/g. This indicates the break through pressure at which 
mercury intrudes the strut-porosity. 
 
Figure 3-6 Typical MIP Intrusion Curve 
Sample shown is β-TCP. The difference in intrusion curve between this material (β-
TCP) and that shown above in Figure 3-5 demonstrates that the two test materials have 
















































Pore Interconnection Size (microns)
Role of Physiochemical Parameters in the Osteogenic Potential of CaP Biomaterials 
Charlie Campion  Page 80 of 299 
Figure 3-7 Typical Pore Interconnection Size Distribution by MIP  
The log differential intrusion plot clearly demonstrates the existence of two populations 
of porosity in the silicate-substituted calcium phosphate test material over the pore 
interconnection sizes of 0.1-5 microns and 10-1000 microns. Sample shown is SiCaP-
23G. 
 
Figure 3-8 Typical Pore Interconnection Size Distribution by MIP. 
A similar bi-modal pore size distribution was evident in the β-TCP test material. There 
appeared to be a greater volume of porosity overall in the β-TCP test material and a 
greater proportion in the strut-porosity population compared to the macroporosity 
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Table 3-2 Method comparison acceptance criteria 
Challenge Pass Criteria Fail Criteria 
Linearity r2 ≥ 0.9 r2 < 0.9 
Range Min & max within 95% 
confidence level of linear 
regression
Min & max outside 95% 
confidence level of linear 
regression 




Accuracy Measurements of standard 
reference material within 
95% reproducibility limits 
Measurements of standard 
reference material outside 
95% reproducibility limits 
 
Table 3-3 Reference Material Parameters and Acceptance Criteria for Accuracy 
  Acceptance Criteria 
Material 
Coarse silica powder 
(SiO2)
N/A 
Catalogue No. 3002 N/A
Lot No. 107 N/A 
Total Intruded 
volume 
0.2847 cc/g ± 0.0464 




42.40 μm ± 7.48 34.92 – 49.88 
(95% CL) 
 
For each set of sample results, an F-test for sample variance was performed to 
determine whether the variances of the sample can be assumed to be the same. 
Where this was the case (F < F-critical) a two-tailed t-test was carried out with 
p=0.05, assuming equal variances.  Where the variances are dissimilar (F > F-
critical) the t-test was performed assuming unequal variances.  In both cases, the null 
hypothesis was that the sample means are similar.  The alternative hypothesis was 
that the sample means are different.  The null hypothesis was accepted where t-stat < 
t-critical. An ANOVA was used to determine the variance in the results, and this will 
be compared to that of optical microscopy. A linear regression with a 95% 
confidence level will be plotted using means of the measurements from each batch.   
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Figure 3-9 Linear regression for Strut-porosity OMvMIP 
A linear regression for strut-porosity measured by Mercury intrusion porosimetry and Optical 
Microscopy provided a reasonable correlation between the two techniques (R2=0.895).
 
A residual is defined as the difference between the observed and fitted values of the 
dependent variable in the regression analysis (y = yx – yy); basically, it is the distance 
between the data point and the regression line (Twomey and Kroll 2008). The y-axis 
is freely scalable and the x-axis consists of the comparative method and bisects the 
y-axis at zero. The residual plot is useful for the judgement of linearity – if there is 
an even spread of points around y = 0 throughout the x-axis this implies that there is 
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Table 3-4 Repeatability data  












1 3.0723 23.56 2.75 1.66 27.31 4.42 2.10
2 3.0288 23.78 2.35 1.53 26.22 10.48 3.24
3 3.1373 24.18 8.88 2.98 26.46 3.58 1.89 
4 3.0437 22.64 4.20 2.05 23.87 4.15 2.04 
5 3.0826 13.69 2.63 1.62 11.30 0.45 0.67
6 3.1489 28.61 5.31 2.30 43.60 14.78 3.85
7 3.1882 19.69 3.32 1.82 18.22 6.11 2.47 
  Average: 4.21 2.00 Average: 6.28 2.32 
3.3.2.F.d Accuracy 
Standard reference materials (Quantachrome, UK) were tested in order to determine 
whether the technique accuracy was within the tolerances specified by the equipment 
supplier.  
 
Table 3-5 Accuracy data 
Sample 
Total Intruded Volume 
(cc/g) 
Median Pore Diameter 
(micron)
Measured Limits Measured Limits 
1 0.2662 0.2383 - 0.3311 45.18 34.92 - 49.88 
2 0.2711 0.2383 - 0.3311 42.17 34.92 - 49.88 
 
3.3.2.F.e Range 
The model generated with the use of experimental data in this validation can be used 
reliably to predict the equivalent strut-porosity by optical microscopy when the 
measured values by mercury porosimetry coupled with helium pyconometry are 
between 5.00-33.00 %. This range of data from mercury porosimetry coupled with 
helium pyconometry is equivalent to 5.00-47.00 % by optical microscopy. 
 
3.3.2.F.f Method Comparison Results summary 
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considers closed pores. The density of water was read from Table 3-7 provided with 
a density determination kit (Sartorius, UK) and an LE225D 5-point analytical 
balance (Sartorius, UK).  
 
Table 3-7 Density table of deionised water (dH2O) 
(Table adapted from Ohaus)  
 
Temperature (oC) Density (g/ml)  Temperature (oC) Density (g/ml)  
17.5 0.9987 21.5 0.9979 
18 0.9986 22 0.9978 
18.5 0.9985 22.5 0.9976 
19 0.9984 23 0.9975 
19.5 0.9983 23.5 0.9974 
20 0.9982 24 0.9973 
20.5 0.9981 24.5 0.9972 
21 0.9980 25 0.9971 
 
 
For the analysis of specimens, samples were weighed dry (Wdry). Following this, the 
same specimens were placed in boiling deionised water for 1 hour to ensure all 
possible pores are filled with water. Specimens were then weight again (Wsat) and 
submerged (Wsub) in deionised water. This was performed using the Density AP 
solids Kit (Ohaus, Leicester, UK). The balance used was an Analytical Plus 
electronic balance AP250D (Ohaus, Leicester, UK). The commercially available β-
TCP group was not analysed for total porosity as the granule sizes available from the 
manufacturer (1-4mm) were not compatible with the water immersion densitometry 
method. The total porosity provided by the manufacturer (Orthovita, USA) was used 
for reference. 
 
The results obtained were used to determine closed strut porosity and total porosity 
using Equation 9 and Equation 10. HA was assumed to have a density of 3.156g/cm3 
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Figure 3-16 Typical XRD Spectra 
X-ray diffraction spectra for the silicate-substituted hydroxyapatite test group showed 
narrow peaks, indicating a high degree of crystallinity, which corresponded with the 
library file for phase pure hydroxyapatite. There was no evidence of phase impurities 
such as calcium oxide or tricalcium phosphate. Spectra shown is for SiCaP-32P 
 
 
Analysis of the crystalline composition the β-TCP group with X-Ray diffractometry 
demonstrated that the β-TCP material was phase pure. All spectral peaks could be 
accounted for by the beta-tricalcium phosphate powder diffraction file (9-348). The 
diffraction spectra showed narrow, high-resolution peaks and were consistent with 
highly crystalline material (Figure 3-17). 
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crystallinity in order to confirm the claims of the manufacturers from whom the 
commercially available products were supplied (Table 3-1). Chemical 
characterisation of the SiCaP materials provided by ApaTech revealed the samples to 
be phase-pure, highly crystalline, silicate-substituted hydroxyapatite with a Ca/P+Si 
ratio of 1.67 and 0.80% silicon by weight substituted into the crystal lattice. This is 
consistent with all previous research for materials manufactured by the same novel 
aqueous precipitation and foaming route. The presence of hydroxyapatite as a highly 
crystalline phase is consistent with other bone graft substitutes characterised by the 
same techniques (Tadic and Epple 2004).  
 
X-ray Fluorescence spectroscopy (XRF) confirmed the absence of any metal 
contaminants in the form of metal oxides, including: titanium dioxide; aluminium 
oxide; iron (III) oxide; magnesium oxide; potassium oxide; sodium oxide; chromium 
(III) oxide; manganese (II, III) oxide; zirconium oxide; hafnium oxide; lead oxide; 
zinc oxide; barium oxide; strontium (II) oxide; and tin (IV) oxide. There was no 
noticeable change in chemistry with increasing porosity. Nor was there an 
appreciable difference in phase purity, crystallinity, or ionic composition between 
those SiCaP groups incorporating an aqueous poloxamer carrier and those not. 
 
Fourier transform infrared spectroscopy (FTIR) of the silicated calcium phosphate 
confirmed all SiCaP materials to be free of impurity moieties which is consistent 
with that reported by previous researchers (Figure 3-25). 
 
Figure 3-25 FTIR Analysis of SiCaP-
32G  
 
FTIR trace for SiHA as reported in 
the literature – reproduced with 
permission from (Hing, Revell et al. 
2006);  
 
The FTIR trace for the silicate-
substituted calcium phosphate test 
group (Figure 3-18) shared similar 
peak patterns over the range of 500-
1500 cm-1 as those reported 
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strut-porosity would impact the clinical utility of the materials, specifically the 
handling strength of the material and its suitability for use in further preclinical 
studies and eventually as a bone graft substitute in humans. All porous SiCaP groups 
were found to fail in a manner typical of an elastic-brittle foam, exhibiting a linear 
elastic region during which brittle failure of the macropores dominated, followed by 
a second elastic region characteristic of brittle fracture of the struts. This is consistent 
with previous finding for coralline hydroxyapatite materials (Hing, Best et al. 1999). 
The mechanical properties were modified by increasing strut-porosity, as might be 
expected. Increasing the strut-porosity led to a significant increase in the 
displacement measured at maximum load. However, interestingly, whilst there was a 
significant difference in the maximum displacement for SiCaP-23G versus SiCaP-
32G and SiCaP-46G, there was no significant difference between SiCaP-32G and 
SiCaP-46G. This is likely to be attributed to variations in structural parameters other 
than strut-porosity volume taking precedence in determining the nature of brittle 
failure, such as variations in pore shape, pore interconnection size, and macropore 
size distribution. Despite there being a detectable change in mechanical properties 
with increasing strut-porosity, all groups retained a sufficient degree of structural 
integrity for use as a bone void filler. The significance of the impact of intrinsic 
mechanical properties on the biological performance of the materials is explored 
further in Chapter 4. 
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4. Chapter Four: Effect of Strut-Porosity on the 




Several studies have investigated the influence of substrate properties on mechano-
stimulation of bone cell cultures but the majority of these studies have focussed on 
one attribute of the material alone, such as substrate roughness (Di Palma, 
Guignandon et al. 2005), substrate chemistry (Di Palma, Douet et al. 2003, 
Sikavitsas, Bancroft et al. 2005), or pore size (Tanaka, Sun et al. 2005). The greater 
body of work has focussed on the empirical responses of individual, and 
occasionally co-cultured cells, to experimental mechanical and chemical stimuli 
(Klein-Nulend, Semeins et al. 1995, Klein-Nulend, van der Plas et al. 1995, 
Roelofsen, Klein-Nulend et al. 1995, Klein-Nulend, Roelofsen et al. 1997, Klein-
Nulend, Helfrich et al. 1998, Pavalko, Chen et al. 1998, Sterck, Klein-Nulend et al. 
1998, Ajubi, Klein-Nulend et al. 1999, Joldersma, Burger et al. 2000, Westbroek, 
Ajubi et al. 2000, Bakker, Soejima et al. 2001, Bakker, Joldersma et al. 2003, 
Bacabac, Smit et al. 2004, McGarry and Prendergast 2004, Bacabac, Smit et al. 
2005, McGarry, Klein-Nulend et al. 2005). Research in this area has centred on the 
effects of either fluid shear stress or direct strain (or both) on cell regulation. The 
design of these in vitro models has predominantly been based on empirical 
calculations for the expected fluid stress or direct strain in physiological bone but 
few, if any at all, have calculated the expected physical properties of biomaterial 
substrates when applied in the clinical setting and related this data to in vitro or in 
vivo data for the same biomaterial. 
 
In this chapter we determine the mechanical environment of porous calcium 
phosphate biomaterials in clinical application and explore the use of computational 
tools to allow better understanding of structure-property relationships for 
experimental and hypothetical biomaterials.  
 
The specific objectives are:  
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aggregate will slide, the interlocking or cohesion of the particles, c, expressed as a 
stress and the normal (compressive) stress, σ, produced by the load supported by the 
aggregate.  
 
 tan c  Equation 18 
        
 
The inter-particle cohesion and the angle of internal friction were measured for 
SiCaP-23G and SiCaP-46G materials using a modification of the "Jenike" or Cam 
shear test (Bolland, Partridge et al. 2006). 
 
The test apparatus is shown schematically in Figure 4-1 and photographs of the 
actual test set-up are shown in Figure 4-2. The principal components of the apparatus 
are an upper and lower stainless steel ring which together forms a cylindrical 
chamber in which the material under test is placed. A plunger, which passes through 
a fixed vertical linear bearing, allows the application of normal stress to the sample 
via dead-weights. The lower ring is mounted in horizontal linear bearings, and 
application of horizontal force to the lower ring causes the sample to be subjected to 
shear stress, with failure in the ideal situation occurring at the shear plane at the 
junction of the upper and lower rings. Small holes in the lower ring beneath sample 
allow the escape of excess fluid from the sample during test and eliminate any 
hydraulic stiffening effects. By conducting tests at each of several fixed normal 
forces and measuring the change in load as the lower ring is displaced horizontally 
under controlled conditions, the shear strength at a range of normal stresses and 
hence the Mohr-Coulomb failure law for the material under test can be determined. 
 
Forty gram (40g) samples of each material were each mixed with 40 ml of 25% 
bovine serum in water (with sodium azide preservative). Three tests at three different 
normal stress levels were performed for each material, giving a total of 18 tests. 
Dead-weights of 50, 150 and 250 N were chosen to give normal stresses of 102, 306 
and 509 kPa respectively. The rate of displacement of the lower ring in all tests was 
0.02 mm/sec (1.2 mm/min). 
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Figure 4-1 Schematic of the Jenike shear test apparatus 
The principal components of the apparatus are an upper and lower stainless steel ring which 
together forms a cylindrical chamber in which the material under test is placed. A plunger, 
which passes through a fixed vertical linear bearing, allows the application of normal stress to 
the sample via dead-weights. The lower ring is mounted in horizontal linear bearings, and 
application of horizontal force to the lower ring causes the sample to be subjected to shear 
stress, with failure in the ideal situation occurring at the shear plane at the junction of the 
upper and lower rings.  
 
 
Figure 4-2 Jenike shear test set-up 
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Figure 4-4 Plots of the shear stress vs. shear strain as a function of normal load 
(Bottom group – 50N; Middle group – 150N; Top group – 250N) 
 
Figure 4-5 Plot of shear stress at 10% shear strain as a function of normal stress 
The Mohr-Coulomb failure parameters were determined by measuring the shear stress at a 
shear strain of 0.1 (10%) for each sample, then plotting this value against the normal stress. 
Error bars represent plus/minus one standard deviation; Top trendline = SiCaP-23G; Bottom 
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A Drucker-Prager material model as described above was used to model the silicate-
substituted calcium phosphates. The parameters for material SiCaP-46G (Table 4-1) 
were used. In many particulate materials dilation accompanies shearing as particles 
ride-up over each other. However, the simple Drucker-Prager plasticity model tends 
to predict excessive dilation, so following Phillips et al, a modification to the 
standard Drucker Prager model using a non-associated flow rule, which introduces a 
further materials parameter, the dilatancy angle, was used. The dilatancy angle was 
set at half the internal friction angle (if the dilatancy angle is equal to the friction 
angle, the flow rule is associative). 
 
 
Figure 4-7 Plots of the distribution of Young's modulus (MPa) in the bone 
Element-by-element materials properties for bone were derived from the CT scans using a 
modified version of the Bonemat software described by Taddei et al (Taddei, Pancanti et al. 
2004). The distribution of modulus in the loaded simulation indicates that bone tissue is stiffest 
in the cortical regions. The defect was in a region of cancellous bone with a modulus lower than 
the surrounding cortical bone.
 
Other materials properties used in the finite element model are shown in Table 4-2. 
The value of Young's modulus for the silicate-substituted calcium phosphate was 
determined from the minimum value of the shear modulus from the mechanical tests 
(6 MPa for SiCaP-46G-50N, Figure 4-3) and the standard equation relating Young's 
modulus E, shear modulus G, and Poisson's ratio υ, (Equation 19). A Poisson's ratio of 
0.4 was assumed, based on the value relevant to medium to loose sands (Anon 
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Figure 4-9 Plot of 1st principal stress (MPa) in the femoral defect model 
The analysis revealed high first principal stresses (indicative of predominantly tensile stresses) 
on the lateral aspect of the femur (green regions)
 
 
Figure 4-10 Plot of 3rd principal stress (MPa) in the femoral defect model 
The analysis revealed high third principal stresses (indicative of predominantly compressive 
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Figure 4-11 Plots of various parameters charactering the mechanical environment of the 
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compute time. The bone, facet joint cartilage, hardware, disc nucleus and the annulus 
ground substance were modelled using 10 node tetrahedral solid elements and the 
ligaments and the fibres of the annulus modelled using link elements. Contact at the 
facet joints and between the silicate-substituted calcium phosphate  and the spinous 
processes was modelled using frictionless contact. Since the material model used to 
represent the silicate-substituted calcium phosphate could result in the silicate-
substituted calcium phosphate becoming geometrically (and hence numerically) 
unstable, the silicate-substituted calcium phosphate  was surrounded by a layer of 
membrane elements of low stiffness to simulate the supporting effects of the 
surrounding soft tissues. Note that the soft tissues (or their confining effects) were 
not explicitly included in the model, although the application of external pressure to 
the membrane elements to simulate the soft tissue confinement could be explored in 
further work. Four views of the complete model are shown in Figure 4-13. 
 
 
Figure 4-13 Finite element model of the lumbar spine undergoing fusion 
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phosphate occurred in the vicinity of the contact of the silicate-substituted calcium 




Figure 4-16 Plot of overall displacements (m) in the spinal model under load 
Red, yellow and green regions indicate peak displacement under load. 
 
 
Figure 4-17 Plot of overall von Mises strain in the spinal model under load 
Peak regions of strain are indicated in light blue, green and yellow. These corresponded with 
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Figure 4-18 Plot of von Mises stress (Pa) in the silicate-substituted calcium phosphate 
component of the spinal model under load. 
The distribution of stress in the silicate-substituted calcium phosphate material was non-
uniform (light blue, green and yellow regions).
 
Figure 4-19 Plot of von Mises strain in the silicate-substituted calcium phosphate component of 
the spinal model under load 
The distribution of strain in the silicate-substituted calcium phosphate material was non-



















































 and has th
































ed in the 
ies. The c
what highe





















r than the 
ngle of in



















8 - 20 kPa
ternal fric




















































Role of Physiochemical Parameters in the Osteogenic Potential of CaP Biomaterials 
Charlie Campion  Page 132 of 299 
phosphate are, in effect, "stress-shielded" by the surrounding bone in much the same 
way as bone may itself be "stress-shielded" in the presence of stiffer materials such 
as joint replacement components. In such circumstances the impact of stress-
shielding is the resorption of bone leading in some cases to the failure of the joint 
replacement. The impact of stress-shielding on the progress of bone repair in our 
simulated defect is also likely to be negative to a certain extent. The in vitro studies 
of mechanobiology reviewed in section 2.3 teach us that osteocytes and osteoblasts 
are upregulated in the presence of direct substrate strain and in response to fluid 
shear stress. In regions of low stress, such as those observed in our simulated defect, 
one might expect the osteocytes and osteoblasts to be upregulated to a lesser extent 





Figure 4-21 Distribution of Young's modulus (MPa) in the region of the defect 
The silicate-substituted calcium phosphate appears to be "stress-shielded" by the surrounding 
bone in much the same way as bone may itself be "stress-shielded" in the presence of stiffer 
materials such as joint replacement components, owing to the considerably greater stiffness 
(Young's modulus) of the surrounding bone. Red, yellow and green regions indicate peak 
stiffness. 
 
One possible source of error is that the present model does not take into account the 
stress-dependence of the Young's modulus of the silicate-substituted calcium 
phosphate. While the effect of stress on the Young's modulus of silicate-substituted 
calcium phosphate is currently unknown, other comparable materials are known to 
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have stress-dependent Young's modulus. For example, Phillips et al. used a linear 
relationship to describe the variation of Young's modulus of morcellised bone graft 
as a function of stress (pressure),  
 
21 ccE          Equation 20 
 
where c1 and c2 are constants set to 5 N/mm² and 35, when and are expressed in units 
of N/mm². 
 
Assuming a similar relationship holds for silicate-substituted calcium phosphate 
(Figure 4-3 suggests that it does), the increase in Young's modulus induced by the 
imposed stresses (approximately 0.016 MPa maximum) would be less than 5%, a 
negligibly small amount. 
 
In the spinal model, stresses in the silicate-substituted calcium phosphate were also 
rather low, reaching peak values of around 22 kPa. This again reflects the low 
Young's modulus of the silicate-substituted calcium phosphate in particulate form 
and its limited load-carrying capacity. In clinical use in this application it is likely 
that tensile stresses applied to the region occupied by the silicate-substituted calcium 
phosphate would be carried by fibrous tissue derived from the haematoma and 
subsequent tissue differentiation within the region rather than the silicate-substituted 
calcium phosphate itself, at least until cellular activity began to generate hard tissue 
bridges between the silicate-substituted calcium phosphate particles. 
 
4.3 Effect of Porosity on Elastic Modulus  
To estimate the Young's modulus of the biomaterials in this study, 2D plane stress 
finite element models were generated from electron micrographs. Segmentation of 
the images into pore and non-pore regions followed by finite element meshing of the 
non-pore regions has been carried out in order to explicitly model the microstructure 
of the biomaterial. The non-pore regions were assumed to have the same mechanical 
properties as bulk "pore-free" biomaterial. Young's modulus was determined from 
the induced continuum level displacements and strains. Local stresses and strains in 
the biomaterials were derived for loadings equivalent to those described in Section 
4.2. 
 
Samples from a single batch of porous silicate-substituted calcium phosphate in 
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Figure 4-22 Image processing and segmentation sequence 
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Figure 4-23 Image processing and segmentation sequence 
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Figure 4-25 Operations for converting image objects into finite element models  
 
In the final mesh preparation step, any elements that were not connected to other 
elements in the mesh ("islands") were also deleted. Since these elements lacked 
continuity with the rest of the mesh, loads could not be transmitted to them and they 
thus had no structural function, so deletion had no effect on the overall behaviour of 
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A comparison of the measured Young’s Modulus from static uni-axial testing with 
the 2-planar FEA model prediction and predictions according to empirical models 
developed for trabecular bone by Linde et al. (Linde, Norgaard et al. 1991, Rho, 




Figure 4-31 Individual plot for static uniaxial compression testing compared to FEA-predicted 
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A comparison of the measured Young’s Modulus from static uni-axial testing along 
with the 2-planar FEA model prediction and data reported from several studies in 
which calcium phosphate of varying density was tested for stiffness is provided in 
Figure 4-32. In this plot data is reproduced from studies in which a variety of 
mechanical testing techniques were used. These include static uni-axial testing 
(Akao, Aoki et al. 1981a, Charriere, Terrazzoni et al. 2001), ultrasonic testing (De 
With, van Dijk et al. 1981, Liu 1998), resonance testing (Arita, Wilkinson et al. 
1995), and indenter testing (Patel 2003). All data reported from the literature was for 
stoichiometric hydroxyapatite containing various levels of porosity in the micropore 
size range. No comparative data for silicate-substituted calcium phosphate could be 
located in the literature.   
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variables (Y) and strain rate and apparent density as independent variables were 
performed. Interestingly, the variations of strength and stiffness were explained 
equally well by the linear and the power function relationship to strain rate. The 
exponent was 0.07 in the power function relationship between strength and strain 
rate and 0.05 between stiffness and strain rate. This dependency of Young’s Modulus 
on strain rate is important and should be considered for future studies. As per Rho’s 
study, the variation of strength and stiffness was explained equally well by the linear, 
power function and quadratic relationship to apparent density. The cubic relationship 
between stiffness and apparent density showed a less good fit.  
 
Figure 4-32 demonstrates that, compared to some previous studies for synthetic 
calcium phosphate, our finite element models under-predicted the effective Young's 
modulus of the ceramic materials by a factor of 2 to 3 (Akao, Aoki et al. 1981a, De 
With, van Dijk et al. 1981, Arita, Wilkinson et al. 1995, Liu 1998, Charriere, 
Terrazzoni et al. 2001). Other authors (Meille and Garboczi 2001) have found similar 
behaviour, albeit for materials made up of "particles" of much greater aspect ratio 
than those considered in this study. Interestingly, the difference between plane stress 
and plane strain two-dimensional models in Meille and Garboczi's study was much 
smaller than the difference between either two dimensional model and the three-
dimensional model, suggesting that the plane stress approach taken in this study was 
not the source of the discrepancy between predicted and experimental results from 
other studies, rather that it was due to the limitations inherent in the reduction from 
three to two dimensions. Since both the two and three-dimensional models of Meille 
and Garboczi were generated from geometric models of hypothetical materials 
(rather than micrographs of real materials, as in the present study), they were able to 
compare other morphological parameters for both two and three dimensional models, 
and found that the percolation threshold (the simplest definition of the percolation 
threshold is that it is the value of porosity at which a large ("infinite") sample of a 
material becomes permeable) for their three-dimensional models was reached at 
about 80% porosity, whereas for the two-dimensional models it was at around 60% 
porosity, suggesting that for a given porosity, the three dimensional model would 




In this chapter we sought to achieve two distinct objectives. These were (a) to use 3D 
finite element models to ascertain the mechanical environment of calcium phosphate 
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biomaterials in clinical applications; and (b) to develop a procedure for generating 
microstructural-level finite element models of calcium phosphate biomaterials from 
electron micrographs and to use the models to estimate the effective Young's 
modulus and the microstructural level stress and strain distribution under loading 
representative of the clinical mechanical environment. 
 
Mechanical testing revealed silicate-substituted calcium phosphate to have similar 
mechanical behaviour to morcellised cancellous bone under similar test conditions. 
Furthermore, we discovered through the creation of novel 3D FEA models that bone 
grafts such as silicate-substituted calcium phosphate appear to be stress-shielded 
when applied in typical applications such as a tumour defect void or in a spinal 
fusion defect. We also learned through the use of novel 2D FEA models that there is 
an inverse exponential relationship between porosity and Young’s Modulus which is 
similar to that described for trabecular bone and hydroxyapatite materials in previous 
studies. 
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5. Chapter Five: Effect of structure and chemistry on the 
Bioactivity of Calcium Phosphate Biomaterials 
5.1 Introduction 
Synthetic biomaterials designed for orthopaedic applications are no longer only 
considered safe and effective if they are inert and do not cause inflammatory 
reactions when implanted in the body. They must now also elicit a response from the 
body which favours the integration of the implant within the host bone 
(Osteointegration) whether the implant is intended for mechanical fixation, in the 
case of a pedicular metallic screw, or for repair; augmentation; or replacement of 
diseased or injured bone, in the case of bone graft extenders and substitutes. Since 
the early 1990’s the potential for osteointegration of a material (its bioactivity) has 
been evaluated by examining the propensity of so-called ‘bone-like apatite’ to form 
on its surface after immersion in a simulated body fluid (SBF) with ion 
concentrations similar to those of human blood plasma (Kokubo, Ito et al. 1990). 
Although other solutions have been used to determine bioactivity, such as 
Dulbecco’s phosphate buffered saline (DPBS) (Gandolfi, Ciapetti et al. 2009), the 
majority of  researchers have applied the method described by Kokubo et. 
al.(Kokubo, Ito et al. 1990, Kokubo, Kushitani et al. 1990) Despite some controversy 
as to the methods reliability, its relevance to the understanding of mechanisms 
behind osteointegration, and the actual nature of the calcium-rich precipitate formed 
on materials Kokubo’s SBF has been used to evaluate the bioactivity of numerous 
types of materials ranging from calcium phosphate ceramics and bioglasses through 
to Chitosan and natural Pearl (Table 5-1).  
 
The objective of this study was to compare the bioactivity of calcium phosphate 
bone grafts of varying chemistry and strut-porosity through determining the rate of 
formation of hydroxycarbonate apatite (HCA) crystals on the material surface and 
the extent to which these crystals formed after the material was soaked in simulated 
body fluid for time periods ranging from 3 to 30 days. 
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Table 5-1 Examples of various materials tested for Bioactivity in Simulated Body Fluid 
Ceramics : Polymers : Biologics / Metals : 
Diopside (Miake, Yanagisawa et al. 1995) Polysulfone (Marcolongo, Ducheyne et al. 
1997) 
Collagen (Li, Zheng et al. 1998) 
Hydroxyapatite (Weng, Liu et al. 1997, Kobayashi, 
Nakamura et al. 1998, Shirkhanzadeh 
and Azadegan 1998, Weng, Wang et al. 
2002, Leng, Chen et al. 2003, Zhang, 
Chen et al. 2003, Yonggang, Wolke et 
al. 2007, Morejon-Alonso, 
Carrodeguas et al. 2008, Oliveira, Silva 





(Du, Klasens et al. 2002) Chitosan (with 
Calcium 
Phosphate) 
(Zhang and Zhang 2002, Liu, Li 
et al. 2006, Leonor, Baran et al. 
2008, Li, Yubao et al. 2009) 
Tricalcium 
phosphate 
(Kobayashi, Nakamura et al. 1998, 
Leng, Chen et al. 2003, Saint-Jean, 
Camire et al. 2005, Camire, Saint-Jean 
et al. 2006, Huan and Chang 2007, 
Morejon-Alonso, Carrodeguas et al. 
2008, Hesaraki, Safari et al. 2009, 
Huan and Chang 2009, Sanchez-
Salcedo, Balas et al. 2009, Vani, Girija 
et al. 2009) 
Polycaprolactone (Rhee, Choi et al. 2002, 
Jaakkola, Rich et al. 2004, 
Chouzouri and Xanthos 2007) 
Starch (with 
Hydroxyapatite) 
(Leonor, Ito et al. 2003) (Leonor 
and Reis 2003, Oliveira, Malafaya 
et al. 2003) 
Wollastonite (Kobayashi, Nakamura et al. 1998, 
Matsuoka, Akiyama et al. 1999, Greish 
and Brown 2001, Cortes, Medina et al. 
2004, Zhang, Ye et al. 2009) 
Polylactic-co-
glycolic acid 
(Lu, El-Amin et al. 2003) Alginate (Kokubo, Hanakawa et al. 2004) 
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Ceramics : Polymers : Biologics / Metals : 
Calcium silicate (Siriphannon, Kameshima et al. 2000, 
Zhao, Wang et al. 2005, Ni, Chang et 
al. 2006, Huan and Chang 2007, Li, Shi 
et al. 2007, Zhao, Chang et al. 2007, 
Ni, Lin et al. 2008, Zhao, Chang et al. 
2008, Coleman 2009, Coleman, 
Awosanya et al. 2009, Gandolfi, 
Ciapetti et al. 2009, Lin, Li et al. 2009, 
Ni and Chang 2009) 
Poly(methyl 
methacrylate 
(Miyazaki, Ohtsuki et al. 
2003, Mori, Ohtsuki et al. 
2005, Sugino, Miyazaki et al. 





(Yoshida, Miyazaki et al. 2006) 
Silica  (Peltola, Jokinen et al. 2001, Izquierdo-
Barbaa 2005, Heinemann, Heinemann 
et al. 2009, Mariappan, Yunos et al. 
2009, Shi, Wang et al. 2009) (El-





(Leonor and Reis 2003) Gelatin (Yoon, Kim et al. 2008) 
Calcium aluminate (Oh, Choi et al. 2003) Polyamide (CaP 
coated) 
(Auclair-Daigle, Bureau et al. 
2005, Kawai, Ohtsuki et al. 
2007) 
Pearl (Shen, Zhu et al. 2006) 




(Lu, Tang et al. 2005) Titanium 
(plasma 
sprayed) 
(Ha, Eckert et al. 1997, Peltola, 
Jokinen et al. 1999, Takadama, 
Kim et al. 2001, Ning and Zhou 
2002, de Medeiros, de Oliveira et 
al. 2008, de Souza, de Lima et al. 









(Huang and Miao 2007) Tantalum (Miyaza, Kim et al. 2002) 
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Ceramics : Polymers : Biologics / Metals : 
Tobermorite (Lin, Chang et al. 2007) Poly-DL-lactic 
acid (45S5 
bioglass additive)
(Chen and Boccaccini 2006, 
Maeda, Maquet et al. 2007) 
 





(Salinas, Merino et al. 2007) 
Octacalcium 
Phosphate 
(Zhang, Leng et al. 2009, Orii, 
Masumoto et al. 2010, Yu, Yu et al. 
2011) 
Polyglutamic acid (Sugino, Miyazaki et al. 
2008b) 
Soda lime (O'Donnell, Watts et al. 2009) Poly(lactic acid) 
(b-TCP and 
Chitosan additive) 
(Wang, Qu et al. 2008) 
Silicon carbide (Will, Hoppe et al. 2010) Hydroxyethylmet
hacrylate 
(Miyazaki, Imamura et al. 
2009) 
Silico Carnotite (Lu, Duan et al. 2010) Poly(lactic acid) 
(b-TCP additive) 
(Kang, Yao et al. 2009) 
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SiO2, TiO2, P2O5, 
Na2O, ZnO, CaF2, 
MgO, SrO, K2O, 
B2O3) 
(Chen, Miyaji et al. 1999, Peltola, 
Jokinen et al. 1999, Vallet-Regi, 
Izquierdo-Barba et al. 1999, Chen, 
Miyata et al. 2000, Miyata, Fuke et al. 
2002, Sepulveda, Jones et al. 2002, 
Fujibayashi, Neo et al. 2003, Oki, 
Parveen et al. 2004, Boyd and Towler 
2005, Vakiparta, Forsback et al. 2005, 
Chen, Thompson et al. 2006, 
Kamitakahara, Ohtsuki et al. 2006, 
Pirhonen, Niiranen et al. 2006, Ni, 
Chang et al. 2008, Wren, Boyd et al. 
2008, San Miguel, Kriauciunas et al. 
2009, Seol, Kim et al. 2009, Towler, 
Boyd et al. 2009, Labbaf, Tsigkou et al. 
2011, Wu, Hill et al. 2011) 
Polyamide 
(CaSiO3 treated) 
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Table 5-2 Simulated body fluid 
 
Order of 











1 NaCl 8.035 g 99.5 58.4430 
2 NaHCO3 0.355 g 99.5 84.0068 
3 KCl 0.225 g 99.5 74.5515 
4 K2HPO4.3H2O 0.231 g 99.0 228.2220 
5 MgCl2.6H2O 0.311 g 98.0 203.3034 
6 1.0M - HCl 39ml - - 
7 CaCl2 0.292 g 95.0 110.9848 
8 Na2SO4 0.072 g 99.0 142.0428 
9 Tris 6.118 g 99.0 121.1356 
10 1.0M - HCl 0-5 ml - -  
 
Table 5-3 Examples of various ratios of test material : SBF solution in the literature 
 
As a concentration (mgml-1) : 
 
 
Per unit area of device (cm-1) : 
0.20 (Peltola, Jokinen et al. 2001) 0.014 (Peltola, Jokinen et al. 1999) 
0.50 (Shi, Wang et al. 2009) 0.020 (Will, Hoppe et al. 2010) 
1.00 (Oki, Parveen et al. 2004, Li, 
Shi et al. 2007, Coleman 
2009) 
0.500 (San Miguel, Kriauciunas et al. 2009) 
1.50 (Lin, Chang et al. 2007) 0.080 (Marcolongo, Ducheyne et al. 1997) 
2.00 (Peltola, Jokinen et al. 1999) 1.000 (Lu, El-Amin et al. 2003) 
10.0 (Sepulveda, Jones et al. 2002) 0.100 (Peltola, Jokinen et al. 1999, Lu, Tang et 
al. 2005, Zhao, Wang et al. 2005, 
Pirhonen, Niiranen et al. 2006, 
Chouzouri and Xanthos 2007, Huan and 
Chang 2007, Zhao, Chang et al. 2007, 
Morejon-Alonso, Carrodeguas et al. 
2008, Ni, Chang et al. 2008, Ni, Lin et al. 
2008, Zhao, Chang et al. 2008, Huan and 
Chang 2009, Lin, Li et al. 2009, Ni and 
Chang 2009, Towler, Boyd et al. 2009, 
Lu, Duan et al. 2010) 
30.0 (Cortes, Medina et al. 2004)  




The test described herein was carried out in duplicate for each test material and 
negative controls at every time-point. The calculated volume of SBF was pipetted 
into a tube (centrifuge) and heated to 36.5oC. After heating the test materials were 
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All treatment groups comprised porous granules which when observed at low 
magnification under scanning electron microscope were found to be formed from 
highly interconnected ultra-macropores. In all groups micropores were visible in the 
walls of the macropores and were also highly interconnected, forming channels 
between the macropores (Figure 5-2a, b, c). At high magnification there was a clear 
difference between the treatment groups in the amount and the morphology of 
microporosity.  The SiCaP-23; SiCaP-32; and SiCaP-46 groups were formed from 
crystallites of approximately 0.5 - 1.0 microns diameter fused together to form 
agglomerates of approximately 2.0 - 20 microns diameter (Figure 5-2b, c). The space 
formed between the packed and sintered agglomerates formed the microporosity 
with the level of porosity visible under the microscope increasing according to the 
following trend: SiCaP-23 < SiCaP-32 < SiCaP-46. The Vitoss group was formed 
from crystallites of approximately 2.0 - 5.0 microns diameter fused together to form 
the walls of the macropores (Figure 5-2a). The micropores in this material were 
formed between the crystallites themselves and not between agglomerated 
crystallites. The volume of microporosity observed in the Vitoss group was 
approximately equivalent to that observed in the SiCaP-46 group. A small number of 
surface contaminants of approximately 0.2 - 1.5 microns diameter were observed on 
all un-treated materials. This observation was attributed to particles being dislodged 
from surface during preparation and initial analysis before immersion in SBF. No 
HCA was present on the surface of the un-treated specimens.  
 
Evidence of carbonate apatite formation was observed on the surface of all test 
materials as early as day 3 after being immersed in SBF. The mode of HCA 
formation for SiCaP-23; SiCaP-32; and SiCaP-46 was consistent between test 
groups. Formation of the HCA layer covered the entire surface of the material after 
only 3 days and was not localised to any one particular surface artefact (Figure 
5-2e,f). In contrast, only very small crystals were formed on the Vitoss and the 
formation of HCA seemed to be localised to grain boundaries and defects or pits on 
the Vitoss material surface (Figure 5-2d). The morphology of the layer formed after 
3 days varied between groups. HCA precipitated on Actifuse had a rod-like 
appearance (Figure 5-2e). The rods were approximately 0.2 microns in length, 0.05 
microns in diameter, and formed a continuous coral-like matrix across the surface of 
the test material. The morphology of the HCA layer on SiCaP-32 and SiCaP-46 was 
lath-like and formed sheets of approximately 0.2 microns in length/depth and 0.01 
microns in thickness (Figure 5-2f). The HCA formation on Vitoss was similarly lath-
like but only in present in small quantities as spherical formations at grain 
boundaries (Figure 5-2d). 
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After 6 days, the rod-like structure observed on Actifuse at 3 days had matured into 
the lath-like structure observed on SiCaP-46 at the earlier time-point (Figure 5-3a) 
whilst the maturity of HCA on SiCaP-32 and SiCaP-46 had reached a state at which 
HCA began forming a secondary architecture above the primary surface layer of 
crystals resulting in a well-established crystal microstructure including pores and 
concavities (Figure 5-3b). The formation of the secondary layer of HCA on Actifuse 
was observed later in the experiment (day 14) (Figure 5-3c). There was no 
substantial change in the size or frequency of the spherical crystal formations 
observed on Vitoss between 3 and 14 days (Figure 5-2a and Figure 5-3d). 
Dissolution of the precipitated carbonate apatite layer was observed after 14 days for 
SiCaP-46 (Figure 5-3e) and 18 days for Actifuse (Figure 5-3f). A number of cracks 
and fissures were observed in the dried HCA layer as early as 14 days for SiCaP-46 
(Figure 5-3e) and after 25 days for Actifuse (Figure 5-4a). This observation was 
absent for Vitoss as no continuous layer of HCA was formed on the surface over the 
course of the experiment although the number of spherical crystal formations 
observed did increase between days 18 (Figure 5-4b) and 30 (Figure 5-4c) and 
secondary structures were observed on the primary HCA crystals after 30 days 
(Figure 5-4c). After 30 days the precipitated HCA on Vitoss continued to form at 
defects or at grain boundaries on the material surface and did not appear to be 
present as a result of interactions (in the form of dissolution – precipitation) with the 
bulk material itself (Figure 5-4d). On the contrary after 30 days immersion all SiCaP 
groups were completely covered in an intimate layer of HCA (Figure 5-4e) with a 
tertiary structure consisting of lath-like sheets forming globular structures in between 
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Figure 5-6 Change in concentration of Calcium ions per day across all groups 0-30 days (a). Change in concentration of Phosphorus ions per day across all groups 
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5.4 Discussion 
The number of clinical procedures performed in the USA in which bone graft was 
implanted was estimated at 1,109,000 in 2010 and is projected to reach 1,295,260 in 
2015 (BioMedGPS 2012). This increasing demand for bone graft substitutes as a 
result of an ever-ageing population coupled with recent reports in the clinical 
literature of concerns regarding the safety of recombinant bone morphogenetic 
proteins such as rh-BMP-2 (Carragee, Ghanayem et al. 2011, Carragee, Hurwitz et 
al. 2011a, Carragee, Hurwitz et al. 2011b, Carragee, Mitsunaga et al. 2011) has led 
to an increased clinical interest in synthetic alternatives, such as porous calcium 
phosphate ceramics, to allograft; autograft; and recombinant growth factors. Whilst 
the preclinical and clinical efficacy of calcium phosphates is relatively well 
described in the scientific and clinical literature there is still a need to better 
understand the mechanisms behind their therapeutic action so that the next 
generation of synthetic bone graft substitutes can be developed with improved safety 
and efficacy.  The effect of structure and chemistry on the in vivo performance of 
calcium phosphate bone graft substitutes in animals has been reported extensively in 
the scientific literature. (Hing, Best et al. 1998b, Hing, Gibson et al. 1998, Hing, 
Merry et al. 1999, Hing, Gibson et al. 2001, Hing 2004b, Hing 2004a, Hing, Saeed et 
al. 2004, Hing, Best et al. 2004, Hing 2005, Hing, Annaz et al. 2005, Hing, Revell et 
al. 2006, Hing, Wilson et al. 2007, Campion, Chander et al. 2011) For example, a 
recent study by this author investigated bone graft performance in an ovine critically-
sized femur defect model and found that increasing the strut-porosity of silicate-
substituted calcium phosphates enhances osteogenesis.(Campion, Chander et al. 
2011) A gap in understanding currently exists between knowing how to manipulate 
the properties of such devices to elicit the desired biological response in situ and 
knowing by which mechanisms this manipulation takes effect. One way to reduce 
this knowledge gap is through the use of in vitro models. The test for bioactivity is 
one such assay and has been reported in the scientific literature for over 20 years. A 
large volume of scientific work investigating the bioactivity of biomaterials has 
preceded this study but only a handful of studies have used the assay described by 
Kokubo et. al. in 1990 as a means for comparing the impact of microstructure on the 
bioactivity of biomaterials and none have specifically investigated the effects of 
chemistry and structure on the bioactivity of porous calcium phosphate bone graft 
substitutes. One such study concluded that the induction period for HCA growth is a 
function of both composition and textural properties such as surface area, pore 
dimensions, density, and porosity (Coleman 2009). This study was designed to 
establish whether the microstructure or chemistry is the predominant factor in 
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determining a calcium phosphate ceramic bone graft substitute’s bioactivity. 
 
Our study was validated as being predictive for the assessment of in vitro HCA 
formation through the use of a negative control. We investigated whether a layer of 
HCA could spontaneously form on the surface of polypropylene containers over the 
30 days of the study. Energy dispersive X-ray analysis and scanning electron 
microscopy of the surfaces of the polypropylene containers confirmed that no such 
spontaneous HCA layer formation occurs under the conditions of the study, 
therefore, any such HCA formation observed for the test materials could be 
presumed to be directly related to the material substrate and not super-saturation of 
the SBF fluid with calcium and phosphorus ions. 
 
We demonstrated that when porous SiCaP ceramics are immersed in simulated body 
fluid a thick continuous layer of carbonate apatite crystals with a complex 
microstructural architecture forms over the surface of the material. The process of 
crystal growth appears multifarious as the layer continues to mature through several 
distinct phases of development. In the initial days following immersion small rod-
like formations were present across the surface of the silicate-substituted materials 
with 23% strut-porosity whereas larger plate-like formations were observed across 
the surfaces of the silicate-substituted materials with 46% strut-porosity. This 
observation of two distinct morphologies of apatite crystal in the same system is 
consistent with the rod-like morphology of hydroxyapatite (HA) and blade-like 
morphology of octacalcium phosphate (OCP) observed in a study investigating the 
method of so-called central dark line formation. (Tseng, Mou et al. 2006) OCP and 
HA are structurally similar so OCP is proposed as a precursor in the development of 
biological apatite’s in vivo. The presence in biological appetites of the central dark 
line, a crystallographic interference occurring at the interface between OCP and HA 
phases, is the evidence substantiating this theory. The hypothesis is further 
corroborated through comparison of dissolution profiles for calcium phosphates; 
OCP is the only phase with stability to dissolution approaching that of HA. 
(Heughebaert 1984) Hydroxyapatite forms more readily in solution at a pH of 7 or 
above(Akao, Aoki et al. 1981b) whereas OCP forms more readily as a pH of 6 or 
below. (Heughebaert 1984) In our study the pH of SBF was adjusted to ~7 by TRIS 
buffer so the fact that we observed both HA and OCP is not surprising. However, the 
rod-like morphology of HA was only observed at early time-points (3 days) and as a 
layer in intimate contact with the underlying SiCaP substrate. At all other time-
points only crystals with the plate-like morphology of OCP were observed, thus, at 
pH ~7 the hydration of OCP to HA does not progress to any great extent and OCP 
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appears to be the more favourable phase.  
 
Whilst on the subject of OCP and HA it is noteworthy that the need for caution to be 
exercised when claiming that precipitates on bioactive ceramics in SBF are “bone-
like apatite” has been identified by other investigators in the past. A study using 
TEM crystal diffraction showed that precipitates on biphasic calcium phosphate 
(BCP) were neither bone-like or apatite (but OCP instead). (Leng, Chen et al. 2003) 
The significance of this in vivo is likely to be negligible as both HA and OCP are 
precursors for the formation of biological apatite, but this author proposes the term 
“precursor of biological apatite” as more appropriate than “bone-like apatite”. 
 
Far fewer crystals with the OCP characteristic and no HA-like crystals were 
observed on the β-TCP materials. After 3 days OCP was present in low quantities 
and only at surface artefacts such as grain boundaries or pore junctions. Other 
investigators have reported similar findings for β-TCP. (Juhasz, Best et al. 2008) 
Juhasz et. al. tested non-porous pressed disks of HA; β-TCP; and Brushite alongside 
each other and found that when β-TCP was placed in SBF there was slight 
dissolution on the surface and at the edges of individual grains of β-TCP, as well as 
the formation of small apatite crystals. In that study the materials were aged for 14 
days and consequently most of the apatite crystals remained sub-micron sized 
although some grew into larger apatite clusters. The tendency of the porous β-
tricalcium phosphate included in our study to develop infrequent HCA globules is, 
however, in contradiction to the majority of earlier reported findings. Most studies 
investigating β-TCP in this assay show no formation of HCA at all (Huan and Chang 
2007, Hesaraki, Safari et al. 2009, Ni and Chang 2009); including an in vivo study in 
rats in which undecalcified sections of the interface between bone and β-TCP were 
examined with SEM-EPMA and no formation of surface apatite layer was observed 
despite there being a high mechanical bone-bonding strength.(Kotani, Fujita et al. 
1991) The results of our study demonstrate that there is a much lower propensity for 
the formation of an OCP-like layer on β-TCP compared to SiCaP after immersion in 
SBF. 
 
At the 6 day time-point a new phase of HCA development on SiCaP treatment 
groups which comprised both new crystal formation and dissolution into the SBF 
was observed in our study. This was evidenced through both our scanning electron 
microscopy of the material surface and ICP-OES analysis for ionic concentrations in 
the SBF supernatant. A large number of OCP-like globular crystals were observed 
by SEM forming over the initial HA-like HCA layer, an observation consistent with 
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those reported in the literature.(Siriphannon, Kameshima et al. 2000) In other studies 
the formation of this secondary layer was noted as proceeding much more readily 
than the initial layer formation although this was not corroborated by our own 
findings.(Saint-Jean, Camire et al. 2005) The formation of these crystals was 
accompanied by HCA dissolution; evidenced through the formation of pits in the 
initial HCA layer, an observation also consistent with findings of previous 
experiments.(Zhao, Wang et al. 2005, Huan and Chang 2007, Zhao, Chang et al. 
2007) Further evidence for the counteracting processes of deposition and dissolution 
can be found in our analysis of the ionic composition of the SBF over the duration of 
the test. Calcium ion concentrations in SBF have been seen to fluctuate over time in 
a large number of previous experiments.(Peltola, Jokinen et al. 1999, Peltola, 
Jokinen et al. 2001, Takadama, Kim et al. 2001, Miyata, Fuke et al. 2002, Leonor 
and Reis 2003, Kokubo, Hanakawa et al. 2004, Kamitakahara, Ohtsuki et al. 2006, 
Chouzouri and Xanthos 2007, Guo, Zhou et al. 2008, Leonor, Baran et al. 2008, 
Coleman 2009, Leonor, Balas et al. 2009, Li, Yubao et al. 2009, Lopes, Corbellini et 
al. 2009) In our study there was a significant drop in calcium concentrations for all 
treatment groups between days 0 and 6. After day 6 the extent of fluctuation between 
dissolution and precipitation depended on the strut porosity of the material. The 
materials with low strut porosity (23%) gave rise to the most notable fluctuations 
between days 6 and 14 which then subsided thereafter whereas the materials with a 
higher strut porosity (32, 46%) resulted in less extreme fluctuations which continued 
through to day 30. The changes in phosphorus ion concentrations follow the same 
pattern as observed for calcium. These observations confirm that there is a structural 
dependence in the precipitation-dissolution dynamics of HCA formation in SBF. 
 
Let us first consider the dependence of precipitation on substrate structure. The 
presence of pores has been demonstrated as important for the precipitation of HCA. 
(Izquierdo-Barbaa 2005, Li, Shi et al. 2007) Previous investigators have argued the 
size of HCA crystals is related to the number of available nucleation sites; the fewer 
the number of nucleation sites, the larger the spherical crystals can grow.(Zhang, 
Chen et al. 2003) Therefore, the morphology of the starting material surface can 
contribute nucleation sites for HCA crystallisation, more specifically the surface area 
of the substrate and the presence of micropores or microcracks in the surface of a 
bioactive substrate which can provide sites for HCA nucleation.(Saint-Jean, Camire 
et al. 2005) It is proposed that as the superposition of the surface potentials inside 
micropores increases the ionic concentration and degree of super-saturation of Ca 
and P ions, the precipitation of HCA is more likely to occur first inside the 
pores.(Pereira MM 1994) According to the literature pores of approximately 3 
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microns, such as those in the SiCaP treatment groups, are favourable to implant 
bioactivity, since the pores contribute to the anchorage of HA nuclei preceding the 
layer growing. (de Souza, de Lima et al. 2011) In one previous study nucleation of 
HCA began firstly on the surfaces of recessed regions and pores, or along micro 
cracks pre-existing in the surface prior to exposure to SBF which is consistent with 
this theory and with our own observations for the beta-TCP treatment group on 
which HCA was only associated with cracks or fissures in the surface of the material 
and the SiCaP groups on which the greatest overall amount of HCA deposition was 
observed (through SEM analysis) on the material with the greatest amount of strut-
porosity.(Weng, Liu et al. 1997) The dependence of HCA layer dissolution on 
substrate structure will follow the same principle: the fewer the number of size of 
pores and cracks in the surface of the material, the lower the probability for any local 
increases in calcium and phosphorus in the SBF, and the greater the probability for 
dissolution. This may explain the greater fluctuation in the ionic concentrations of 
these ions in the SBF for materials with a lower strut-porosity. 
 
5.5 Conclusions 
The propensity for the formation of either HA or OCP as a continuous, un-broken 
layer over the implant surface immediately after implantation into bone is in theory 
likely to be significant to the processes of osteointegration; the greater the surface 
area covered by this layer the better the opportunity for interdigitation with host 
bone. In practice this assumption is still under debate as the in vivo studies in support 
of the outcomes of the bioactivity test are often contradictory.   In our study 
formation of HCA was noted on all four test materials. The rates of formation and 
quantities of HCA varied among different materials. Under the conditions of the test, 
the fastest rate of HCA growth was observed on SiCaP-32 and SiCaP-46 followed by 
SiCap-23 (Actifuse).  The quantity of HCA formed on Vitoss surface was much 
lower than the other three test materials. These results indicate that the strut-porosity 
of a material substrate should be increased to maximise the potential for formation of 
a precursor to bone-like apatite after implantation in osseous defects and further 
confirms previous reports that beta-tricalcium phosphate is much less bioactive than 
silicate-substituted hydroxyapatite and thus less likely to facilitate successful 
osteointegration when implanted in bone. 
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6. Chapter Six: Effect of Microstructure and Delivery 
Presentation on Osteoinductivity of Calcium Phosphate 
Bone Graft Substitute Biomaterials 
 
6.1 Introduction 
A considerable number of scientific articles have been published describing the 
osteoinductivity of calcium phosphate (CaP) based bone graft substitutes since the 
mid 1990’s (Chan, Coathup et al. , Yang, Yuan et al. 1996, Yang, Yuan et al. 1997, 
Yuan, Yang et al. 1998, Yuan, Zou et al. 1998, Yuan, Kurashina et al. 1999, Yuan, 
Li et al. 2000, Eid, Zelicof et al. 2001, Yuan, De Bruijn et al. 2001a, Yuan, Yang et 
al. 2001, Gosain, Song et al. 2002, Barrere, van der Valk et al. 2003, Daculsi 2004, 
Fujibayashi, Neo et al. 2004, Habibovic, Yuan et al. 2005, Le Nihouannen, Daculsi 
et al. 2005, Habibovic, Sees et al. 2006, Habibovic, Yuan et al. 2006, Kondo, Ogose 
et al. 2006, Yuan, van Blitterswijk et al. 2006a, Yuan, van Blitterswijk et al. 2006b, 
Bodde, Cammaert et al. 2007, Li, Habibovic et al. 2007, Fellah, Gauthier et al. 2008, 
Habibovic, Gbureck et al. 2008, Habibovic, Kruyt et al. 2008, Cheng, Ye et al. 2009, 
van Gaalen 2009, Coathup, Samizadeh et al. 2011, Coathup, Hing et al. 2012). As a 
result of this extensive research a number of investigators have put forward 
hypotheses for the mechanisms for calcium phosphate derived osteoinductivity. 
These include Ripamonti who suggested that the concavities in the surfaces of such 
materials could lead to the condensation of elevated levels of bone morphogenetic 
proteins from the circulation and thus provide sites where there was a greater 
likelihood for stem cell differentiation down the osteoblastic lineage (Ripamonti 
1996). After observing a difference in osteoinductive properties of calcium 
phosphates apparently according to their solubility, Habibovic later suggested that 
Osteoinductivity could be attributable to the formation of an apatite-like layer on the 
surface of substrates following a process of calcium and phosphorus dissolution and 
re-precipitation (Habibovic, van der Valk et al. 2004, Habibovic, Yuan et al. 2005). 
At the same time Le Nihouannen et al made a link between dissolution of calcium 
phosphates and the formation of particulate debris and subsequent bone formation in 
muscle pouches formed in sheep (Le Nihouannen, Daculsi et al. 2005). This group 
suggested that the local release of inflammatory cytokines as a result of macrophage 
activation might then stimulate circulating stem cells to differentiate into osteoblastic 
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cells producing bone tissue. This pathway, they argued, was corroborated by the 
absence of chondrocytes in these sites of new intramembranous bone formation. A 
useful summary of all proposed mechanisms for ectopic bone formation by calcium 
phosphate based ceramics is provided by Barrere et al. (Barrere, van der Valk et al. 
2003). This group proposed that osteoinduction by porous calcium phosphate 
ceramics can be attributed to either (1) the incorporation and concentration of bone 
morphogenetic proteins (BMPs) by CaP crystals; (2) a low oxygen tension in the 
central region of the implant that triggers the pericytes of microvessels to 
differentiate into osteoblasts; (3) a rough surface produced by the 3D microstructure, 
which causes the asymmetrical division of mesenchymal cells that produce 
osteoblasts; (4) the surface charge of the substrate, which triggers cell differentiation; 
(5) the bone-like apatite layer formed in vivo that is recognized by mesenchymal 
cells; and/or (6) the local high level of free Ca2+ provided by the CaP material, which 
triggers cell differentiation and bone formation. However, despite what is known 
about calcium phosphate derived osteoinductivity there remains a great deal that is 
unknown. The primary objective of this chapter is to dig deeper into these 
mechanisms by comparing the results of our own osteoinductivity studies with those 
reported previously in the literature.  
 
When used clinically calcium phosphate based bone graft substitutes are typically 
delivered in a carrier which provides the device the desired mouldability, cohesivity, 
and adhesivity to suit application by surgeons to irregularly shaped bone defects 
deep inside the human body. A recent study by Barbieri et al. investigated the 
influence of different polymeric gels on the ectopic bone forming ability of an 
osteoinductive biphasic calcium phosphate ceramic (Barbieri, Yuan et al.). This 
study concluded that the chemistry and dissolvability of aqueous based carriers can 
affect the osteoinductivity of biphasic calcium phosphates and that aqueous 
Poloxamer did not significantly reduce the amount of bone formed in muscle defects 
compared to a control biphasic calcium phosphate implanted without a carrier. A 
further study by the same group, however, proposes that the prolonged storage of tri-
calcium phosphate (TCP) or biphasic (BCP) CaP ceramics in such aqueous carriers 
will eventually lead to their hydrolysis over time, which could ultimately be 
detrimental to the osteoinductivity of the TCP or BCP through changes to the 
biomaterial. As a secondary objective for this chapter we aim to investigate the long-
term chemical stability of silicate-substituted calcium phosphate (SiCaP) stored in an 
aqueous carrier and to determine the effects of this carrier on the osteoinductivity of 
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chondrocytes began to calcify in regions closer to the centre of the forming bone. 
Eventually this boundary reached a deep, rich fuscia colour which indicated the zone 
of ossification and the presence of ossified tissue. This endochondral bone was 
clearly distinct from the intramembranous bone in the same defects due to the 
presence of circular voids formed as the chondrocytes became hypertrophic (Figure 
6-6b). Endochondral bone formation is most typical at epiphyseal end plates or at 
sites of secondary fracture healing and thus the macroscopic morphology follows the 
necessary function of the preceding cartilaginous structure in these sites. The same 
was true in our studies in which the morphology of the endochondral bone matched 
the pre-existing spaces formed between the implanted granules into which 
fibrocartilagenous and cartilaginous tissues had infiltrated and colonised. The precise 
origin of these cartilaginous tissues was not evident using histological analysis as 
there were no signs of stromal cells at any of the 8, 12, or 24 week time-points. 
 
Intramembranous bone formation exhibited all the expected traits for ossification via 
this pathway despite being formed in a non-bony site. The gradual layering down of 
new bone in a centripetal fashion on the surfaces of macropores was seen in all 
groups at all time-points (Figure 6-7a). Of interest was the observation that new bone 
formation took place in the smallest of the macropores, some measuring below 
100microns (Figure 6-7b & Figure 6-7b). Layers of blue-staining cuboidal 
osteoblasts generated osteoid which was then mineralised to form pink-staining 
mature lamellar bone (Figure 6-7a-c). This new layer of mineralised tissue was 
usually found in intimate contact with the graft surface but also bridged between 
granules (Figure 6-7a & Figure 6-7c). Considerable numbers of osteocytes were 
located deep within the osteoid, evidently trapped in the mineralising tissues as the 
ossifying front increased in thickness layer by layer (Figure 6-7a-c). In sites of 
mature bone formation the development of Haversian-like systems in which 
neovessels penetrated through the osteoid matrix were also observed (Figure 6-7c). 
Osteoclasts were found located on the surfaces of the graft itself, indicating that 
some degree of cell-mediated resorption of the silicate-substituted calcium phosphate 
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being found in most sites alongside graft degradation, some regions in the defects 
were completely devoid of bone and this appeared to correlate to areas in which the 
ceramic granules had undergone substantial graft dissolution and in which a large 
population of phagocytic cells had subsequently began to assemble (Figure 6-13a-
cc). The approximate frequency for this observation was two to three granules from 
each defect site and there appeared to be no pattern to the distribution of these 
degraded granules with regard to location in peripheral or central regions of the 
defect. The infiltrated tissues in these granules were characterised by large numbers 
of macrophages containing graft particles. The engulfed particles appeared to be sub-
micron in size and to have emanated from the material surface. The inflammatory 
response appeared to be predominantly mediated by degradation of the material 
surface and not caused by the presence of phagocytic cells. However, the presence of 
active osteoclast or macrophage like cells at the graft surface suggested that the 
degradation was at least in part cell-mediated (Figure 6-13a).  
 
This characteristic degradation and associated mild inflammatory response was most 
apparent inside the macropores of the granules, where the highest numbers of 
macrophages were observed. It was not clear whether this was due to a greater 
amount of degradation occurring within the deeper macropores compared to external 
surfaces of the granules or whether this was attributed to there being less effective 
transport of particles away from these deeper pockets in the graft. Although not 
quantified with semi-quantitative histopathology there was an apparent trend for 
increasing graft degradation with increasing strut-porosity. There was no noticeable 
difference between the SiCaP-32G and SiCaP-32P treatment groups so the aqueous 
carrier did not appear to exacerbate the dissolution prior to implantation (Figure 
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were present at 891, 839 and 757 cm-1 as a result of the presence of SiO4 groups in 








Figure 6-21 (a) XRD traces for aged and un-aged SiCaP-32P, (b) XRF data for 
aged and un-aged SiCaP-32P, (c) FTIR traces for aged and un-aged SiCaP-32P 
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amount of heat provided to a densifying green body during sintering will affect the 
amount of resultant porosity in the sintered product; the greater the amount of heat 
energy provided to the system during sintering, the greater amount of shrinkage and 
smaller the volume of voids (pores) found between the fusing particles. Yang et al. 
began investigating the impact of the amount of micro-porosity (manipulated 
through sintering) on the osteoinductivity of calcium phosphate ceramics in the mid 
1990’s (Yang, Yuan et al. 1996, Yang, Yuan et al. 1997). This group’s observations 
in their initial research were of intramembranous bone formation in very close 
contact with the material surface after implantation in the dorsal muscle of dogs and 
under the dermal tissues of pigs. At fifteen days post-implantation they observed 
granulation-type fibroconnective tissue containing fibroblasts, macrophages, and 
newly formed vessels in the defects. After thirty days the fibroconnective tissue was 
well-organised parallel to the surface of the implanted material and polymorphic cell 
aggregates as well as multinucleated giant cells were observed. By forty five days 
the cell aggregation was more obvious and osteoblastic cell differentiation occurred 
directly within the polymorphic mesenchymal cell clusters which were evident at the 
pore surfaces. Woven bone was present by day sixty. The observations made by 
Yang et al. mirror our own study in which woven bone was found in direct contact 
with the implanted graft materials approximately sixty days post-implantation 
(Figure 6-18 & Figure 6-19).  
 
Yang et al. also reported that at ninety and one hundred and twenty days post-
implantation there were signs of osteoclasts and the development of trabeculated, 
remodelled bone. This observation is also corroborated by our own data as we also 
observed osteoclast-like cells on the surface of the graft (Figure 6-13) and also found 
evidence of cell-mediated resorption (Figure 6-7) as well as the development of a 
mature, trabeculated bony structure after nearly six months implantation (Figure 
6-11 & Figure 6-12). Yang et al. proposed that (micro-cellular) environmental 
mechanisms for osteoinductivity are facilitated by: vessel ingrowth as a result of 
large, well-interconnected macropores; cellular adsorption and differentiation of 
cells as a result of the microporosity; crystallisation of apatite on the material 
surface; and increased localised calcium concentrations. Each of these mechanisms 
appears to be plausible based on our own observations in our present study but 
further interpretation of our own result is required to determine which mechanism is 
most influential.  
 
The same group later published a study in which hydroxyapatite with and without 
microporosity, in addition to microporous alpha tricalcium  phosphate, beta 
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tricalcium  phosphate, biphasic calcium phosphate (HA/TCP), and titanium dioxide 
materials were implanted into the dorsal muscles of dogs (Yuan, Yang et al. 1998). 
The hydroxyapatite containing microporosity was sintered at 1100oC or 1200oC and 
thus two HA groups containing different levels of microporosity were implanted in 
total. In this important study the researchers found that there was no bone formation 
in any of the HA implants in which there was no microporosity whereas bone was 
observed in HA constructs with microporosity. The amount and quality of bone 
seemed to improve with increasing porosity i.e. more mature bone was found at 
earlier time-points in materials with greater levels of microporosity (those sintered at 
1100oC rather than 1200oC). Yuan et al.’s study was the first to characterise and 
report the impact of amount of microporosity as a specific pore population on the 
osteoinductivity of calcium phosphates. The same group went on to publish a 
number of articles exploring the role of micro- and macro- porosity in ectopic bone 
formation (Yuan, Kurashina et al. 1999, Yuan, De Bruijn et al. 2001a, Yuan, de 
Bruijn et al. 2001b, Yuan, Yang et al. 2001, Habibovic, Yuan et al. 2005, Habibovic, 
Sees et al. 2006, Habibovic, Yuan et al. 2006, Yuan, van Blitterswijk et al. 2006a, 
Habibovic, Gbureck et al. 2008, Habibovic, Kruyt et al. 2008). Their continuing 
research, although confounded through the inclusion of a variety of calcium 
phosphate phases including alpha tricalcium phosphate; beta-tricalcium phosphate; 
hydroxyapatite; biphasic calcium phosphate amongst others, demonstrated a clear 
link between microporosity and the propensity of calcium phosphate scaffolds to 
form bone in non-bony defect sites. The data from their research closely matches the 
outcomes for our own study in which we observed a trend of increasing bone 
formation with increasing strut-porosity that reached statistical significance (p<0.05) 
at 12 weeks when comparing materials with 23% microporosity with materials with 
46% microporosity (Figure 6-18). When plotting the Bone Area for each treatment 
against time on a scatter plot a pattern for more bone at earlier time-points in more 
microporous materials became apparent (Figure 6-22). 
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Figure 6-22 Summary of increase in Bone Area over time for each treatment group 
 
Yuan et al. characterised osteoinductivity as a process in which osteogenic precursor 
cells became attached to the pore surface, aggregated, proliferated, differentiated, 
produced bone matrix, and ossified. Their team observed that bone formation started 
on the pore surface and proceeded to the pore centre in a centripetal fashion, much 
the same as might be expected in an orthotopic defect (Campion, Chander et al. 
2011). We observed the same close association between the surface of the material 
and the integrating bone tissue (Figure 6-7, Figure 6-8, Figure 6-11, Figure 6-12). 
We also observed the same centripetal bone formation which started on the surface 
of macropores and grew layer by layer towards the centre of the pore (Figure 6-7). 
Perhaps uniquely, we also found bone cells attaching to the surface and infiltrating 
the graft itself (Figure 6-9 & Figure 6-10). This may go some way to explaining why 
we observed an apparent lag in the volume of bone forming in materials with less 
microporosity in these ectopic sites (Figure 6-22). This lag is even more apparent 
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Figure 6-23 Summary of increase in Bone Contact over time for each treatment group 
 
In our study there appeared to be a substantial improvement in the amount of bone-
surface contact through the inclusion of more microporosity in the material substrate. 
It seems logical that providing a three-dimensional network of surface connecting 
pores - which are preferentially colonised by circulating osteoblastic precursor cells - 
would lead to a greater propensity for the material to form intramembranous bone on 
its surface. To further expand on this point – this may be preferential for more than 
just the obvious reason that more cell attachment leads to greater differentiation of 
precursor cells into osteoblasts. The cells which colonised the micro-pores in our 
study appeared to have the morphology of osteocytes, in that they were multi-
dendritic and were in many cases connected to one another through these cellular 
extensions (Figure 6-12). Osteocytes have been well-characterised as the 
predominant bone cell phenotype responsible for modulating bone formation and 
remodelling through mechanotransduction, since an interconnected three-
dimensional network is a very attractive structure for providing a mechano-sensing 
function and this is where osteocytes, which comprise >95% of the number of cells 
in bone, are located in physiological bone (Burger and Klein-Nulend 1999b). The 
lacunar-canalicular network in natural bone is an interconnected porous scaffold 
which allows for the transfer of fluid and small molecules from the surface to the 
centre of bone. This lacunar-canalicular porosity allows for the recruitment of new 
osteoblasts with anabolic paracrine factors excreted in the extracellular matrix by 
osteocytes, the mechanosensing cells of bone (Sikavitsas, Bancroft et al. 2003). In 
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When combined, the amount of graft and new bone in the defects characterised in 
our study appeared to reach equilibrium at between 35-40% defect area for all 
groups at all time-points excluding SiCaP-46G (Figure 6-24a-c). In contrast, for the 
SiCaP-46G group there was a trend for increasing overall area occupied by graft and 
new bone (Figure 6-24d). At 24 weeks post-implantation this had reached 
approximately 45% of the total defect area. There is variation in the reported 
literature as to how much bone is observed in biomaterials at relatively longer time-
points post-implantation. Bone and graft material were absent at only 150 – 168 days 
post-implantation for TCP (Yuan, De Bruijn et al. 2001a) and OCP (Barrere, van der 
Valk et al. 2003). Whereas bone and graft were present after 1 - 2.5 years for HA 
(Yuan, Yang et al. 2001, Gosain, Song et al. 2002) and after a similar amount of time 
in Titanium materials (Fujibayashi, Neo et al. 2004). This indicates that graft 
stability and the sustained presence of a scaffold may be important in the long-term 
osteoinductive effect of biomaterials. In our study there was clear evidence of 
dissolution of the graft over time (Figure 6-24). This reduction in graft volume was 
at least in part through cell mediated mechanisms, but with the extent of graft 
dissolution observed, chemical dissolution must also have contributed to this trend. 
However, even at 24 weeks post-implantation the scaffold was present in all defects 
analysed and despite the SiCaP-46G generally having a lower amount of scaffold 
remaining at 24 weeks compared to the other groups the graft still occupied 
approximately 15% of the area of analysed sections on average. This reduction in 
graft volume over time corresponded to an increase in contact between new bone and 
graft surface so clearly the graft continues to be of utility to ongoing bone growth 
and remodelling even after nearly six months implantation in these ectopic sites. 
This again points to the importance of the provision of a three-dimensional network 
and scaffold to the formation of bone in ectopic sites. There is no better evidence for 
this than the fact that resorbable grafts such as TCP and OCP do form bone in 
ectopic sites but as soon as they dissolve, as they inevitably do, the bone resorbs 
whereas for non-resorbable grafts, such as HA and Titanium, bone is present for as 
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propensity to form a bioactive layer than a tricalcium phosphate with a high surface 
area.  
 
One fundamental finding in our study seems to dispel the theory that the propensity 
of materials to form bone in ectopic sites is almost entirely linked to their surface 
area. In a scenario where a layer of bone-promoting material is formed on the surface 
of an implant of fixed volume but with varying surface area, the proportion of bone 
contact would be expected to remain constant with increasing surface area (as 
surface area increases the amount of sites available for bone growth increases 
proportionally) but the relative volume of bone in the graft would increase with 
surface area (as the absolute amount of bone forming within the fixed volume would 
increase with more bone nucleation sites). Hypothetical representations of this are 
provided in Figure 6-25. 
 
  
 Figure 6-25 Hypothetical schematics for increase in bone contact and bone area over time with 
varying surface area 
 
In our study however, whilst the contribution of surface area to amount of bone 
present in the voids was as expected (Figure 6-22 c.f. Figure 6-25) the surface area 
also contributed to the proportion of surface area covered by new bone (Figure 6-23 
c.f. Figure 6-25). In fact, there was a greater lag for bone contact than for bone 
volume. This hints at the involvement of factors other than surface area in the rate of 
bone development. 
 
In addition to our observations, there exist a substantial number of articles which 
contradict the notion that dissolution-reprecipitation reactions govern bone formation 
in ectopic sites. In a previous study microporous hydroxyapatite materials which 
were implanted into fatty tissues and intraperitoneal sites of hamsters were shown to 
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hydroxyapatite in terms of (a) morphology (size and shape) of crystals; (b) the 
intimate association of the new inorganic phase with the surrounding organic tissues; 
(c) inclusion of carbonate (CO3-) groups; (d) electron diffraction pattern which in 
contrast to phase pure stoichiometric hydroxyapatite shared the same peaks as 
natural bone mineral (Heughebaert, LeGeros et al. 1988). Heughebaert et al. also 
reported that the same inorganic layer was observed on materials implanted in both 
anatomical sites so the process behind this formation was, to a large extent, 
independent of cellular and acellular microenvironment. However, despite the 
formation of bone-like mineral in these sites mature bone itself was not observed. 
This may be a result of a genetic disposition of hamsters which, like other small 
animals such as rodents and rabbits, are reported not to tolerate bone formation in 
calcium phosphates implanted in ectopic sites – a common theme in the available 
scientific literature. However, despite hydroxyapatite being widely reported as a 
highly bioactive substrate, readily capable of forming an apatite-like layer on its 
surface (Weng, Liu et al. 1997, Kobayashi, Nakamura et al. 1998, Shirkhanzadeh 
and Azadegan 1998, Weng, Wang et al. 2002, Leng, Chen et al. 2003, Zhang, Chen 
et al. 2003, Yonggang, Wolke et al. 2007, Morejon-Alonso, Carrodeguas et al. 2008, 
Oliveira, Silva et al. 2009, Sanchez-Salcedo, Balas et al. 2009, Campion, Ball et al. 
2013), microporous hydroxyapatite has been reported as having a low 
osteoinductivity by the researchers supporting the theory connecting apatite-layer 
formation and osteoinductivity (Habibovic, Yuan et al. 2005, Habibovic, Kruyt et al. 
2008, Yuan, Fernandes et al. 2010). Perhaps even more remarkable is a study in 
which macroporous Bioactive glass (45S5) was implanted into the thighs of dogs 
wherein bone was found throughout the graft but more preferably in regions where 
an apatite-like layer was not present (Yuan, de Bruijn et al. 2001b). This study 
highlights the potential role of silicon in the upregulation of attached osteoblast cells 
instead of having a role in the development of an apatite-like layer on the surface of 
the biomaterial. The mechanisms for the direct role of silicon in upregulation of 
osteoblasts are described in section 2.5.3.A. The same researchers have reported a 
high-level of osteoinductivity for pure beta-tricalcium phosphate (Yuan, Fernandes 
et al. 2010) despite beta-tricalcium phosphate having been found previously to have 
a very low propensity to form a bioactive layer of bone-like apatite on its surface 
(Huan and Chang 2007, Juhasz, Best et al. 2008, Hesaraki, Safari et al. 2009, 
Campion, Ball et al. 2013).  
 
The data substantiating the importance of calcium and phosphorus dissolution and 
re-precipitation on the osteoinductivity of calcium phosphates is thus unclear from 
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6.5 Conclusions 
Our study corroborates the findings in the literature that the mechanism for calcium 
phosphate derived osteoinductivity is not likely to be closely associated with any 
biological reactions to the graft which take place in the first twenty four hours after 
implantation. Coupled with the observed colonisation of micro-pores by cells with an 
osteocyte-like morphology, the fact that the implanted and host microporous 
networks were continuous with each other appears to substantiate the importance of 
the role of osteocytes in the rate of bone formation in materials with microporosity 
and it seems logical that with more microporosity there is a greater opportunity for 
their role to be more influential. 
 
Our data substantiates the importance of the provision of a three-dimensional 
network and scaffold to the formation of bone in ectopic sites. There is no better 
evidence for this than the fact that resorbable grafts such as TCP and OCP do form 
bone in ectopic sites but as soon as they dissolve, as they inevitably do, the bone 
resorbs whereas for non-resorbable grafts, such as HA and Titanium, bone is present 
for as long as the graft remains in situ. 
 
Unlike Le Nihouannen and many other researchers, we found endochondral bone 
formation as well as intramembranous bone formation, often in close proximity to 
one another, thus demonstrating that not only a macrophage-induced inflammatory 
trigger for stem cell differentiation is responsible for bone formation in ectopic 
defects. 
 
We found abundant levels of bone in direct contact with phase pure hydroxyapatite 
but there were no obvious signs of a boundary layer between the hydroxyapatite and 
the newly formed bone. The zone of integration appeared to be continuous from the 
synthetic phase to the physiological phase of mineral. In our study the pre-requisite 
for a bone-like apatite to form on the surface in order for bone formation to take 
place was not apparent. 
 
Our chemical analyses confirm that over the period of accelerated aging equivalent 
to five years aging at room temperature there were no changes in chemical 
composition of silicate-substituted hydroxyapatite ceramic when combined with an 
aqueous Poloxamer gel. 
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7. Chapter Seven: Effect of Strut-porosity on the 
Performance of Calcium Phosphate Biomaterials in an 
Orthotopic Bone Defect Study 
7.1 Introduction 
The structural characteristics of synthetic bone graft materials are also pivotal to the 
extent to which they can elicit a positive cellular response to their implantation.  The 
microenvironment within the graft appears to influence the process of osteogenesis.  
One of the key features of synthetic bone grafts is the level of macroporosity (where 
macroporosity can be considered as pores >50 m in size) and strut (micro) porosity 
(pores <50 m in size) which play an important role in vascularisation of the bone 
graft, which supports the proliferation and differentiation of osteoblasts and the 
ingrowth of new bone into the graft itself (Hing 2004b).  In common research terms, 
microporosity and strut porosity are used interchangeably.  Strut pores are formed 
from the interconnected spaces existing between particles of calcium phosphate 
which have been sintered together to form the struts in the scaffold of calcium 
phosphate biomaterials.  The term ‘strut-porosity’ is used to describe the average 
pore volume fraction within the struts that form the walls around the macropores.  
Studies conducted with various different bone graft materials suggest a greater 
degree and faster rate of bone penetration as the macroporosity of the scaffold 
increases (Klawitter, Bagwell et al. 1976, Holmes, Mooney et al. 1984, Eggli, Muller 
et al. 1988, Kuhne, Bartl et al. 1994, Hing, Best et al. 2004).  Increased levels of strut 
porosity also appear to promote the faster apposition of greater volumes of new bone 
demonstrating a more dense morphology within time points up to 24 weeks post-
implantation (Hing 2004b, Hing, Annaz et al. 2005).  Similarly, the degree of 
structural interconnectivity between the pores of the graft material appears to 
influence the speed and extent of the development of the vascular network vital for 
new bone formation (Eggli, Muller et al. 1988, Rubin, Popham et al. 1994). 
 
The primary purpose of the current study was to investigate the potential benefits of 
increasing the strut porosity in synthetic bone graft substitutes on osteogenesis bone 
graft implants in an ovine critical-sized intraosseus defect model.  The first study 
(Study A) validated the ovine critical defect model and its capacity for repair using 
microporous synthetic bone graft substitutes.  The biological response of empty 
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Assessment of the absolute graft volume (CTAGV) in SiCaP-46G and SiCaP-46P 
treated defects by micro CT indicated that there was a reduction in CTAGV from 8 to 
12 weeks but these differences were not statistically significant (Figure 7-13).  
 
Figure 7-12 Mean percentage normalised bone volume (micro CT) for SiCaP-23G 
and SiCaP-23P over 12 weeks 
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Figure 7-13 Mean percentage absolute graft volume (micro CT) 
For SiCaP-46G and SiCaP-46P over 12 weeks 
 
7.4 Discussion 
Synthetic bone graft substitutes are utilised for a number of indications including 
spinal fusion procedures.  The various synthetic bone graft substitutes available for 
clinical use appear to differ somewhat in their bone forming properties (Patel, 
Brooks et al. 2005, Hing, Wilson et al. 2007).  The physiochemical properties of 
these materials appear to be critical to the potential for osteogenesis observed under 
pre-clinical settings.  For example, in previous studies, we have highlighted the 
importance of silicate ion incorporation into a hydroxyapatite scaffold (SiCaP) on 
the bone forming properties of synthetic bone graft substitutes (Patel, Brooks et al. 
2005, Samizadeh, Coathup et al. 2007 ).  In this study, we evaluated how the strut 
porosity of the scaffold material may affect the osteogenic response of synthetic 
bone graft substitutes.  We modified the strut porosity of SiCaP and determined the 
osteogenic properties (or capacity) of six SiCaP test materials in the ovine cancellous 
defect model.  The critical defect model represents controlled injurious environments 
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that preclude spontaneous healing by physiologic repair processes that are ideal for 
testing the in vivo properties of synthetic bone graft materials (Schmitz and Hollinger 
1986, Hollinger and Kleinschmidt 1990).  The ovine model has been used 
successfully in other studies to assess the osteogenic capacity of calcium phosphate-
based implants (Simmons 1976 , Patel, Brooks et al. 2005).  The rationale for 
selecting this model was based on the similarity between bone metabolism in sheep 
and that in humans (Staller, Richardson et al. 1995) and the fact that sheep support 
their body weight post surgery on treated limbs (Nunamaken 1998, Flautre, 
Delecourt et al. 1999), and the size of the animal permits the creation of a 
practically-sized defect (Patel, Best et al. 2002).  We made metaphyseal defects in 
the medial femoral condyle as this site bears more weight and so would be expected 
to encourage mechanical stimulation around the implant, thus encouraging bone 
ingrowth and remodelling.  The site is also physiologically challenging since it is 
only constrained at the lateral aspect by a loose muscle fascia and thus also tests for 
graft migration from the defect.   
 
The findings from Study A supported previous validations of this model as a 
critically-sized defect model, where spontaneous bone formation did not occur in 
untreated (control) defects over the study time period and demonstrated that both 
SiCaP-23 graft materials were osteogenic. Study B was conducted to compare the 
influence of varying levels of strut porosity on the osteogenic properties of SiCaP 
synthetic bone graft substitutes and to also evaluate the effect of increasing strut 
porosity on graft degradation or resorption over the study time period of 12 weeks by 
assessing graft volume at 8 and 12 weeks post implantation of the most porous test 
materials.  None of the formulations investigated displayed any histological evidence 
of osteolysis, nor did the most porous formulation (SiCaP-46G and SiCaP-46P) 
show a significant level of degradation over the test period, although a slight trend in 
graft resorption was noted (Figure 7-13).   
 
Our findings are in agreement with previous observations that the level of strut 
porosity markedly affects the post-implantation response in porous HA scaffolds 
(Hing 2004b, Hing, Annaz et al. 2005)and Habibovic and co-papers!.  The combined 
findings from Study A and B support the concept that the phase pure SiCaP scaffold 
is osteogenic.  Increasing the strut porosity of the scaffold appeared to promote bone 
apposition (percentage HISTOABV) without significantly affecting the stability of the 
graft (percentage CTAGV).  There was little evidence of excessive inflammation, 
osteolysis or other tissue reactions that could have adversely affected the success of 
the graft.  In previous studies investigating the effect of calcium phosphate cements 
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implanted in an ovine model reported the formation of fibrous capsules around the 
site of implantation thus impeding repair (Annaz, Hing et al. 2004c).  In contrast, 
there was no evidence of the formation of a fibrous capsule with any the 
formulations used in this study.   
 
In terms of the mechanism(s) leading to enhanced bone formation with higher strut 
porosity (32%–46%), it is possible that increasing the permeability of struts within 
the scaffold increased physical accessibility of nutrients to support infiltration and 
proliferation of cells.  An increase in surface area may also have affected the overall 
protein binding capacity, thus promoting osteogenic protein adsorption and cell 
anchorage that could lead to more rapid bone apposition (McFarland, Thomas et al. 
2000, Hing, Annaz et al. 2005).  The protein species that are adsorbed to the graft 
immediately on implantation and the subsequent change in structural conformation 
are critical in promoting osteogenic cell attachment (Green, Davies et al. 1999, Guth, 
Campion et al. 2010a), spreading (Rouahi, Champion et al. 2006), proliferation 
(Kilpadi, Chang et al. 2001) and morphology (Rouahi, Gallet et al. 2006).  
Establishing the cellular and micro environmental infrastructure for subsequent 
neovascularization is accepted as an essential precursor step prior to successful and 
sustained bone apposition (Stevenson, Emery et al. 1996).  
 
Histological assessment showed that the patterns of in vivo tissue responses to all the 
test materials were similar, all exhibiting the formation of a neo-vascular network, 
centripetal bone growth and direct bone apposition.  The magnitude of the tissue 
response depended on the levels of strut porosity.  Evidence suggests that the more 
rapid and greater degree of vascularisation seen in the test materials with increased 
strut porosity (32%–46%) facilitated an increase in volume of new bone tissue 
ingrowth into the graft at 8 weeks.  It was, however, difficult to differentiate further 
between the test materials (32% versus 46%) or the carrier (microgranules or 
aqueous poloxamer).  Further evidence that increased strut porosity enhances the 
osteogenic capacity of the graft material was observed at 12 weeks where, although 
thicker layers of mineralised bone was more prominent for all graft materials 
compared with that at 8 weeks, a higher strut porosity (32%–46%) was associated 
with a larger area of more mature bone tissue in contact with the graft.  
 
These findings indicate that all test material-treated sites had achieved an 
equilibrium level of bone formation throughout the defect site by 12 weeks, i.e. the 
volume of bone within the defect had reached a dynamic steady state, as modulated 
by the combination of local host and graft-related environmental and biomechanical 
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factors (Hing, Best et al. 2004, Hing, Annaz et al. 2005, Hing, Revell et al. 2006).  
However, the equilibrium level of absolute bone volume was greater in both 32% 
and 46% strut porosity grafts, moreover, evidence of earlier neo-vascularisation and 
greater levels of bone-graft contact suggested more rapid attainment of an 
equilibrium bone volume within these more microporous grafts, as has previously 
been observed with stoichiometric HA (Hing, Annaz et al. 2005).  Augmentation 
(both temporal and volumetric) of the dynamic healing processes would offer 
particular clinical benefits to patients with either conditions or under therapeutic 
treatments associated with impaired bone repair.  In otherwise healthy patients, it 
may also reduce healing times.  Clearly, further investigations are required to 
discover whether our in vivo findings can be extrapolated to a clinical setting.   
 
7.5 Conclusions 
In conclusion, bone formation in the critically-sized defect confirmed the clinically 
relevant osteogenic properties of a porous silicate-substituted (0.8 wt% Si) calcium 
phosphate bone graft substitute with a strut porosity of 23% when applied either as 
granules or in an aqueous poloxamer carrier. Increasing the strut porosity appeared 
to augment the osteogenic potential of the matrix in terms of encouraging earlier 
neovascularization and increasing the absolute equilibrium volume of bone growth 
within the graft.  
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8. Chapter Eight: Critical Review 
 
With this research we tested the hypothesis that modifying the micron-scale physical 
structure of a hierarchical porous calcium phosphate based biomaterial influences its 
functional performance in vitro, which can be applied to improve its performance 
outcomes in ectopic and orthotopic treatment sites in vivo. In order to test this 
hypothesis the literature was examined, computational models were applied, 
experimental tests were performed, and clinically relevant research models were 
executed. The outcomes of which are perhaps best examined in totality by asking the 
following four questions: 
 
1. Does changing the micron-scale physical properties of calcium phosphate 
biomaterials change their physiochemical response to acellular tissue fluids 
and is this relevant to biological performance in vivo? 
2. Do computational finite element analysis models correspond to empirical 
studies of calcium phosphate biomaterial physical properties and can they be 
used to predict cellular responses in vitro and in vivo? 
3. Is osteoinductivity a suitable predictor for orthotopic performance of calcium 
phosphate biomaterials? 
4. Are we any closer to understanding the mechanisms leading to osteogenic 
potential in calcium phosphate biomaterials?  
 
In the following sections these questions will prompt a discussion of the prior art in 
respect of this research, an examination of the relevance of the outcomes to the 
research hypothesis, an assessment of the novelty of the work, and lastly proposals 
for future research in the field. 
 
8.1 Does changing the micron-scale physical properties of calcium 
phosphate biomaterials change their physiochemical response 
to acellular tissue fluids in vitro and is this relevant to biological 
performance in vivo? 
The propensity for the formation of either HA or OCP as a continuous, un-broken 
layer over the implant surface immediately after implantation into bone is in theory 
likely to be significant to the processes of osteointegration; the greater the surface 
area covered by this layer the better the opportunity for interdigitation with host 
bone. In practice this assumption is still under debate as the in vivo studies in support 
Role of Physiochemical Parameters in the Osteogenic Potential of CaP Biomaterials 
Charlie Campion  Page 240 of 299 
of the outcomes of the bioactivity test are often contradictory.  Many researchers 
have suggested a primary factor in the formation of bone in ectopic implantation 
sites is the ability of the material to form a bone-like-apatite on its surface once in 
situ (Yang, Yuan et al. 1997, Yuan, Yang et al. 1998, Yuan, De Bruijn et al. 2001a, 
Barrere, van der Valk et al. 2003, Le Nihouannen, Daculsi et al. 2005, Habibovic, 
Sees et al. 2006). These groups have suggested, as a direct result of their findings, 
that a calcium phosphate phase with a greater propensity to chemically dissolve, 
such as beta-tricalcium phosphate (as compared hydroxyapatite), will more readily 
form a bone-like-apatite on its surface and therefore lead to a greater level of stem 
cell differentiation either directly through an interaction between the stem cells and 
the apatite surface or indirectly by forming a layer which will more preferentially 
adsorb circulating bone morphogenetic proteins. Most of these groups have also 
linked the surface area contributed to by microporosity as being influential in the 
subsequent formation of an apatite-like layer. Thus overall with these two material 
parameters (dissolution profile and surface area) combined an HA with a low surface 
area will have a much lower propensity to form a bioactive layer than a tricalcium 
phosphate with a high surface area.  
 
In our study we examined the formation of HCA on materials of varying strut-
porosity (23%; 32%; 46%) and chemistry (SiCaP and beta tricalcium phosphate). 
Formation of HCA was noted on all four of the test materials. The rates of formation 
and quantities of HCA varied among different materials. Under the conditions of the 
test, the fastest rate of HCA growth was observed on SiCaP-32 and SiCaP-46 
followed by SiCap-23.  The quantity of HCA formed on the beta tricalcium 
phosphate surface was much lower than the other three test materials. These results 
indicate that the strut-porosity of a material substrate should be increased to 
maximise the potential for formation of a precursor to bone-like apatite after 
implantation in osseous defects and further confirms previous reports that beta-
tricalcium phosphate is much less bioactive than silicate-substituted hydroxyapatite. 
These results appear, in part, to contradict the theory that a layer of a precursor to 
bone-like apatite is a prerequisite to ectopic bone formation. Beta tricalcium 
phosphate is reported to have a low bioactivity (Huan and Chang 2007, Hesaraki, 
Safari et al. 2009, Ni and Chang 2009), yet has been claimed to have a high 
osteoinductive potential (Yang, Yuan et al. 1997, Yuan, Yang et al. 1998, Yuan, De 
Bruijn et al. 2001a, Barrere, van der Valk et al. 2003, Le Nihouannen, Daculsi et al. 
2005, Habibovic, Sees et al. 2006). 
 
Moreover, we found in our studies of osteoinductivity abundant levels of bone in 
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direct contact with phase pure silicate-substituted calcium phosphate with no obvious 
signs of a boundary layer or dark line between the silicate-substituted calcium 
phosphate and the newly formed bone. The zone of integration appeared to be 
continuous from the synthetic phase to the physiological phase of mineral. In this 
part of our study the pre-requisite for a bone-like apatite to form on the surface in 
order for bone formation to take place was not apparent. 
 
A large volume of scientific work investigating the bioactivity of biomaterials has 
preceded this study but only a handful of studies have used the assay described by 
Kokubo et. al. in 1990 as a means for comparing the impact of microstructure on the 
bioactivity of biomaterials and few had specifically investigated the effects of 
chemistry and structure on the bioactivity of porous calcium phosphate bone graft 
substitutes. In this respect our study was novel, however no new techniques for 
characterisation were developed during the course of our experimentation. The 
limitations of our own studies of bioactivity were that the test was performed under 
static conditions and that submersion was performed in simulated body fluid without 
the addition of the proteins that one would expect the biomaterial to be exposed to in 
vivo. Both of these experimental conditions may have elicited a modified response in 
bioactivity from the test materials. Future studies should consider the use of dynamic 
conditions and the use of serum-based simulated body fluids. 
 
In summary, we found that the bioactivity of a calcium phosphate based biomaterial, 
that is the propensity of the material to form a layer of a precursor to a bone-like 
apatite on its surface after submersion in simulated body fluid, is influenced by the 
structure and chemistry of the biomaterial. This is a novel finding, however, we 
found no evidence that this dictated the subsequent biological performance in 
orthotopic and ectopic implantation sites in vivo.  
 
8.2 Do computational finite element analysis models correspond to 
empirical studies of calcium phosphate biomaterial physical 
properties and can they be used to predict cellular responses in 
vitro and in vivo? 
To characterise the mechanical properties of hierarchical porous silicate-substituted 
calcium phosphate we used a “Jenike” or “cam shear” testing rig which has 
previously been used by researchers to characterise the shear properties of allograft 
bone (Bolland, Partridge et al. 2006). This mechanical testing revealed porous 
silicate-substituted calcium phosphate to have similar mechanical behaviour to 
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morcellised cancellous bone under similar test conditions. Moreover, we discovered 
through the creation of novel 3D FEA models that bone grafts such as silicate-
substituted calcium phosphate appear to be stress-shielded when applied in typical 
applications such as a tumour defect void or in a posterolateral spinal fusion defect. 
Previous research has used mechanical testing in combination with finite element 
analysis to predict the behaviour of bone grafts in clinical applications such as for 
impaction grating of uncemented femoral hips (Wong, New et al. 2005, Bolland, 
Partridge et al. 2006, Tilley, Bolland et al. 2006, Bolland, Tilley et al. 2007, Bolland, 
New et al. 2008, Leung, Browne et al. 2008, Dopico-Gonzalez, New et al. 2009, 
Dopico-Gonzalez, New et al. 2010) and in the spine for posterior lumbar interbody 
fusions (Zander, Rohlmann et al. 2002), but this is the first time, to this authors 
knowledge, that this combined approach has been used to study the expected 
mechanical environment experienced by a bone graft following implantation in an 
instrumented posterolateral fusion site in the lumbar spine. The fact that the graft is 
shielded to the extent that it is only exposed to stresses close to 22kPa is an 
interesting one. Immediately after implantation this would be advantageous to a 
certain extent, as the surgeon would want the spinal motion segment to be 
mechanically stable for as long as the fusion mass is remodelled to mature bone, and 
this can only be achieved by the implanted metalwork. However, from a bone 
remodelling consideration this low level of stress may in fact cause slower than 
desired bone formation according to Wolff’s law. There exist a vast array of 
technical and engineering solutions to stabilising a spinal motion segment following 
posterolateral fusion, with tens of commercial systems being available across the 
world. Our model could find use in the future as a tool to determining the stresses 
experienced by a bone graft in posterolateral fusion dependent upon the design of the 
metalwork implanted alongside it for immediate post-operative motion segment 
stability. 
 
There were limitations to the present model, as it did not take into account the stress-
dependence of the Young's modulus of the silicate-substituted calcium phosphate. 
An improved model would include a treatment of this behaviour. While in the femur 
model stresses were sufficiently low compared to those in the surrounding bone that 
changes in the Young's modulus of the silicate-substituted calcium phosphate as a 
result of the imposed stresses could be neglected, this might not be the case where 
the silicate-substituted calcium phosphate would be expected to carry greater loads, 
for example if it were considered for use in impaction bone grafting in joint 
replacement. An improved material model could in these cases be essential. 
Furthermore, in vivo, the spine is subject to a wide variety of loading conditions 
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reflecting the wide variety of daily activities. In the present study only one load case 
has been considered. Further load cases to simulate the effects of a greater range of 
activities, for example flexion-extension, lateral bending, axial torsion should be 
considered to more fully characterise the mechanical environment of the silicate-
substituted calcium phosphate in clinical application. Lastly, the effects of soft tissue 
constraint on the silicate-substituted calcium phosphate have not been included. An 
improved model would take the effects of soft tissue constraint into account. This 
could be implemented either by applying pressure loads to the silicate-substituted 
calcium phosphate surface (simpler but cruder) or by explicitly modelling the soft 
tissues (more complex and computationally expensive but potentially more realistic). 
 
We also learned through the use of novel 2D Planar FEA models that there is an 
inverse exponential relationship between porosity and Young’s Modulus that is 
similar to that described for trabecular bone and hydroxyapatite materials in previous 
studies (Akao, Aoki et al. 1981a, De With, van Dijk et al. 1981, Linde, Norgaard et 
al. 1991, Arita, Wilkinson et al. 1995, Rho, Hobatho et al. 1995, Liu 1998, Charriere, 
Terrazzoni et al. 2001, Patel 2003). Our experimental results were in agreement with 
our 2D-Planar finite element analysis model and with values predicted using 
empirically derived model equations from two previous research studies for 
trabecular bone (Linde, Norgaard et al. 1991, Rho, Hobatho et al. 1995). There was 
less agreement (usually an under-prediction) between our own results and with 
previous studies of calcium phosphate materials (Akao, Aoki et al. 1981a, De With, 
van Dijk et al. 1981, Arita, Wilkinson et al. 1995, Liu 1998, Charriere, Terrazzoni et 
al. 2001), although there was good agreement to an indenter study of a similar 
silicate-substituted calcium phosphate material (Patel 2003). These outcomes suggest 
that it is important to use mechanical testing of investigative materials wherever 
possible in building finite element analysis models. The difference between our own 
data and that of previous studies could be explained by the difference in 
manufacturing methods used to produce the test materials (e.g. slip casting versus 
uniaxial pressing of HA powders) or by variations in the way in which the samples 
were mechanically tested (e.g. uniaxial compression versus ultrasonic or shear rates 
of 0.03s-1 versus a shear rate of 0.001s-1).  The limitation of taking a 2D Planar 
approach is that a three dimensional model will always show greater inter-particle 
connectivity and therefore be stiffer, and perhaps more accurate, than the two-
dimensional model. Future studies may improve on the accuracy of FEA modelling 
of silicate-substituted calcium phosphates by taking a 3D approach. 
 
The finite element analysis model was very insightful when it came to visually 
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comparing the relative stress distributions in the micron-scale structure as a result of 
the application of load to the test materials. We learned that the distribution of von 
Mises stress for materials with low porosity was relatively uniform throughout the 
micron-scale structure but higher porosity led to stress-risers at the point of pore-
pore boundaries. We were not able to investigate the likely stress-distributions under 
physiological loading due to time constraints during the study; however, this analysis 
could prove significant in determining the variation in stress experienced by cells at 
a micron-scale. Based on all of the research highlighted in the survey of literature 
provided in Chapter 2, this FEA model could prove useful in comparing the 
relationship between known levels of stress activation in osteocytes, as determined 
through empirical cellular studies, and the predicted stress in the region of cell 
attachments as a result of substrate strain at a micron scale after a substrate is loaded 
with a physiologically representative load pattern. An alternative and extremely 
novel approach, which this author is keen to investigate in future studies, would be to 
run similar FEA analysis of histological images in which osteoblasts and osteocytes 
are clearly identifiable, such as those in Chapter 7. This would permit the 
comparison of cell location and morphology with the points of likely stress 
concentration within the construct. 
 
In summary, we found that computational 2D Planar and 3D finite element analysis 
models do correspond with empirical data, albeit with some discrepancy likely due 
to manufacturing process and analysis technique variations. We have put forward 
several ideas as to how these models might be used to predict in vitro and in vivo 
behaviour of silicate-substituted calcium phosphate biomaterials. For our own 
purposes these models have shown that our experimental materials behave similarly 
to trabecular bone of a similar porosity and that the stress distribution within the 
micro-scale structure does vary considerably with porosity.  
 
8.3 Is osteoinductivity a suitable predictor for orthotopic 
performance of calcium phosphate biomaterials? 
Our research was not the first to perform concurrent ectopic and orthotopic models 
for calcium phosphate based biomaterials (Urist 1965, Pollick, Shors et al. 1995, 
Yuan, Li et al. 2000, Habibovic, Yuan et al. 2006, Yuan, van Blitterswijk et al. 
2006a, Li, Habibovic et al. 2007, Habibovic, Gbureck et al. 2008, Habibovic, Kruyt 
et al. 2008, Cheng, Ye et al. 2009, van Gaalen 2009). Urist found a good agreement 
between his ectopic (Rectus abdominus) and orthotopic (ulna defect) results for 
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approximately 100-fold difference in bone scaffold contact length between the two 
locations.  
 
There were limitations in our researching of the ectopic and orthotopic performance 
of silicate-substituted calcium phosphate. For example, our orthotopic study did not 
extend to the full 24 weeks studied for ectopic outcomes. In addition, both studies 
involved implanting multiple test groups within a single test subject. This is the only 
ethically acceptable approach to performing such studies but does provide a 
confounding variable, particularly for ectopic studies in which the exact mechanisms 
of osteoinductivity have not yet been elucidated. There is a very small chance that 
systemic effects caused in one implantation site lead to an over estimation or 
underestimation of osteogenic potential in an adjacent defect site. This would be 
particularly likely if, for example, the inflammatory system was discovered to have a 
significant role in osteoinductivity. Despite these limitations, from the data presented 
above and in the preceding chapters it seems reasonable to assume that 
osteoinductive propensity is indeed a marker for expected orthotopic performance. 
The rate of onset of bone formation and the eventual amount of bone formation does 
vary between ectopic and orthotopic defect sites for a given material, but on the 
whole our own research and the research of others teaches us that if a material forms 
bone in an ectopic implantation site it is more likely to lead to successful healing in 
an orthotopic site than a material which does not form bone in ectopic sites. 
 
8.4 Are we any closer to understanding the mechanisms leading to 
osteogenic potential in calcium phosphate biomaterials?  
It’s at this point that this author wishes he were studying for a doctorate in the study 
of logic, since with so many confounding variables across the studies, both in the 
literature and in our own research, it is challenging to pull out common threads of 
data which can irrevocably substantiate the mechanisms behind biomaterial-derived 
osteoinductivity. Several authors have attempted to decipher the plethora of 
proposals in the literature but none have achieved the ultimate goal. Several logical 
arguments will follow which are based on the review of the literature and the 
observations of our own empirical research: 
 
 Osteoinductivity is dependent on the species of the test subject. A 
common theme is apparent in the literature: osteoinductivity of calcium 
phosphate biomaterials is more frequently observed in larger animals, such as 
rabbits; dogs; and goats, than in smaller animals, such as rodents (Urist 1965, 
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Urist and Strates 1971, Piecuch 1982, Heughebaert, LeGeros et al. 1988, 
Okumura, Ohgushi et al. 1991, Ripamonti 1991, Yang, Yuan et al. 1996, 
Gosain, Song et al. 2002, Daculsi 2004, Yuan, van Blitterswijk et al. 2006b, 
Bodde, Cammaert et al. 2007, Li, Habibovic et al. 2007). 
 
 Osteoinductivity is dependent upon the strain of the test subject. In a 
recent study the investigators screened mice from 11 different inbred mouse 
strains for their responsiveness to subcutaneous implantation of 
osteoinductive tricalcium phosphate (TCP). In only two strains (FVB and 
129S2) the ceramic induced bone formation, and in particularly, in FVB 
mice, bone was found in all the tested mice (Barradas, Yuan et al. 2011).  
 
 Osteogenic materials i.e. those containing a cellular component tend to 
be more osteoinductive. Cell-seeding can increase osteogenic potential of 
calcium phosphate based materials (Ohgushi and Okumura 1990, Ohgushi, 
Okumura et al. 1990, Okumura, Ohgushi et al. 1991, van Gaalen 2009) and 
non calcium phosphate based materials (Li, Habibovic et al. 2007). 
 
 Microporosity plays a fundamental role in osteoinduction. This is 
demonstrated by studies in which authors report no bone formation for non-
porous materials whereas bone is observed in equivalent constructs 
containing microporosity (Yuan, Yang et al. 1998). Recent studies have 
demonstrated that the size and morphology of the surface substructure are 
critical parameters to osteoinduction (Davison, Luo et al. 2014, Zhang, 
Barbieri et al. 2014, Zhang, Luo et al. 2014). 
 
 Ectopic bone formation tends to occur via the intramembranous route 
and in a centripetal diction to the pore surface, although not exclusively 
so: (Yuan, Kurashina et al. 1999, Yuan, De Bruijn et al. 2001a, Yuan, de 
Bruijn et al. 2001b, Yuan, Yang et al. 2001, Habibovic, Yuan et al. 2005, 
Habibovic, Sees et al. 2006, Habibovic, Yuan et al. 2006, Yuan, van 
Blitterswijk et al. 2006a, Habibovic, Gbureck et al. 2008, Habibovic, Kruyt et 
al. 2008). In our study In all treatment groups both intramembranous and 
endochondral bone formation were observed, often in very close proximity to 
one another. Endochondral bone formation tended to occur in intra-granular 
spaces within the graft, whereas intramembranous bone formation tended to 
be closely associated with the surfaces of the graft.  
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 Anoxia and vascularisation is not always a determining factor in 
osteoinductive bone formation. As we observed both intramembranous and 
endochondral bone formation in very close proximity to one another, we 
propose anoxia or vascularisation was not always a factor in determining the 
mechanism of bone formation. Furthermore, recent studies in which TCP was 
implanted subcutaneously in FVB strain mice with and without local 
treatment of VEGF demonstrated there to be very little direct effect of the 
application of VEGF on the incidence of bone formation or the amount 
observed in the graft (Barradas, Yuan et al. 2012). 
 
 Osteocytes are likely to be involved in osteoinductivity. We observed cells 
of the osteocyte morphology colonising the microporosity of the graft. This 
lacunar-canalicular-like porosity might potentially allow for the recruitment 
of new osteoblasts with anabolic paracrine factors excreted in the 
extracellular matrix by osteocytes, the mechanosensing cells of bone 
(Sikavitsas, Bancroft et al. 2003). 
 
 Bone formation in ectopic sites does not begin until week 8 post-
implantation in larger animals. In the literature there is very little or no 
bone observed in test article treated defects within 21 days (Eid, Zelicof et al. 
2001) or 8 weeks (Piecuch 1982, Ohgushi and Okumura 1990, Ripamonti 
1996) of implantation. However, bone is generally observed in other studies 
at later time-points, including: 3 months (Ripamonti 1991, Yang, Yuan et al. 
1996, Yuan, Kurashina et al. 1999); 4 months (Pollick, Shors et al. 1995); 5 
months (Yuan, De Bruijn et al. 2001a); 1 year (Gosain, Song et al. 2002, 
Fujibayashi, Neo et al. 2004); and 2.5 years (Yuan, Yang et al. 2001). 
 
 Macrophages may play a role in osteoinductivity but are not the sole 
initiators of the process. In our study there was a complete absence of bone 
in regions of the defect where there was considerable scaffold degradation. It 
may be that these cells do play a role in ectopic bone formation but our study 
suggests that this is counteracted in the most severe cases of graft degradation 
through another process. Furthermore, unlike Le Nihouannen and many other 
researchers, we found endochondral bone formation as well as 
intramembranous bone formation, often in close proximity to one another, 
thus demonstrating that not only a macrophage-induced inflammatory trigger 
for stem cell differentiation is responsible for bone formation in ectopic 
defects. 
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 The formation of a precursor to bone-like-apatite is not a prerequisite to 
osteoinductive bone formation. Perhaps the best evidence for this is a study 
in which macroporous Bioactive glass (45S5) was implanted into the thighs 
of dogs wherein bone was found throughout the graft but more preferably in 
regions where an apatite-like layer was not present (Yuan, de Bruijn et al. 
2001b). In addition, the same researchers have reported a high-level of 
osteoinductivity for pure beta-tricalcium phosphate (Yuan, Fernandes et al. 
2010) despite beta-tricalcium phosphate having been found previously to 
have a very low propensity to form a bioactive layer of bone-like apatite on 
its surface (Huan and Chang 2007, Juhasz, Best et al. 2008, Hesaraki, Safari 
et al. 2009, Campion, Ball et al. 2013). 
 
After summarising the key facts in the story of biomaterial-derived osteoinductivity 
it becomes clear that there is one common thread to these logical scenarios: the 
fundamental needs of cells, in particular pre-osteoblasts; osteoblasts; osteocytes; and 
osteoclasts. What seems the most logical explanation for species-dependency, strain-
dependency, and anatomical dependency of osteoinductivity is the number of 
circulating stem cells available for the colonisation of the graft. The fact that in 
orthotopic sites most bone is formed within 8 weeks whereas in ectopic sites bone is 
not formed until 12-24 weeks points heavily towards a cellular influence on 
proceedings, as does the fact that pre-seeding biomaterials with osteoprogenitor cells 
also gives the process a kick-start. The role of macrophages, surface apatite, 
anoxia/hypoxia environments, VEGF, BMP, and substrate nano-structure are likely 
to be secondary to the fundamental need of circulating stem cells, which is to find a 
structure on which to attach and differentiate. The impact of various microstructures 
is well described in the literature and in our research. However, what isn’t described 
is a study of the availability of circulating stem cells in various species of test subject 
and anatomical locations within those subjects. Further work should investigate the 
availability of circulating stem cells in osseous and non-osseous tissues within a 
variety of species, including humans.  
 
Our research has provided us with some novel insight into the role of 
physiochemical parameters on the osteogenic of calcium phosphate biomaterials. We 
have learned that the propensity to form a precursor to bone-like apatite on its 
surface is a low driver for osteoinductivity. We have also reported for the first time, 
as far as this author can discover, the presence of both intramembranous and 
endochondral bone formation alongside each other in an ectopic site following 
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implantation of a calcium phosphate based biomaterial. We have also observed the 
presence of osteocytes deep inside the microporosity of biomaterials implanted in 
ectopic sites.  
 
8.5 Concluding remarks 
With this research we tested the hypothesis that modifying the micron-scale physical 
structure of a hierarchical porous calcium phosphate based biomaterial influences its 
functional performance in vitro, which can be applied to improve its performance 
outcomes in ectopic and orthotopic treatment sites in vivo. Our research has 
confirmed our hypothesis; small changes in the micron-scale structure of silicate 
calcium phosphates can have a big impact on their osteogenic potential, which can 
be successfully predicted using in vitro and ectopic in vivo models. 
 
After having traveled a significant journey over the last eight years, perhaps what 
emanates in my own mind as the bigger question at stake is: how relevant is it to use 
ectopic animal models to predict orthotopic outcomes in humans? We have 
discovered through analysis of the literature that a variety of osteoinductive bone 
grafts are commercially marketed around the world. The claims for these products 
are supported through the use of in vitro and in vivo tests, which are conducted for 
every batch sold. However, the tests conducted tend to be performed in small 
animals such as mice or rats (Bacterin , Etex , Synthes , Zhang, Powers et al. 1997b, 
Zhang, Powers et al. 1997a, Edwards, Diegmann et al. 1998, Coulson and Lalor 
2000, Takikawa, Bauer et al. 2003, Kay 2004, Honsawek, Powers et al. 2005, Boyan, 
Ranly et al. 2006a). This is in spite of other research studies, which demonstrate a 
substantial amount of species-related dependency when it comes to measuring 
osteoinductivity for a given material (Urist 1965, Ripamonti 1996, Yuan, van 
Blitterswijk et al. 2006b, Barradas, Yuan et al. 2012). It is not ethically viable to 
correlate human ectopic and orthotopic implantation performance prior to bone graft 
products being marketed. However, many of these commercially available products 
are now supported by published clinical data. It would benefit the clinical 
community if future studies investigated the correlation of osteoinductivity of these 
commercial products, as determined with in vitro and in vivo studies, with the 
reported performance outcomes in vivo in humans. 
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9. Appendix I: Literature for Mechanotransduction Studies 
Table 9-1 A historical review of in vitro studies of fluid flow and mechanical strain –induced upregulation of fibroblasts, osteoblasts, osteocytes and osteoclasts 









Intermittent hydrostatic compression. 
Compression of CO2 gas phase in a 
closed chamber. Maximum pressure 
= 13kPa above ambient. Pulse 
frequency was 0.3Hz. The maximum 
pressure rate was  32.5kPa/sec. 
Controls were run in same chamber 
without IHC. 
DNA content / AP activity / 
protein content 
IHC did not affect the growth of OB's and OPR's as shown by 
DNA and protein content. IHC had no adverse effects on cell 
viability or proliferation. IHC increased AP mRNA levels. 
IHC upregulated COL-1 and actin expression in Obs 
(Klein-Nulend, 
Semeins et al. 
1995) 







Pulsating fluid flow. 5Hz with a fluid 
shear stress of 0.5±0.02Pa and the 
peak shear stress rate 0.4 Pa/sec. 
Samples were analysed after 
5,10,15,30,45,60 mins 
NO production using Greiss 
reagent; PGE2 was measured sung 
enzyme immunoassay (EIA) 
Purified Osteocytes produced higher basal and PFF-stimulated 
levels of NO than mixed bone cells; whilst Fibroblasts did not 
respond to flow at all. The characteristic osteocytic 
morphology is restored in vitro. PFF also increased PGE2 
production. PGE2 production was delayed but continued 
throughout the hour whilst NO production was transient and 
only occurred for the first 5 mins. 
(Klein-Nulend, 







Culture dish Intermittent hydrostatic compression. 
Compression of CO2 gas phase in a 
closed chamber. Maximum pressure 
= 13kPa above ambient. Pulse 
frequency was 0.3Hz. The maximum 
pressure rate was  32.5kPa/sec. 
Controls were run in same chamber 
without IHC / Pulsating fluid flow. 
5Hz with a fluid shear stress of 
0.5±0.02Pa and the peak shear stress 
rate 0.4 Pa/sec. 
PGE2 / PGI2 production For IHC Osteocytes responded by an increase in PGE2 after 
6/24 hours and an increased PGI2 after 24hours. Osteoblasts 
only showed a significant increase after 6hours. Periosteal 
fibroblasts didn’t respond at all. PFF stimulated release of 
PGE2 from Osteocytes but not from Osteoblasts or from 
fibroblasts. No effect was found for PGI2 in any cell group 
after PFF treatment. Osteocytes response was sustained 1hour 
after flow whereas Osteoblasts/fibroblasts did not respond 
after 5 mins after flow. 
(Klein-Nulend, 
Roelofsen et al. 
1997) 




Culture chamber Intermittent hydrostatic compression. 
Compression of CO2 gas phase in a 
closed chamber. Maximum pressure 
= 13kPa above ambient. Pulse 
Osteopontin In 1o osteoblasts (OB) OPN expression decreased in the 
control but increased for the treatment group. OPN expression 
was higher in the differentiating culture than in the 
proliferating culture. The 44kDa type of OPN expressed 
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Author Year Cell type Material type Mechanical stimuli Response Observations 
M3T3-E1 frequency was 0.3Hz. The maximum 
pressure rate was 32.5kPa/sec. 
Controls were run in same chamber 
without IHC. 2 wks culture 
during bone formation was observed. IHC upregulated OPN 
protein production in both differentiating and proliferating 
groups, but was most noticeable in the differentiated cell 
population. OPN is functional in cell adhesion. 
(Pavalko, Chen 
et al. 1998) 
1998 M3T3-E1 Culture chamber 
(Cytodyne, CA, 
USA) 
Fluid shear stress using perfusion 
chamber (Cytodyne, CA, USA). 
18ml/min equivalent to 12 dyn/cm2. 
1hr treatment. 37C. 
B-integrin ; A-actin ; Cox2 ; c-fos 
upregulation 
Application of fluid shear induces development of actin stress 
fibers and formation of focal adhesions containing B-integrins 
and A-actinin. Osteoblasts upregulate Cox-2 and c-fos 
expression in response to fluid shear. Disruption of 
microfilaments with cytochalasin D inhibits fluid shear 
induced increases in Cox-2 protein expression. Microinjection 
of the integrin binding domain of a-actinin inhibits linkage of 
actin filaments to integrins and blocks fluid shear induced 
cytoskeletal reorganisation and gene expression. 
(Sterck, Klein-
Nulend et al. 
1998) 
1998 Mature human 
osteoblasts 
Glass slide Pulsating fluid flow 5Hz. Mean shear 
stress 0.7±0.03Pa with a peak shear 
rate of 12.2Pa/s. 1 hour treatment. 
37C 
NO production using Greiss 
reagent; PGE2 was measured sung 
enzyme immunoassay (EIA); 
TGF-ß1 measured by ELISA; 
Protein content 
PGE2 release was marked after 24 hours post-incubation for 
the non-osteoporotic group. PFF did not induce PGE2 release 
in any of the 5 OP cultures. All OP donors were treated with 
Vit D which cannot be excluded from findings although the 
cell cultures had been growing for 4-5wks pre treatment so 
external factors were considered unlikely. NO production was 
increased whilst TGF-B1 was inhibited during treatment but 
increased after 3 days. 
(Klein-Nulend, 
Helfrich et al. 
1998) 




Pulsating fluid flow 5Hz. Mean shear 
stress 0.7±0.03Pa with a peak shear 
rate of 12.2Pa/s. 1 hour treatment. 
37C 
NO production was determined 
with Greiss reagent; RT-PCR for 
mRNA content; protein content 
Mechanical stimulation of cells resulted in increased NO 
production. Maximum levels were detected after 5 mins 
indicating the presence of constitutive NOS activity. The 
ecNOS isoform of NOS was most active.  
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(Ajubi, Klein-
Nulend et al. 
1999) 
1999 Chicken calvarial 
osteocytes  
Glass slide Pulsating fluid flow 5Hz. Mean shear 
stress 0.7±0.03Pa with a peak shear 
rate of 12.2Pa/s. 1 hour treatment. 
37C 
PGE2 with non-radioactive 
enzyme immunoassay system; 
DNA content 
Cellular deformation as a result of fluid flow induced stresses 
leads to actin dependent opening of Ca2+ - permeable, 
gadolinium sensitive ion channel. Ca2+ influx near surface 
membrane stimulates PLC, which generates secondary Ca2+ 
responses from internal stores. DAG (byproduct of PLC) and 
Ca2+ activate PKC which enhances PLA sensitivity to Ca2+, 
leading eventually to increased AA release. This together with 
NO production mediated COX-2 activation leads to PG 
synthesis. 
(Westbroek, 
Ajubi et al. 
2000) 








Pulsating fluid flow. 5Hz; shear 
stress  0.7±0.03Pa with a peak stress 
12Pa/sec. 15 minute treatment 
PGE2 with non-radioactive 
enzyme immunoassay system; 
PHGS-2 expression via DNA 
Osteoblasts and Osteocytes do exhibit inducible PGHS-2 
activity, therefore, observations made regarding effects of PFF 
are linked to mechanosensitivity of OB's and OCY's and not 
ability to express PGHS-2. OCY's are more sensitive to fluid 
shear stress than OB's, as measured by PHGS-2 expression. 
Klein-Nulend may have observed PGE2 expression in OB's 
due to presence of OCYs in the culture of the state of 
differentiation in the relatively mature neonatal murine cell 
culture. 
(Joldersma, 
Burger et al. 
2000) 




Pulsating fluid flow 5Hz. Mean shear 
stress 0.7±0.02Pa with a peak shear 
rate of 12.2Pa/s. 1 hour treatment. 
37C 
PGE2; PGI2; PGF2 were 
measured sung enzyme 
immunoassay (EIA) / COX-2 
mRNA expression was measured 
with RT-PCR 
PGE2 and PGI2 were upregulated following PFF treatment. 
PGF2 was upregulated for 1 hour only. Treatment with PFF 
increased COX-2 but not COX-1 expression. Shear stress-
induced responses were independent of species and 
anatomical location. The levels of prostaglandin production 
varied significantly between donors and was related to the 
variation in osteocyte population numbers. A correlation 
analysis showed no relationship between age and bone cell 
sensitivity. 
(Bakker, 
Soejima et al. 
2001) 
2001 Mature Osteoblasts Polylysine-coated 
glass slide 
Low PFF (3Hz; 0.39Pa; amplitude 
0.12Pa; peak shear stress 2.26Pa/s) / 
Medium PFF (5Hz; 0.64Pa; 
amplitude 0.127Pa; peak shear stress 
8.40Pa/s) / High PFF (9Hz; 1.20Pa; 
amplitude 0.37Pa; peak shear stress 
NO production using Greiss 
reagent; PGE2 was measured sung 
enzyme immunoassay (EIA) 
Bone cells respond to flow in a dose-dependent manner. 
Increasing viscosity also increases responses. Increasing the 
viscosity will simultaneously heighten the mean shear stress 
and the amplitude of the pulsatile shear stress - the exact mode 
of upregulation was not determined. Bone cells are sensitive 
to low flow rates (0.20±0.06ml/s) 
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20.90Pa/s) / Dextran PFF (3Hz; 
1.20Pa; amplitude 0.0.37Pa; peak 
shear stress 6.97Pa/s) 
(Di Palma, 





HA Plasma sprayed 
Ti-4Al-4V discs. 
Ca/P 1.663-




4V and polystyrene. 
Gamma sterilised 
piezoelectric induced strain for 15 
mins 3 times a day for 1,3,5 days at 
0.25Hz and 600µstrain 
Cell number, cell adhesion and 
spreading and ALP were 
measured 
Cellular adhesion takes longer (48 hours) but is more effective 
on rougher (HA group) surfaces than smoother (controls) 
surfaces. Mechanical regimen was important - short repeated 
deformations increased ALP after 5 days but not continuous 
24 hours deformation. MG-63 cells expressed mechano-
sensitivity by increasing differentiation not proliferation. 
Human osteoblasts responded in an opposite trend and so it 
was postulated that the state of confluence of the cells governs 
their response to mechanical strain 
(Wang, Uemura 
et al. 2003) 
2003 Bone Marrow 
Derived Osteoblastic 





75% porosity; pores 
100-400um.Heat 
sterilised 
Perfusion chamber (minucells, 
Germany). 2mL/h. 37C. 1,2,3,4 
weeks 
ALP activity and Osteocalcin 
content 
ALP and Osteocalcin was increased in perfused samples 
compared to control (n=12 ; p<0.01) 
(Sikavitsas, 
Bancroft et al. 
2003) 




vol porosity of 86% 
and fibre diameter 
of 40µm. The 
average pore size 
was ~250µm. 
Fluid flow @ 0.3ml/min. 37C DNA / AP / Ca-deposition Addition of dextran to the media increased viscosity and 
increased mineralised matrix deposition. AP was significantly 
higher for fluid sheared cells. Upregulation from a change in 
fluid shear stress modulated by viscosity and not flow rate 
indicates that the rate of chemotransport is not a factor in the 
upregulation of Osteoblastic cells in response to increased 
fluid shear. 
(Bakker, 
Joldersma et al. 
2003) 
2003 M3T3-E1 Polylysine-coated 
glass slide 
Pulsating fluid flow 5Hz. Mean shear 
stress 0.6Pa with a pulse amplitude 
of 0.3Pa and peak stress rate of 
8.4Pa/s 37C 
NO production using Greiss 
reagent; PGE2 was measured sung 
enzyme immunoassay (EIA) 
Treatment with PTH without shear stress stimulated PGE2 
production but not NO production. When PTH was added 
<1min before shear stress treatment it blocked NO production. 
PTH inhibits NOS (ecNOS) in bone cell production of NO. 
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Cyclic pressure in the range 10-
40kPa at 1Hz for 1 hour daily for 
5,12,19 days. 
Gene expression by RT-PCR; 
Total RNA; Collagen; Total 
DNA; Calcium 
Expression of Transforming growth factor-ß1 mRNA was not 
different across the groups; total DNA was not different 
between groups. Amount of acid-soluble collagen and calcium 
in osteoblasts exposed to cyclic pressure was significantly 
higher after 19days culture. 
(Bakker, Klein-
Nulend et al. 
2003) 




Pulsating fluid flow 5Hz. Mean shear 
stress 0.6Pa with a pulse amplitude 
of 0.3Pa and peak stress rate of 
8.4Pa/s 37C 
PGE2 was measured sung enzyme 
immunoassay (EIA); Total RNA 
and protein; COX-1 and COX-2 
Mrna 
PGE2 was completely inhibited when COX-1 and COX-2 
were blocked. PFF induced COX-2 mRNA expression. PGE2 
production dependent on COX-2 not COX-1 expression. 
1hour PFF stimulated COX-2 mRNA expression. COX-2 




2004 Bone Derived 
Osteoblastic cells 
(BO) from Humans 
Culture plate (PS) Fluid shear stress (0.6±0.3 Pas; 5Hz) 
for 1hr in a laminar flow plate 
perfusion chamber / Substrate strain 
(1000µstrain; 1Hz) for 1 hr using 4-
point bending apparatus 
NO production using Greiss 
reagent ; PGE2 using enzyme 
immunoassay ; Collagen type I as 
measured by Western blot 
analysis. Wilcoxon signed rank 
test (NO/PGE2) and Linear model 
(Collagen type I) 
FEA modeling revealed that fluid flow effected on all cell 
model components whereas strain only effected the cell 
attachments. Fluid flow (not strain) increases PGE2 due to 
upregulation of Cox2 and re-organization of actin. 
Mechanically induced NO production results from activation 
of ecNOS in the plasma membrane and is affected most by 
fluid-shear. Collagen production was upregulated by strain 
and not fluid shear. Applied strain induces cell behaviour 
associated with the Osteoblastic phenotype. Whereas, fluid-
shear does not illicit responses of the osteoblast phenotype. 
Instead increased cell signaling molecules (NO/PGE2) are 
reported. Both of which are thought to be involved in 
osteocyte mediation. 
(Bacabac, Smit 





Fluid shear stress with a Parallel-
plate flow chamber.  Steady shear 
stress (0.70Pa) ; High/Low 
amplitude (0.70±0.31 / 0.70±0.70 
Pa) AND High/Low frequency (5/9 
Hz) shear stress and static controls 
were used. 
NO production using Greiss 
reagent 
Bone cell response to fluid shear stress is rate-dependent. 
Increasing amplitude or frequency without changing average 
stress enhanced NO production. NO production is rapid 
(<15mins). NO production is linearly dependent on the rate of 
fluid shear stress. 
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(Mauney, 
Sjostorm et al. 
2004) 






Four point bending induced strain. 
Mean tensile strain of 505 ± 196 
µstrain and -521 ± 216 µstrain in 
compression 
Cell number; ALP activity; Total 
RNA; Mineralized matrix 
production 
ALP transcript levels were significantly higher after 
mechanical stimulation compared to the static controls. OPN 
transcript levels of mRNA were increased in response to 
mechanical stimulation. Mechanically stimulated OPN 
expression was dexamethasone dependent which was 
attributed to be an effect of BMPs in the DBM. Osteocalcin 
levels were not significantly affected by mechanical 
stimulation. Mineralised matrix production was substantially 
increased in mechanically stimulated specimens compared to 
static controls.  








CA, USA) Pores 
89±28µm/22±7µm 
piezoelectric induced strain for 
3mins (1Hz ; 0-3000 µstrain) Fluid 
flow was measured with 3µm 
polystyrene microspheres 
(Polysciences, USA) 
RT-PCR was used to determine 
the mRNA levels of selected load-
sensitive genes c-fos, egr1, cox2, 
Osteopontin 
Amplitude and velocity of fluid flow was greatest in fine 
pores. Strain induced flow was greater stimulus than strain 
alone on the expression of load-induced genes. Strain alone 
elevated c-fos/Osteopontin mRNA. Strain-induced flow 









Pulsatile fluid flow-derived shear 
stress. 0.39Pa @ 3Hz / 0.64Pa @5Hz 
for 10mins. 37C 
NO production using Greiss 
reagent; PGE2 was measured sung 
enzyme immunoassay (EIA) 
Cytoskeleton modulates PFF-induced NO response in OB and 
involves stress fiber formation and alignment. The enhanced 
PGE2 response in OB is related to pulsatile fluid flow 
stimulation of focal adhesions formed when the cytoskeleton 
is disrupted. In OCY modulation of NO production occurs by 
cytoskeleton disruption. Inhibition of PFF-induced PGE2 
response in OCY with cytoskeleton disruption indicates a high 
dependence of OCYs on actin-rich cytoskeleton. It is also 
possible that the PGE2 response is governed by shear/stretch 
sensitive ion channels which are known to be dominant in 
OCY response to mechanical loading. 
(Bacabac, Smit 
et al. 2005) 
2005 M3T3-E1 Polylysine-coated 
glass slide 
Fluid shear stress with a Parallel-
plate flow chamber.  Steady shear 
stress (0.70Pa;0PaHz) ; low 
amplitude (0.70±0.31Pa) at 2 
frequencies (5Hz;9.70PaHz / 
9Hz;17.5PaHz) ; high amplitude 
(0.70±0.70 Pa) at 1 frequency 
(5Hz;22.0PaHz) 
NO production using Greiss 
reagent 
Bone cell response to fluid stress is rate dependent, but an 
initial stress kick is required for the cells to respond.  
Cytoskeletal arrangement during a pretreatment phase may 
explain the lack of response without a stress kick. Cellular 
sensitivity to stress occurs in under 1 min. However, cells 
were not affected by a short stress kick (10s; 0.7Pa) so the 
effect of stress on NO production occurs between 10s - 1min. 
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blasted with glass 
balls (2) Ti-6Al-4V 
sandblasted (3) 
Alumina (>80%) 
piezoelectric induced strain for 15 
mins 3 times a day for 1,3,5 days at 
0.25Hz and 600µstrain 
ALP activity; cell number; 
Fibronectin; Vincullin; N-
cadherin; Fibronectin 
IMS had no effect on cell number for any treatment group. 
Osteoblastic cells upregulate ALP activity in response to stain 
irrespective of the surface stiffness. FN synthesis was 
increased for Ti-Al by 60% but not for other groups. Surface 
topography differences or perhaps a delayed response for the 
other groups were attributed to this observation.  There was no 
difference in the total amount of Vincullin for any groups over 
all timepoints. Surface roughness is determinant for the up-
regulation of N-cadherin by mechanical stretch. FN and N-
cadherin probably act as mechanosensors. 
(Ignatius, 
Blessing et al. 
2005) 
2005 Human fetal 
Osteoblastic cell line 
Hfob 1.19 
Type I collagen gel Cylindrical stretching at 1Hz with a 
strain of 10,000µstrain. Gels were 
stretched for 30mins a day for 3 
weeks. 
RNA by RT-PCR Static forces promoted both cell proliferation and AP/OC 
expression whereas dynamic stresses slightly stimulated OC 
expression but inhibited cell growth and AP expression. 
(Sikavitsas, 
Bancroft et al. 
2005) 






Thickness = 1.7mm; 
vol porosity = 99%; 
fibre diameter 17µm 
Fluid flow @ 0.6ml/min. 37C DNA content / AP activity / 
Calcium deposition / µct 
PLLA nonwoven scaffolds allowed the attachment, growth 
and differentiation towards Osteoblastic phenotype of rat 
MSCs seeded on them. Treatment with fluid flow allowed for 
(i) accelerated proliferation at 7days (ii) enhanced mineral 
deposition at 16 days (iii) enhanced spatial distribution of 
deposited ECM compared to static controls 
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10. Appendix II: Literature for Biomaterial-related Osteoinductivity 
Table 10-1 Biomaterial related osteoinductivity  
Author Title Material Model Summary 
(Urist 1965) Bone: Formation 
by Autoinduction 
Acellular, devitalized, decalcified, bone 
matrix. 
Samples of HCl-decalcified homogenous diaphyseal bone 
from rabbits; laboratory animals; or humans were 
implanted into (i) a pouch in the belly of either the rectus 
abdominus, quadriceps, or erector spinae muscles of 
approximately 250 rabbits, 20 rats, 10 mice, and 5 guinea 
pigs; (ii) a defect in the ulna in 10 rabbits or a bed of bone 
on the lumbar vertebrae in 3 dogs; (iii) a defect in a bone 
in various skeletal system disorders in 21 human beings. 
>90% success new bone formation inside decalcified bone 
matrix. First use of term ‘osteogenesis by autoinduction’. 
Bone formation seen in well-vascularised regions at 4-6 
weeks. Endochondral bone formation seen between 8-16 
weeks. Wherever bone induction occurred there was a pool of 
stem cells, osteoprogenitor cells, and small capillaries, 
surrounded by palisades of deeply basophilic plump 
osteoblasts. Lamellar bone formation was evidenced by 
appositional formation of new bone, layers of osseous tissue 
with intermediate cement lines were deposited on the surface 
of decalcified dead matrix. The deposits were always enclosed 
in excavation chambers, either within the external surface or 
deep inside the old matrix; new bone never extended outside 
the implant. 
(Winter 1970) Heterotopic Bone 




Sponge was implanted in the fatty tissue under the dermis  
in the skin of pigs of the age 15-30 weeks. Implants were 
retrieved 9 weeks later. 
Bone was present in the implants from 6 animals. All implants 
retrieved at 60 days post-implantation were ossified.  





Acellular, devitalized, decalcified, bone 
matrix. 
The diaphyseal segment of long bones of 200 adult rats, 
Sprague-Dawley strain, were decalcified and implanted 
for 4 weeks in the muscle ovxczlogeneic rats. 
After a period of two weeks after implantation and exposure to 
the enzymes of the recipient muscle, the implanted matrix 
gradually lost the cross-banded structure of collagen fibrils 
and the interfibrillar lacelike conformation of proteoglycans. 
Although calcification occurred as soon as osteoblasts 
differentiated and new bone matrix was deposited on the 
surface of the implanted matrix, the bulk of the old bone 
collagen did not recalcify. 
(Piecuch 1982) Extraskeletal 




Based on the skeleton of a common reef-
building coral, porous hydroxyapatite 
ceramic was produced by hydrothermal 
conversion of the coral's aragonite 
(CaCO3) structure. The resulting coralline 
replamineform hydroxyapatite (RHAP) 
was characterized by uniform 
interconnecting pores having a diameter of 
Twelve identical 5 x 5 x 10 mm blocks of porous 
hydroxyapatite were implanted in a subcutaneous pocket 
in twelve adult, male, laboratory-bred beagle dogs. 
Implants were retrieved and evaluated histologically eight 
weeks following placement. 
The results of this study suggest that porous hydroxyapatite 
ceramic does not act as a bone-inducing agent. The implant 
material is well-tolerated by host tissues, and was rapidly 
infiltrated by connective tissue. No evidence of rejection was 
observed. Likewise, no bone or osteoid was seen within any of 
the specimens. This was felt to be a significant finding, despite 
the short time frame (eight wk) of the study, since previous 
work had shown considerable bony ingrowth as early as six 
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140-160 µm. wk after subperiosteal implant placement. The author suggests 
that osseous ingrowth is apparently dependent on contact of 
the implant with bone. 
(Heughebaert, 









Pellets of well-characterized microporous 
hydroxyapatite (HA) ceramic 
Pellets of well-characterized microporous hydroxyapatite 
(HA) ceramic were implanted in hamsters in two 
nonosseous sites: (1) in the fatty tissue of the gingival 
crease, far from bony tissue and (2) in intraperitoneal 
sites. The implants in site 1 were placed directly in 
contact with tissues, cells, and extracellular fluids while 
the implants in site 2 were placed in special chambers 
made of plexiglass cylinders covered in both ends with 
millipore filters, preventing contact with tissues and cells, 
but not with extracellular fluids. The hamsters were 
sacrificed and the implants recovered after 8, 16, 30, 150, 
and 365 days. The pellets were characterized using x-ray 
diffraction, infrared absorption, thermogravimetry, 
scanning and transmission electron microscopy, and 
calcium and phosphate analyses before and after 
implantation. 
Physicochemical analyses of HA ceramic implants before and 
after implantation demonstrated the formation of new material 
which was significantly different from the HA ceramic in 
terms of the following: (a) morphology (size of shape) of 
crystals; (b) intimate association of the inorganic phase of the 
new material with an organic phase similar to 
inorganic/organic association in bone; (c) the inorganic phase 
of the new material is a CO3-apatite, similar to that of bone, 
while the HA in ceramic is CO3-free; (d) electron diffraction 
of apatite of new material is similar to that of bone apatite. 
This study also demonstrated that the new material associated 
with the HA ceramics implanted in two different nonosseous 
sites were identical in spite of the differences in their 





capacity of rat and 
human marrow 






Replaniformed Coralline Porous 
hydroxyapatite (HA) and tricalcium 
phosphate (TCP), ceramic discs were 
implanted with or without rat marrow 
cells, The discs of HA and TCP had 
identical microstructures: pore size was 
190-230 microns, porosity was 50-60%, 
and they were fully interconnected. 
Porous hydroxyapatite ceramics, alone and combined with 
rat marrow cells, were implanted subcutaneously in 22 
nude mice. 
The ceramics alone were invaded by fibrovascular tissue 
without any bone formation. In contrast, all the ceramics 
combined with marrow cells had bone formation in the pores 4 
to 8 weeks after implantation. The bone formation began on 
the surface of the ceramic with direct bonding of the bone to 
the ceramic and proceeded to the center of the pores. The 
ceramics were also combined with bone marrow cells from 7 
humans and implanted in nude mice. In five experiments, bone 
formation occurred after implantation. In addition, the 
ceramics were combined with in vitro cultured fibroblastic 
cells, resulting in bone formation in 2/6 cases.  
(Ohgushi, 











Replaniformed Coralline Porous 
hydroxyapatite (HA) and tricalcium 
phosphate (TCP), ceramic discs were 
implanted with or without rat marrow 
cells, The discs of HA and TCP had 
identical microstructures: pore size was 
190-230 microns, porosity was 50-60%, 
and they were fully interconnected. 
Ceramic discs were implanted with or without rat marrow 
cells into subcutaneous sites in syngeneic rats. 
Implants without marrow cells (discs themselves) did not 
show bone formation, whereas implants with marrow cells 
showed bone formation in the pores of the ceramics. The bone 
formation of both HA and TCP occurred initially on the 
surface of the ceramic and progressed towards the center of 
the pore. The de novo bone was quantitated from decalcified 
serial sections of the implants. One month after implantation 
with marrow cells, the percentage fractions of the pore area 
filled with bone for implanted HA and TCP were 16.9 and 
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c study of ectopic 
bone formation 
15.1, respectively. At 2 months after implantation with 
marrow cells, the fractions of bone were 34.3 and 30.9, 
respectively.  
(Okumura, 







bone marrow cells 
Replaniformed Coralline Porous 
hydroxyapatite (HA) and tricalcium 
phosphate (TCP), ceramic discs were 
implanted with or without rat marrow 
cells, The discs of HA and TCP had 
identical microstructures: pore size was 
190-230 microns, porosity was 50-60%, 
and they were fully interconnected.  
Coralline hydroxyapatite ceramics alone (control) and the 
ceramics combined with rat marrow cells were implanted 
subcutaneously in the backs of syngeneic Fischer rats and 
harvested at 1,2,3,4,6,8 and 24 wk after surgery. 
None of the control ceramics (without marrow) showed bone 
formation. However, ceramics combined with marrow cells 
showed consistent new bone formation in the pore regions. 
Histometrical results revealed increased new bone formation 
over time. Undecalcified sections of the ceramics studied by 
fluorochrome labelling showed that the osteogenesis began 
directly on the surface of the ceramic and proceeded 
centripetally towards the centre of the pores (bonding 
osteogenesis). SEM-EPMA analysis of the bone-ceramic 
interface also revealed direct bonding of bone to the ceramic 
surface. 
(Ripamonti 1991) The 
morphogenesis of 








Replicas of porous hydroxyapatite that had 
been obtained after hydrothermal 
conversion of the calcium carbonate 
exoskeleton of coral (genus Goniopora) 
Samples were implanted intramuscularly in twenty-four 
adult male baboons (Papio ursinus). Samples were 
retrieved after 3, 6, and 9mnths  
Sections showed that initially the formation of fibrous 
connective tissue was characterized by a prominent vascular 
component and by condensations of collagen fibers assembled 
at the interface of the hydroxyapatite. The morphogenesis of 
bone was intimately associated with the differentiation of the 
connective-tissue condensations. Bone formed without an 
intervening endochondral phase. Although the amount of bone 
varied considerably, in several specimens extensive bone 
developed, filling large portions of the porous spaces and 
culminating in total penetration by bone within the implants. 
The mean volume fraction composition of the specimens was 
20.8±1.0% for bone, 17.3 ± 1.7% for connective-tissue 
condensation, 31.9 ± 1.0 % for fibrovascular tissue, 6.4 ± 0.6 
% for bone marrow, and 34.6 ± 0.5 % for the hydroxyapatite 
framework. The amount of bone and marrow increased at each 
time-period, and the hydroxyapatite framework was 
significantly reduced between six and nine months. Linear 
regression analysis showed a negative correlation between the 
hydroxyapatite framework and the magnitude of bone 
formation within the porosities of the hydroxyapatite (p = 
0.0001). The hydroxyapatite substratum may have functioned 
as a solid-phase domain for anchorage of bone morphogenetic 
proteins. 




Replicas of porous hydroxyapatite that had 
been obtained after hydrothermal 
After exposure of the calvaria, 64 cranial defects, 25 mm 
in diameter, were prepared in 16 adult male baboons 
Histomorphometry on decalcified sections prepared on days 
30 and 90 showed superior osteogenesis in osteogenin-treated 
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of adult primates. 
conversion of the calcium carbonate 
exoskeleton of coral (genus Goniopora) 
(Papio ursinus). Defects were implanted with disks of 
porous nonresorbable and resorbable hydroxyapatite 
substrata obtained after hydrothermal conversion of 
calcium carbonate exoskeletons of corals. In each 
animbal, one disk of each hydroxyapatite preparation was 
treated with osteogenin isolated and purified from baboon 
bone matrix after sequential chromatography on heparin-
Sepharose, hydroxyapatite, and Sephacryl S-200 gel 
filtration columns. The remaining two defects were 
implanted with one disk of each hydroxyapatite 
preparation without osteogenin as control. 
nonresorbable hydroxyapatite specimens as compared with 
controls. On day 90, substantial bone formation also had 
occurred in control nonresorbable hydroxyapatite specimens.  






ceramics placed in 
bone and ectopic 
sites 
Replaniformed Corraline Hydroxyapatite 
derived from Porites (180-230µm pores; 
45-55% porosity) and Goniopora (270-
550µm pores; 60-70% porosity) a.k.a 
Interpore 200 and Interpore 500 
respectively 
Two adult dogs received a total of 56 implants placed in 
the femur, skeletal muscle, and subcutaneous tissues. 
Lateral approach to femur for orthotopic implantation. 
Blunt dissection of vastus lateralis muscle to create 
muscle pouches. Subcutaneous implantation was 
performed through 1.5cm incisions in dorsum. Implants 
were retrieved at 4 months 
Degradation of implant was statistically significant in 
intraosseous sites (16.7-24.4%) but not in intramuscular (4.9-
10.1%) or in subcutaneous (5.0-9.7%) sites.  
ORTHOTOPIC SITES: 
Bone area in osseous sites was 18.4-43.1%. Soft tissues 
accounted for 15-32.0% area. Implant accounted for 13.6-
24.7% area. Bone contact (percentage area of implant surface 
covered by bone) was 81.3±10.8%.  
INTRAMUSCULAR SITES: 
Bone area was 3.3-4.3%. Bone contact (percentage area of 
implant surface covered by bone) was 17.8±32.3%. 
SUBCUTANEOUS SITES: 
Bone area was 5.5-6.6%. Bone contact (percentage area of 
implant surface covered by bone) was 22.7-35.0%. 
Degradation was greatest in the osseous sites and so it is 
assumed that degradation of calcium-rich implants is, in large 
part, a biological phenomenon. 
Bone formation was found in the centre of the defect rather 
than the periphery. 





of different animal 
models 
Replicas of porous hydroxyapatite that had 
been obtained after hydrothermal 
conversion of the calcium carbonate 
exoskeleton of coral (genus Goniopora) 
A total of 40 hydroxyapatite rods were m, implanted 
bilaterally in intramuscular pouches created by sharp and 
blunt dissection in the rectus abdominis, four rods per 
animal: four clinically healthy outbred Chacma baboons 
(Papio ursinus) with normal haematological and 
biochemical profiles; two adult inbred beagles; and four 
adult rabbits were of the New Zealand white strain. 
Implants harvested from rabbits and dogs were less 
vascularised than hose from Baboons at the macroscopic level. 
Bone area in Rabbits was 0.5±0.3%; in Dogs was 0.79±0.49%; 
and in Baboons was 11.3±3.02%. The amount of bone did 
vary considerably between specimens. Author speculates that 
Osteoinductivity is not inherent but that BMP’s bind 
preferentially to the surface (based on previous binding 
studies). Bone differentiation occurred after 60days 
implantation. No bone formation after 30 days implantation so 
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author speculates that this indicates that a critical level of 
endogenous BMP is required to be adsorbed to the surface to 
start the bone formation cascade. Bone formation was not via 
the Endochondral route. 








different kinds of 
animals 
 
Biphasic ceramic consisted of 65% 
hydroxyapatite (HA) and 35% b-
tricalcium phosphate (b-TCP) with 61% 
porosity and an average pore size of 402 
µm. Micropores were 2-5µm in size and 
found on the walls of macropores of 200-
600µm in size. 
 
4 dogs, 2 pigs, 2 goats, 6 rabbits and 10 rats were 
implanted either in dorsal muscle (dogs) or under 
abdomen skins (pigs, goats, rabbits, rats) or in leg muscle 
(rats).n=6. Specimens were harvested at 15 (only for dogs 
and rabbits), 30 (only for dogs and rabbits), 45, 60, 90 and 
120 days after implantation 
DOGS AND PIGS: 
Bone observed in some defects after 45 days. Bone observed 
in all implants after 60/90 days. Woven bone formed via 
intramembraneous route. After 12 days extensive amount of 
trabeculated non-lamelar bone present. Bone was intimate 
with pores but also formed in periphery of graft. Bone was 
remodelled. After 15 days this appeared to be granulation type 
fibroconnective tissue, containing fibroblasts, macrophages 
and newly formed vessels. At 30 days fibroconnective tissue 
was organised parallel to the surface of the graft, polymorphic 
cell aggregates (ALP+), and multinucleated giant cells were 
present. At day 45, cell aggregation was more obvious 
Osteoblast differentiation occurred directly within the 
polymorphic mesenchymal cell clusters aggregated at the pore 
inner surface. Woven bone was in direct contact with the graft 
at 60 days. De novo bone was formed via intramembraneous 
route not Endochondral. Trabeculated, remodeled bone present 
at 90,120 days. Bone was formed inside the graft and not in 
periphery. Multi-nucleated giant cells in contact with material 
surface resembled osteoclasts. 
GOATS, RABBITS, AND RATS: 
No bone was observed in any defect at any timepoint.At early 
timepoints (15-60 days) the graft was full of loosely packed 
fibroconnective tissue. 








ceramics: an early 
stage 
histomorphologica
l study in dogs 
Biphasic ceramic consisted of 65% 
hydroxyapatite (HA) and 35% b-
tricalcium phosphate (b-TCP) with 61% 
porosity and an average pore size of 402 
µm. Micropores were 2-5µm in size and 
found on the walls of macropores of 200-
600µm in size. 
 
A total of 28 cylinders (diameter, 4 mm; length, 5 mm) of 
porous HAÐTCP ceramics were prepared for 
implantation. Cylinders were implanted in the dorsal 
muscles of 4 dogs, all far from osseous tissues (n=4). 
Implants retrieved at  7, 15, 30, 45, 60, 90 and 120 days 
 
After 7 days pores were filled with clotted blood. After 15 
days this appeared to be granulation type fibroconnective 
tissue, containing fibroblasts, macrophages and newly formed 
vessels. At 30 days fibroconnective tissue was organised 
parallel to the surface of the graft, polymorphic cell aggregates 
(ALP+), and multinucleated giant cells were present. At day 
45, cell aggregation was more obvious Osteoblast 
differentiation occurred directly within the polymorphic 
mesenchymal cell clusters aggregated at the pore inner 
surface. Woven bone was in direct contact with the graft at 60 
days. De novo bone was formed via intramembraneous route 
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not Endochondral. Trabeculated, remodeled bone present at 
90,120 days. Bone was formed inside the graft and not in 
periphery. Multi-nucleated giant cells in contact with material 
surface resembled osteoclasts. Proposed environmental 
mechanisms are facilitated vessel ingrowth (macroporosity) > 
favourable adsorption/differentiation of cells (microporosity) 
>crystallization of HA on the surface of material > increased 
calcium concentration (surface area/dissolution 
characteristics)bb 








TCP/HA (30TCP/70HA, porosity, 50-
70%, 
average pore size 400 µm) rods (diameter 
5 mm x 
6 mm) 
4 rods implanted into the dorsal muscle of one pig. 15 
days later another 4 rods implanted on the other side of 
the dorsal muscle of the same animal. All implants 
retrieved after 45 days from start of study. 
Bone formation could be detected inside the ceramics 
implanted in the dorsal muscle of the domestic pig at 45 d, 
while no bone formation could be observed at 30 d At 30 d, 
however, the organic matrix and polymorphic cells on the pore 
surface of the implants and some cells in the pores stained 
positively by bBMP-McAb compared to a negative control. 
 
Calcium phosphate ceramics with the 
same porosity (50%) but different 
chemical constitution (Cl, HA; C2, 
22TCP/78HA; C3, 37TCP/63HA) were 
selected. Ceramic 
rods with the same size (diameter 12 mm] 
8 mm) were used. 
Each ceramic rod was placed in a rubber tube (diameter 
10 mm) and connected in a cycle system in which 10 ml 
bovine BMP solution (300 lg bBMP/ml 4 MGu-HCl) 
circulated at a rate of 50 ml h~1. The bBMP concentration 
in the circulating solution was measured by fluorescene 
specto-photometry (scanning:150-600 nm) at different 
time periods.  After 2 h, the ceramic column with the 
absorbed bBMP was taken out and washed in the cycle 
system with 10 ml distilled water or 0.1% CaCl2 or 
phosphate buffer for 1 h. The bBMP in the evaluate was 
measured by UV-spectrophotometry (scanning: 220-320 
nm). 
Calcium phosphate ceramics had a strong ability to absorb 
bBMP from the solution. At 30 min, a large amount of bBMP 
was absorbed by ceramic rods. In 2 h, most of bBMP in the 
solution was absorbed by the ceramic rods. Among the three 
types of calcium phosphate ceramics, HA has the stronger 
adsorption ability than 22TCP/78HA than 37/68HA .  
 





HA with no microporosity (Mitsubishi); 
HA with microporosity on surface of 
macropores at 2 levels (sintered at 
1100/1200C);TCP/HA (Ca/P=1.60) with 
microporosity; a-TCP with microporosity; 
B-TCP with microporosity; Calcium 
phosphate cement (mixing powders 
containing a-TCP, DCPD and a small 
amount of HA with phosphate solution 
containing N+  and K+); TiO2 with 
microporosity. All implants except 
All materials were implanted into the dorsal muscle 
(excluding the cement paste which was implanted in the 
thigh muscle) and retrieved at 30; 37; 45; 60; 90; 150; 180  
days 
No bone formation was found in any implants of HA without 
micropores, TiO2 ceramic and a-TCP. Only bone-like tissue 
could be detected in HA sintered at 1200degC at 90 and 180 
days, while bone formation could be found in HA sintered at 
1100 degC as early as 30 days. Bone formation could be found 
at 45 d post-operatively in TCP/HA. Bone formation could 
also be found in pores and deep rugged surface of cement, 
both implanted as prehardened form and paste. Bone 
formation in b- 
TCP started before 45 d, while, at longer time implantation, 
the induced bone in b-TCP ceramic demineralized at the 
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cements were rods (3.5 mm x 8.5 mm to 5 
mm x6 mm) 
interface between bone tissue and ceramic. Factors impacting 
Osteoinduction noted as: Microporosity; sintering 
temperature; rate of dissolution; porosity; CaP 
 
A bonding osteogensis process, in which the osteogenic 
precursor cells became attached to the pore surface, 
aggregated, proliferated, differentiated, produced bone matrix 
and ossified, could be observed in calcium phosphate-induced 
osteogenesis. Bone formation started from the pore surface 
and proceeded to the pore center; the induced bone bonded to 
calcium phosphate materials and no chondrocyte could be 
detected during the osteoinduction. 
(Yuan, Kurashina 








Hydroxyapatite ceramic rods, 3.5x8.5 mm, 
provided by Mitsubishi average pore size 
of 200µm, a porosity of 70%, and was 
sintered at 1200degC. S-HA: 
Hydroxyapatite ceramic rods, 5x6 mm, 
average pore size 400 µm, porosity 60-
70%, sintered at 1100degC, prepared by 
Sichuan Union University (Chengdu, 
China). S-HA contained interconnected 
microporosity in the walls of the 
macroporosity 
Materials were implanted into 4 dogs. After disclosing the 
dorsal muscles, parallel incisions were made by scalpel in 
the dorsal muscle bundles (longissimus dorsi) and one 
ceramic implant, which was parallel to the muscle 
bundles, was loaded into each incision. Four ceramic rods 
were implanted 
into the dorsal muscles of each dog, two J-HA implants 
and two S-HA implants. 
Bone formation in all S-HA implants (4/4 at 3 months); (4/4 at 
6 months) and no bone formation in any J-HA implants (0/4 at 
3 months), (0/4 at 6 months). Gross observation showed more 
bone at 6 months than that at 3 months in S-HA implants. No 
bone tissue could be histologically detected in all J-HA 
implants at both 3 months and 6 months only fibrous tissues, 
blood vessels and blood cells were in the pores.  
 
Interestingly the author comments that an insufficient number 
of tests were conducted to perform quantitative analysis. 
However, the number of animals tested was 4 and the 
materials were tested in duplicate. 
 





a study in dogs 
HA powder, a-TCP powder and DCPD 
powder were mixed in the desired ratios of 
5 : 55 : 40% (in weight) to obtain calcium 
phosphate cement powder. Cement 
solution consisted of 15.0 g 
K2HPO4.3H2O, 15.0 g NaH2PO4.H2O 
and 70 ml distilled water. The cement 
paste was prepared by mixing the cement 
powder with sterile cement solution in the 
7 male dogs were used in the study. Cement paste was 
implanted in the femora and dorsal muscles of 4 dogs. 2 
animals wee sacrificed after 3 months and 2 after 6 
months. Pre-hardened cement cylinders were implanted 
into the thigh muscles of the remaining dogs. One animal 
was sacrificed at 1, 2, and 6 months post-operation. 
ORTHOTOPIC SITES: 
After 3 months the cement surface had become irregular and 
was covered by bone. In some areas bone tissue had grown 
into the cement. After 6 months there was evidence of 
resorption lacunae. Osteoclast-like cells were present 
containing cement particles. Direct apposition between bone 
and cement was apparent. Cement had undergone chemical 
dissolution. 
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ratio of 2.2 g : 1 ml, 2 min before 
implantation. 
INTRAMUSCULAR SITES: 
At 1 month macrophages were attached to the surface of the 
cement. At longer time-periods giant cells containing cement 
particles were observed.  Bone formation was seen on the deep 
rugged surfaces of the cements as well as in some pores. Bone 
was in intimate contact with the cement. A seam of secretary 
osteoblasts on the surface of the cement was observed. 
Osteocyte lacunae were also evident with back scattered 
electron microscopy. Bone was not found in all treated defects 
(approximately 50%). The detachment of weakly bound 
cement particles was seen as a short-coming for use in clinical 
practice. 
(Yuan, Yang et al. 
2001) 





Porous glass ceramic, which was prepared 
from Bioglasst powder (45S5, 
U.S.Biomaterials). Pores ranged from 
100–600 µm 
16 healthy adult dogs (1–5 years old, 10–15 kg, 14 male 
and 2 female). A longitudinal incision was made and the 
thigh muscle was exposed by blunt separation. 
Longitudinal incisions were made by scalpel and blunt 
separation, and then the glass ceramic cylinders were 
implanted in the muscle pouches. 
Bone was formed on crystal layers and where pathological 
calcification had occurred. Bone formation was greatest in 
pores where neither of these phenomena existed. The de novo 
bone contained osteoblasts and osteocytes. Bone formation 
was intimate with the surface of the implant and progressed 
inwards into pores. Implant area was 32±4% and bone area 
was 3±2%. Clear morphological distinction between 
pathological calcification and de novo bone formation. No 
Phosphorus was found in the crystallized layers on the surface 
of the material. The excavated centres of Bioglass granules 
provided a nucleation site for mesenchymal cells to 
differentiate into osteoblasts. First reference to the term 
osteoinduction. Bone formation was via the intramembraneous 
route and therefore not related to BMP’s alone. 
(Eid, Zelicof et al. 
2001) 












Particles of various materials:  
HA (250-450/75-250µm), β-TCP (300-
400µm), BCP (HA:TCP 65:35), 
Polyethylene (70-250µm), 
Polymethylmethacrylate (70-250µm) 
Bilateral subcutaneous pockets were prepared by blunt 
dissection over the thoracic area in male rats (28-day-old). 
50mg implants of nrCP, rCPs, PE, or PMMA deposited in 
the cephalad ends of the pockets. Implants were retrieved 
up to 3 weeks later. 
Fibrous reaction to the implantation HA at day 7. Each particle 
was enclosed by layers of fibrous connective tissue. With the 
exception of an occasional multinucleated cell, neither acute 
nor chronic inflammatory cells were evident. No bone or 
cartilage was present. 
 
TCP/BCP generated a fibrous tissue reaction, with TCP 
showing partial resorption after 7 days. The particles were 
surrounded by TRAP-negative foreign body giant cells. 
 
PMMA was surrounded with fibrous tissue and a few foreign 
body giant cells, which were rarely TRAP-positive. 
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Each particle of PE was surrounded by large, multinucleated 
giant cells. The interstitial space was composed of connective 
tissue with small blood vessels and cells resembling 
fibroblasts, mononuclear cells, and occasional 
polymorphonuclear granulocytes. The multinucleated cells 
around PE did not stain strongly for TRAP. 
(Yuan, De Bruijn 




ceramics in soft 






Microporous and Macroporous a-TCP and 
B-TCP sintered ceramic bodies. No details 
as to pore classification data provided. The 
author claims the pore geometries are 
equivalent but the electron micrographs 
appear to show a difference in the quantity 
of microporosity between the two 
materials. 
In four dogs the muscle bundles of longissimus dorsi in 
both sides were disclosed by blunt separation. One 
ceramic rod was inserted into each of two incisions. Two 
a-TCP ceramic rods were implanted in one side and two 
b-TCP ceramic rods in the other side of each dog. 2 
animals at each of 30, 45, and 150 days were sacrificed 
and the implants retrieved. 
No bone formation was observed in any defect treated with a-
TCP at any time point. Macrophages and giant cells were not 
present in large numbers. In the B-TCP implants polymorph 
cells were observed as aggregated in the pores and on the 
surface of the material. After 45 days bone was observed in 
some pores. Bone was in intimate contact with the pore 
surface. Osteoblast and Osteocyte lineage were obvious. At 
150 d, the bone tissues inside the pores of b-TCP implants 
were no longer normal; no bone marrow tissue, no bone 
remodeling process, no osteoblast lineage, even no obvious 
osteocytes could be observed, only a small amount of calcified 
tissue with less osteocytes could be found in the center of 
pores. The tissues between the pore surface and calcified 
tissue seemed to be demineralized bone. Direct bonding 
between bone and b-TCP ceramic was hardly observed at 150 
d. 
 
The author speculates that the dissolution rate of implants 
could affect the rate at which an apatite-like layer is formed on 
the surface of the material, thus affecting the rate of de novo 
bone formation. The author also comments that it is the 
dissolution properties of B-TCP which eventually leads to the 
degeneration of bone in the defect at longer time periods as the 
concentrations of calcium and phosphorus reach a detrimental 
level. 







a 2.5-year study in 
dog 
Two ceramics with macropores between 
100 and 1000 µm in size and micropores 
0.1–10 µm on their macropore surface. 
The HA samples have a macroporosity of 
52 % while BCP has a macroporosity of 
40%. A trace of TCP presents in HA, 
while BCP contains 38%weight TCP. 
1 adult male dog. n=4 of each material was implanted in 
the dorsal muscle of the dog and retrieved 2.5 years after 
implantation. 
All implants were tracelable and none had completely been 
dissolved/remodelled. Mature bone containing osteoblasts, 
osteocytes, and osteoclasts was observed in all treated defects 
apart from ¾ of the a-TCP group. In HA implants 48±4% pore 
area was occupied by bone and in BCP implants bone filled 
41±2% pore area. 
(Gosain, Song et A 1-Year Study of Disc shapes measuring 16.8 mm in 10 adult female sheep. Intramuscular pockets were created There was no bone formation in the cements. 
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al. 2002) Osteoinduction in 
Hydroxyapatite-
Derived 
Biomaterials in an 
Adult Sheep 
Model: Part I 
diameter by 5mm 
Ceramics (45% porous; 200-300µm): 
Interpore and BCP (HA:TCP 60:40) 
Cements (45-55% porous; 2-5nm): 
Bonesource, BCP (HA:TCP 60:40) paste, 
BCP (HA:TCP 20:80) paste 
on RHS and subcutaneous on LHS. All implants were 
retrieved 1 year post-op. Autogeneous bone was harvested 
from the cranium (full thickness) and implanted. 
Mean bone replacement ranged from 6.6±1.4 percent to 
11.7 ± 1.17 percent within both composites of ceramic 
hydroxyapatite implants, with no significant difference in bone 
formation noted between the intramuscular and subcutaneous 
sites. 
(Barrere, van der 





on porous metal 
implants 
Dense titanium alloy (Ti6Al4V surgical 
grade, Smitford Staal BV, The 
Netherlands) and porous tantalum 
cylinders (Hedrocel™, Implex 
Corporation, USA). The OCP coating was 
100% crystalline and was composed of 
octacalcium phosphate crystals [OCP, 
Ca8(HPO4)2(PO4)4 . 5H2O that grew 
perpendicularly to the substrate. The BCA 
coating was 65% crystalline and was 
composed of a carbonate apatite closely 
similar to bone mineral 
14 Dutch milk goats. Grafts were implanted (n=2x2) 
intramuscularly in the spine with 2 un-coated and 2 coated 
implants per side. Implants were retrieved 12 and 24 
weeks post-implantation. 
OCP coatings were all but dissolved in all retrieved implants. 
No bone was found intramuscularly in any of the un-coated 
implants. Only ¼ of the implants contained bone for the OCP-
coated Ti6Al4V (intramembraneous route) whereas ¾ of the 
OCP-coated tantalum cyclinders contained bone at 12 weeks. 
Interestingly at 24 weeks no bone was found but a calcified 
matrix was found. Hedrocel had a higher surface area than 
Ti6Al4V so the author suggests that this led to greater free Ca 
and more BMP adsorption to the surface. 
 
Bone formation not found orthotpically in un-coated Ti6Al4V. 
OCP-coated Ti6Al4V consistently conducted bone right the 
way through the defect. BCA-coated Ti6Al4V only conducted 
bone at the periphery of the defect. 
(Fujibayashi, Neo 




(1) Porous blocks (5x5x7mm3, 
porosity=40–60%, pore size=300–500 µm) 
(2) fibre mesh cylinders (diameter= 
4 mm, length=11 mm, porosity=40–60%, 
pore size=50–450 µm)  
Materials were implanted into the dorsal muscles of 6 
mature beagle dogs for either 3 or 12 months before 
retrieval. 
Bone was only formed in the porous Ti constructs which had 
been thermally and chemically treated after 12 months 
implantation.16.27 ± 7.5% new bone had formed in the pores 
that covered 23.27±5.5% of implant area.  







The material used was a mixture of 
hydroxyapatite (HA) and beta tricalcium 
phosphate (b-TCP) with a weight ratio of 
60/40 % HA/b- TCP, 30 % of 
microporosity of less than 1 micron and a 
specific surface area of the crystal of 
4±0.02 m2/g. The macroporosity was 50 % 
with a range of macropores of 150 to 700 
with a mean of 400 microns (TriositeTM 
Zimmer, MBCPTM Biomatlante, France) 
Small animals (36 Rats and 72 rabbits) and large animals 
(24 dogs, 2 cats). The materials were calibrated cylinders 
or granules implanted in 
subcutaneous areas or in paravertebral muscles. 
No bone formation in any of the rats or rabbits. Bone 
formation was found at 3-7months after implantation in cats 
and dogs. Bone was formed in the centre of the pores. The 
range of bone formation was 1-6%. Bone growth  was related 
to the formation of biological apatite layer on the surface of 
the biomaterial. 
(Habibovic, Yuan 
et al. 2005) 
3D micro-
environment as 
essential  Element 
for osteoinduction 
Porous HA and porous HA/TCP ceramic 
cylinders (4 different groups). 
Macroporosity of between 46-54 (%). 
Mean macropore diameter between 243-
10 dutch goats were implanted (n=10) in the lumbar 
region of the back on the left handside at 0 weeks and 
right handside at 6 weeks and then sacrificed at 12 weeks. 
The author notes that other implants not disclosed in the 
Bone contact of >2% considered measure of effect. Bone 
induction: (BCP1100, BCP1150)4(BCP1200, 
HA1150)4HA1250 (no induction at all). Bone induction in 
individual animals: 42% bone contact in 20% of animals after 
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by biomaterials 380 (µm). Specific surface area of between 
0.07-1.60 (m2/g). Chemical composition: 
88 wt% HA/12 wt% b-TCP in 
BCP versus 100 wt% HA. 
paper were implanted at the same time. 6 weeks and in goats 70% after 12 weeks of implantation. 
Hardly any bone induction in 30% goats. No bone was 
observed on the outside of the implants. Bone formation was 
limited to inside the pores. Significant variation between 
animals. 
 
Interestingly the incidence of bone was reported in the article 
but the absolute volume measured was not, despite being cited 
as being measured. 
(Le Nihouannen, 







particles in sheep 
muscles 
(MBCP) granules of 1–2 mm composed of 
hydroxyapatite and beta-tricalcium 
phosphate (60/40) had 
macropores of 450 (100-600) µm, 
micropores of 0.43 (0.1-0.5) µm, and a 
specific surface area of 1.8 m2/g. Total 
porosity was 70% of which 45% was 
Macroporosity. Macroporosity was not 
always interconnected. 
8 female sheep. Sinus lift augmentation was also 
performed in the same animals. 2cm3 Implants were 
grafted in intramuscular space in the lumbar region. 
Implantation was performed bilaterally. Implants were 
retrieved after 6 months. 
Bone was mature and mineralised and bridged between 
granules in the intramuscular site. Osteocytes were trapped 
within the bone, formed via the intramembraneous route. Bone 
was in direct contact with the MBCP granules surface and was 
present throughout the graft site. A zone with an electron 
density similar to that of mineralized bone, but lacking 
osteocytes and remodelling lacunae, was observed on the 
surface of the MBCP Granules. Author postulates that this 
acellular envelope might be caused by the precipitation of 
biological apatite on the surface of MBCP granules. Ceramic 
and bone density by image analysis 26.9 and 10.2% 
respectively. Ceramic and bone density by Micro-CT analysis 
20.8 and 14.3% respectively. The # and thickness of bone 
trabeculae was similar to natural bone in MBCP treated 
defects. 







in dog dorsal 





The porosity of the block was 75% and the 
surface area was 1.4m2/g. The b-TCP 
block contained macropores of 100–500 
µm and micropores of less than 5 µm. 
Nearly all macropores were interconnected 
via 100–200 mm pores. Five-millimeter 
cubic blocks of b-TCP were used in the 
study. 
Twelve-month-old female beagle dogs were used in the 
study. Materials were implanted in the perivertebral 
muscle in each dog and extracted at 14, 28, 42, 56, 112 
and 168 days post-implantation. 
New bone formed in the implants between 42 and 56 days. 
The TCP area decreased over the time-course from 10.4 to 
2.4mm2. The bone area increased from 0.18 to 0.68%. NB 
bone area was quoted as % of TCP area. 
(Habibovic, Sees 





Porous Biphasic and carbonate apatite 
cylinders (4xBCP and 1xCA groups). 
Macroporosity for all implants was 53-
53%. The macropore diameter of ¾ BCP 
Materials were implanted in 10 goats in the paraspinalis 
muscle by blunt dissection. Subcutaneous implantations 
of the same materials was performed after 8, 10, and 11 
weeks. Animals were sacrificed at 12 weeks and the 
Bone in 9/10 of implants (HA/TCP 80/20) with microporosity 
of 17% and SA of 1m2/g. Bone in 6/10 of implants (HA/TCP 
70/30) with 24% microporosity and SA of 1.4m2/g. No bone 
in any other treatment group or for materials implanted 
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influences groups was 400µm whilst CA group had 
smaller pores and the remaining BCP had 
even smaller pores. Microporosity ranged 
between 4-24% across the groups. Surface 
area ranged 0.2-9.7m2/g. Microporosity 
had a diameter of approx 1µm in all 
groups. 
implants retrieved. subcutaneously. Macroporosity was considered 2o factor as 
increased solubility (SA/TCP content) did not correlate with 
incidence/amount of bone. Macropores in more effective 
material were 400µm whilst macropores in less effective 
material were 100um. Fragments of material were found in the 
less effective group – this coincided with a lack of bone 
formation. This was attributed to a less stable graft and 
micromotion. CA spontaneously dissolved and prevented bone 
formation. Implant size had an effect (larger implants [10mm 
L] performed better than smaller implants [5mm L]). 
Dissolution-precipitation reaction is proposed because there is 
significantly more organic comounds and carbonate found on 
the surface of implants with a higher SA/microporosity. 
(Yuan, van 
Blitterswijk et al. 
2006a) 
A comparison of 





(HA) implanted in 
muscle and bone 
of dogs at 
different time 
periods 
Two ceramics with macropores between 
100 and 1000 µm in size and micropores 
0.1–10 µm on their macropore surface. 
The HA samples have a macroporosity of 
52 % while BCP has a macroporosity of 
40%. A trace of TCP presents in HA, 
while BCP contains 38%weight TCP. 
Ceramic cylinders were implanted in both femurs of dogs. 
Four BCP cylinders were implanted in muscles and 2 
BCP cylinders in femoral cortical bone in one femur; four 
HA cylinders in muscles and 2 HA cylinders in cortical 
bone in the other femur. Animals were sacrificed at 7, 14, 
21, 30, 45, 60, 90, 180, and 360 days after implantation. 
Bone was present after 30 days for BCP (8/8) and 45 days for 
HA (8/8). Bone area increased from 1% at 45 days to 21±4% 
at 360 days for HA. For BCP the bone area increased from 4% 
at 30 days to 34±9% after 360 days. The authors claim that 
osteoinductive potential is reflected in the orthotopic defect 
sites.  
(Habibovic, Yuan 






Biphasic (80%TCP:20%HA) cylinders 
(17x6mm3) of 50-60% Macroporosity; 68 
or 76% total porosity. One group had more 
microporosity (17%/0.7um 
diameter/1.0m2/g) than the second group 
(3%/1.0um diameter/0.2m2/g). 
Materials were implanted in orthotopic (iliac wing) and 
ectopic (paraspinalis muscles) sites of 10 goats. Animals 
were sacrificed at 12 weeks. 
ECTOPIC SITES: 
Bone formed in the more porous implants in all sites after 6 
weeks. Bone area varied considerably between animals (0.05-
6%: mean = 1.5±2.0%). Bone contact also varied considerably 
(0.5-10%=: mean = 2.9±3.8%). No bone was observed in the 
less porous implants. 
 
ORTHOTOPIC SITES: 
Bone was observed in all defects but more was present in 
more porous materials. Bone formation started before 8 weeks 
in porous materials and after 8 weeks in less porous materials. 
No significant diference in bone area (15.2±4.2% vs. 
13.5±5.1%), but a significant difference in bone contact area 
(13.9±3.1% vs.8.1±3.6%). 
(Yuan, van Cross-species Two ceramics with macropores between 8 dogs, 4 rabbits, 8 rats, and 16 mice were included in the Bone incidence in animals dogs (8/8), rabbits (4/4), rats (0/8), 
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100 and 1000 µm in size and micropores 
0.1–10 µm on their macropore surface. 
The HA samples have a macroporosity of 
52 % while BCP has a macroporosity of 
40%. A trace of TCP presents in HA, 
while BCP contains 38%weight TCP. 
study. Materials were implanted in the gluteal muscles of 
dogs, thigh muscles of rabbits & rats, and dorsal 
subcutaneous pouches in the mice. All implants were left 
in situ for 90 days. 
and mice (3/16). For materials retrieved from dogs, bone 
volume was 14±5% in HA implants and 30±6% in the BCP 
implants. Bone volume was only seen in BCP implants in 
rabbits but at <5%. Bone area was quoted normalised to pore 
volume. No bone was seen in any materials implanted in rats 
and only 3/16 materials implanted in mice. Bone found in the 
materials implanted in dogs was mature with trapped 
osteocytes, an osteoblast line, mineralised osteoid and 
osteoclast-like cells.  
(Bodde, 
Cammaert et al. 
2007) 







The total porosity of 
the cement was 59.8%, with a 
macroporosity (pore diameter 
10–300 µm, average 150 µm) of 20.2% 
and microporosity 
(pore diameter <10 µm) of 39.6%. 
Four mature (age 2–4 years) female Saanen goats, 
weighing about 45 kg were used as experimental animals. 
After 3 months only 35% of the graft was remaining after the 
a-TCP phase had completely dissolved. The macrostructure 
was completely lost after this amount of time post-
implantation. There was present a fibrous capsule with few 
inflammatory cells. After 6 months only 25% of the graft 
remained. There was no change to the fibrous capsule of cell 
types observed. No bone or cartilage was observed in any of 
the defects at any time-point. 









Porous Ti6Al4V scaffolds. The diameter 
and space between fibres was 400 µm. 
Porosity was 55%. Permeability, elastic 
modulus, and young’s modulus were 
comparable to cancellous bone. 
Composites of Ti6Al4V and BCP were 
also implanted. Both Ti6Al4V only and 
composite grafts were implanted alone or 
seeded with BMSC. BCP was 80:20 
HA:TCP; 60% porous with macropores 
100-800 microns. Micropores were present 
on the surface sized <10µm 
Ten Dutch goats. Intramuscular defects were created in 
the paraspinalis muscle at T8-L3. Orthotopic sites were 
created on the top of the transverse processes at L4-L5. 
Implants were retrieved and examined after 12 weeks. 
Bone area was normalised for available pore space. 
ECTOPIC SITES: 
No bone formation with Ti6Al4V only scaffolds which were 
filled solely with fibrous connective tissue. 2/10 of the BMSC 
seeded Ti6Al4V implants contained bone. Bone was formed 
between 6-9 weeks (xylenol orange fluorochrome label) in one 
implant and after 9 weeks in the other. In the composites bone 
was preferentially found in the pores of the BCP. For cell-
seeded composites bone was found in 8/10 implants: 
 
3DFT and BMSC 3DFT 2–3% total implant area 
3DFT+BCP and BMSC 3DFT+BCP implants about 8–10% 




3DFT and BMSC 3DFT 2–7% of available pore volume 
3DFT+BCP and BMSC 3DFT+BCP implants about 3–16% of 
available pore volume 
 
Bone formation was prominent at interface between Ti6Al4V 
and BCP components rather than the middle of the BCP 
component suggesting that nutrient and oxygen supply are 
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The brushite surface consisted of 
unreacted particles with a diameter of 10–
20 mm, embedded in a matrix of tabular 
crystals (2–5 mm). The monetite structure 
was similar to that of brushite, however 
the surface contained more micropores 
with a diameter of 10–20 µm. The 
microporosity of brushite and monetite 
was 38% and 44% and the specific surface 
area was 3.60 and 
6.09m2/g, respectively. 
Intramuscular pockets were created in the T8-L3 
paraspinal muscles of goats. Materials were also 
implanted in decorticated regions of T4-T5. A separate 
un-reported material was also screwed to the transverse 
process. Implants were retrieved 12 weeks after surgery. 
Both implant types were considerably resorbed at retrieval. 
Bone incidence was 45% in Brushite implants and 73% in 
Monetite. Generally, a layer of bone with a thickness of about 
100 µm was found in close contact with the implant surface. 
Most bone formed where the implant had resorbed. This was 
in contrast to the pattern of growth in orthotopic sites. The 
bone formed was woven, immature bone. Bone markers were 
only present at 9 weeks, suggesting bone growth starting 
between 6&9 weeks. In some animals markers were not 
present even at 9 weeks, suggesting bone growth after that 
time-point. 
(Fellah, Gauthier 





and bone autograft 
in a goat model 
(MBCP) granules of 1–2 mm composed of 
hydroxyapatite and beta-tricalcium 
phosphate (60/40) had 
macropores of 450 (100-600) µm. 
BCP1050 had micropores of 0.36µm 
diameter, SFA=2.66m2/g and total 
porosity of 65%. BCP1125 had 
micropores of 0.45µm, SFA=1.45m2/g and 
total porosity of 65%. BCP1200 had no 
microporosity, SFA=0.67m2/g and total 
porosity of 55%. 
4 intramuscular sites were created in the paraspinalis 
muscle of goats. Explants were retrieved at 6 and 12 
weeks post-implantation. Materials were implanted within 
a porous PTFE clinder. 
ORTHOTOPIC SITES: 
For BCP1050 the amount of bone increased from 1.01 to 5.6% 
over the period 6-12 weeks. For BCP1125 the amount of bone 
increased from 2.05-9.6% over the same period. For BCP1200 
bone was present only at 0.85-1.5% over the period 6-
12weeks. Graft resrpotion was related to sintering profile and 
microstructure. Graft resorption reduced the graft volume from 
30% to 25% by 12 weeks for all material types. 
 
ECTOPIC SITES: 
No bone formation see in autograft or test articles at any time-
point. 
(Habibovic, Kruyt 
et al. 2008) 
Comparative in 
vivo study of six 
hydroxyapatite-
based bone graft 
substitutes 
 
BCPA = 80:20 B-TCP/HA, 75% total 
porosity, 1.5m2/g;  
BCPB = 80:20 B-TCP/HA, 70% total 
porosity, 0.2m2/g 
BCPC = 70:30 B-TCP/HA, 80% total 
porosity, 1.8m2/g 
BCPC+ = 70:30 B-TCP/HA, 80% total 
porosity, 1.8m2/g (+PLA) 
HA = 80% total porosity, 1.9m2/g 
CA = 80% total porosity, 8.6 m2/g 
 
Intramuscular sites were created in the paraspinalis 
muscles of 12 goats. Orthotpic implantations were also 
performed over decorticated regions of the lumbar spine. 
All anials were euthanized at 12weeks after implantation. 
ECTOPIC SITES: 
Bone incidence: BCPA (9/11), BCPB (0/11), BCPC (9/11), 
BCPC+(4/11), HA (0/11), CA (0/11). 
Bone area of pore: BCPA (2.83), BCPC (2.80), BCPC+ (0.54) 
Bone markers were only evident after 6 weeks implantation. 
 




Biphasic (80%TCP:20%HA) of 50-60% 
Macroporosity; microporosity (17%/0.7um 
diameter/1.0m2/g)  
Materials were implanted in the paraspinalis muscles of 8 
goats. Posterolateral fusions were also performed over L1-
L2 and L4-L5. Materials were retrieved 12 weeks post-
implantation. Half of the materials were seeded with cells 
8/8 of cell-seeded implants grow bone in the ectopic defect 
sites. 4/8 of control (un-seeded) implants grew bone in ectopic 
sites. All samples were well vascularised. In animals treated 
with cell-seeded implants bone markers were evident at 4 
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cultured from bone marrow aspirate. weeks whereas in animals treated with control implants the 
marker was evident until 8 weeks post-implantation. There 
was very little effect of cell-seeding when the same materials 
were implanted in the PLF location. 








with a fractured 
fibula 
Biphasic (60%HA:40% TCP) of 50% 
porosity, with pores 300-500 microns. 
SEM images seem to show low level of 
microporosity in the surfaces of the 
macropores. 
In 30 mice the left fibula was fractured and materials 
implanted in both the left and right leg muscles (groups 1 
and 2). In a further 15 mice the materials were implanted 
subcutaneously in bilateral pouches (group 3). Implants 
were retrieved at weeks 2, 4, 6, 8, and 12. 
No bone was found in any of the subcutaneous defect sites. 
Bone formed in the muscle pouches of the uninjured legs after 
8 weeks. Bone formed in the muscle pouches of injured legs 
after week six. At week 6 the percentage was 6.7 ± 1.25 in 
group 1; at week 8 the percentage was 35.8 ± 1.65 in group 1 
and 8.5 ± 0.98 in group 2; at week 12 the percentage was 42.6 
± 1.86 in group 1 and 35.8 ± 1.32 in group 2; no new bone 
tissue was observed in group 2 at week 6 or in group 3 at any 
time point.  
(Barradas, Yuan 
et al. 2012) 
The influence of 




ceramics in mice 
HA sintered at 1250oC; BCP sintered at 
1150oC and 1300oC; TCP sintered at 
1050oC. All machined to 4x4x4mm 
blocks. 
Subcutaneous implantation in mice of varying strains. 












Implants were retrieved 12 weeks after implantation. 
Bone formation only detected in FVBand 129S2 strains.Bone 
was mostly observed at the periphery of the implanted ceramic 
block, but in contact with the scaffold.Bone formation was via 
intramembraneous pathway as eveidenced by osteocytes 
trapped in osteoid. Bone marrow filled cavities. No 
observations for endochondral bone formation or cartilage 
formation. Incidence of bone formation was 6/6 for FVB and 
4/5 for 129S2.  
 
Bone architecture in the treated animals (bone volume; 
connectivitydensity; structural model index; trabecular 
separation; trabecular thickness) was found to be equivalent 
across FVB and 129S2 groups. 
 
Supplemental VEGF did not induce more bone formation. 
 
The study concludes that the genetic background of the 
individuals is a key element in the osetogenic response to 
synthetic materials. 
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